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Progress towards a concise total synthesis of subincanadine E is reported.  This 
natural product was first isolated from the Picralima nitida cell suspension culture line in 
1982 under the name pericine and later in 2002 from Aspidosperma subincanum as 
subincanadine E.  It is the most potent compound of its class with in vitro cytotoxicity 
against both murine lymphoma L1210 and human epidermoid carcinoma KB cells (LD50, 
0.3 µg/mL and 4.4 µg/mL, respectively) and was found to be six times more potent than 
codeine as an opiate agonist in a 3H-naloxone binding study (IC50, 0.6 µmol/L). 
The first-generation synthesis produced an undesired internal olefin that, upon 
attempted isomerization, catalyzed an unusual intermolecular Diels-Alder reaction.  A 
revised second-generation synthesis employed (±)-harmicine and showcased an 
intramolecular Pd-catalyzed cross-coupling reaction that furnished an unanticipated 5-
membered ring instead of the predicted 6-membered ring via methylene linker activation.  
Further studies utilizing an amide intermediate and organocuprate chemistry produced no 
desired carbon-carbon bond formation. 
A third-generation synthesis was carried out from enantiopure (S)-carvone.  This 
route explored regioselective oxime formation and protecting group manipulations for a 
subsequent Beckmann rearrangement, which provided the first access to 5-amino 
derivatives of carvone.  An intramolecular Pd-catalyzed cross-coupling reaction was 
performed to construct the aza-bicycle prior to indole installation.  Contingent on its 
success, indole introduction and a double alkylation would provide an akuammicine-like 
scaffold that can ring-open upon hydride exposure to afford (15S)-subincanadine E in 16 
overall steps.  This work accomplished 10 steps toward the first total asymmetric 
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 The indole alkaloids1 of the stemmadenine type present an interesting scaffold to 
the synthetic chemist, featuring impressive pharmacological activity and structural 
complexity.  Pericine (5a, Figure 1.2) was first isolated from Picralima nitida cell 
suspension cultures by Joachim Stöckigt in 19822 and later by Kobayashi and 
coworkers from the bark of a Brazilian medicinal plant Aspidosperma subincanum 
Mart in 2002,3 under the name subincanadine E.  It was obtained as a light yellow oil, 
with [!]D +45 (c 0.20, CHCl3).4  This compound, and its N-oxide, was also found in the 
stem-bark extract of the Malayan Kopsia arborea along with valpericine 8, the first 
                                                
1  For reviews of indole alkaloids, see: (a) Kam, T.-S.; Lim, K.-H., Chapter 5 Condylocarpine, 
Stemmadenine, and Akuammicine Alkaloids.  In The Alkaloids, Cordell, G. A., Academic Press: 2008; Vol. 
66, pp 12-19. (b) Gul, W.; Hamann, M. T. Life Sciences 2005, 78, 442-453. (c) Ishikura, M.; Abe, T.; 
Choshi, T.; Hibino, S. Natural Product Reports 2013, 30, 694-752. (d) Fischer, J.; Ganellin, C. R., Chapter 
8 Monoterpenoid Indole Alkaloids, CNS and Anticancer Drugs. In Analogue-Base Drug Discovery, Nemes, 
A., Wiley-VCH Verlag GmbH & Co. KGaA: 2010; Vol. 2, pp 189-215. (e) Joule, J. Chapter 4 Indole 
Alkaloids. In The Alkaloids, Saxton, J. E., The Chemical Society: 1974; Vol. 4, pp. 280-321. (f) Facchini, P. 
J. Chapter 1 Regulation of Alkaloid Biosynthesis in Plants. In The Alkaloids: Chemistry and Biology, 
Cordell, G. A., Elsevier: 2006; Vol. 63, pp 1-44. (g) Takayama, H.; Sakai, S.-I., Chapter 11 Monoterpenoid 
Indole Alkaloid Syntheses Utilizing Biomimetic Reactions.  In The Alkaloids, Cordell, G. A., Academic 
Press: 1998; Vol. 50, pp 415-452. (h). Gribble, G. W. Journal of the Chemical Society, Perkin 
Transactions, 2000, 1, 1045-1075. (i) Hesse, K.; Schmid, H. Lloydia 1971, 34, 269-291. (j) For indole-
containing natural products, see: Nicolaou, K. C. Snyder, S. A. Classics in Total Synthesis II; Wiley-VCH: 
Weinheim, 2003; Chapters 5, 8, 12, 18, 19, 20, and 22, pp. 169. (k) For an overview of indole synthesis and 
reactivity, see: Sundberg, R. J. Indoles; Academic Press: San Diego, 1996; pp 175. 
 
2  Arens, H.; Borbe, H. O.; Ulbrich, B.; Stöckigt, J. Planta Medica 1982, 46, 210–214. 
 
3  Kobayashi, J.; Sekiguchi, M.; Shimamoto, S.; Shigemori, H.; Ishiyama, H.; Ohsaki, A. Journal of 
Organic Chemistry 2002, 67, 6449-6455. 
 
4  Yee, L. Y. (2008). Biomimetic Partial Synthesis of Some Indole Derivatives. Unpublished doctoral 




pentacyclic indole alkaloid of the pericine type.5  Summarized in Figure 1.1 and Figure 
1.2 are subincanadines A-G isolated from A. subincanum6 and the pericine type 





Figure 1.1 Structures of subincanadines A-G. 
 
 
These monoterpenoid alkaloids of the pericine type range from possessing either 
a one-carbon linker at C6 (apparicine, vallesamine, ervaticine) or a two-carbon 
connection at the indolic 3-position to the aliphatic nitrogen (pericine, valpericine, 
stemmadenine).  The seven novel subincanadines provide interesting architectures, 
ranging from an unprecedented 1-azoniatricyclo[4.3.3.0]undecane moiety 
                                                
5  (a) Lim, K.-H.; Low, Y.-Y.; Kam, T.-S. Tetrahedron Letters 2006, 47, 5037-5039. (b) Lim, K.-H.; 
Hiraku, O.; Komiyama, K.; Koyano, T.; Hayashi, M.; Ka, T.-S. Journal of Natural Products 2007, 70, 
1302-1307.  
 





































(subincanadine A-C and G) to a 1-azabicyclo[5.2.2]undecane (subincanadine D-E) as 





Figure 1.2 Indole alkaloids of the pericine type. 
 
 
 In addition to their structural complexity, preliminary biological studies of the 
subincanadines suggest a number of potential medicinal benefits.  In vitro studies 
discovered both subincanadine E and F exhibit cytotoxicity against murine lymphoma 
L1210 (IC50, 0.3 µg/mL; IC50, 2.4 µg/mL) and human epidermoid carcinoma KB cells 
(IC50, 4.4 µg/mL; 4.8µg/mL, respectively).  This pronounced pharmacological activity 
has not been observed in subincanadines A-D (IC50 > 10 µg/mL).2 
Furthermore, the original isolation paper for subincanadine E in P. nitida cell 




















































analgesic potency.  Subincanadine E displayed inhibition of specific 3H-naloxone 
binding, (IC50, 0.6 µmol/L) and was more potent compared to a structurally similar 
secondary metabolite from the same plant named pericalline, (also known as 
apparicine, IC50, 2.3 µmol/L).  The weak analgesic codeine possesses activity within 
this micromolar range (IC50, 3.6 µmol/L) and comparatively, subincanadine E was six 
times more potent.  This remarkable activity suggests the likelihood of it being an 
opiate agonist in vivo.2 
Moreover, the related 17-nor-subincanadine E isolated from Aspidosperma ulei7 
was discovered to be a potential treatment for erectile dysfunction (ED) when studied 
both in vivo and in vitro (Figure 1.3).8  Studies of its mechanism of action reported 
strong relaxant effects on rabbit corpus cavernosum smooth muscle in vitro by a 
mechanism that may benefit patients who also suffer from cardiovascular problems 




                                                
7dos Santos Torres, Z. E.; Silveira, E. R.; Rocha e Silva, L. F.; Lima, E. S.; Carvalho de Vasconcellos, M.; 
Uchoa, D. E. A.; Braz Filho, R.; Pohlit, A. M. Molecules 2013, 18, 6281-6297. 
 
8 (a) Campos, A. R.; Cunha, K. M. A.; Santos, F. A.; Silveira, E. R.; Uchoa, D. E. A.; Nascimento, N. R. F.; 
Rao, V. S. N. International Journal of Impotence Research 2008, 20, 255–263. (b) Campos, A. R.; Lima 
Jr., R. C.; Uchoa, D. E. A.; Silveira, E. R.; Santos, F. A.; Rao, V. S. N. Journal of Ethnopharmacology 
2006, 104, 240-244. 
 
9 Benvindo, O. D.; Nascimento, N. R. F.; Santos, C. F.; Fonteles, M. C.; Silveira, E. R.; Uchoa, D. E.; 





Figure 1.3 (±)-17-nor-subincanadine E. 
 
 
 The challenging framework of subincanadine E in addition to possessing the 
greatest potency among its class, prompted us to put forth a synthetic plan toward its 
total synthesis.  To date, (±)-subincanadine E has been successful constructed once with 
no published proceedings on its asymmetric total synthesis.10  In Chapter One and Two, 
we wish to provide a detailed account of synthetic studies toward the synthesis of (±)-
subincanadine E.  Chapter Three will describe efforts toward the first asymmetric total 










                                                








1.2. Previous total syntheses of related indole alkaloids 
 
Though the main architecture of several pericine type varieties had been 
constructed,11 surprisingly the total synthesis of only (±)-apparicine,12 (")-subincanadine 
A-B,13 and (±)-subincanadine F14 had been successfully completed prior to the 
commencement of this work.  This section will highlight the total synthesis of the 
aforementioned natural products as well as the recently synthesized subincanadine E and 








                                                
11  (a) Pentacyclic framework of subincanadine B: Liu, Y.; Luo, S.; Fu, X.; Fang, F.; Zhuang, Z.; Xiong, 
W.; Jia, X.; Zhai, H. Organic Letters 2006, 8, 115-118. (b) Tetracyclic core of subincandine F: Solé, D.; 
Bennasar, M.-L.; Jimenez, I. Synthetic Letters 2010, 6, 944-946. (c) Ring skeleton of apparicine: Scopes, D. 
I. C.; Allen, M. S.; Hignett, G. J.; Wilson, N. D. V.; Harris, M.; Joule, J. A. Journal of the Chemical 
Society, Perkin Transactions 1977, 2376–2385. (d) Joule, J. A.; Allen, M. S., Bishop, D. I,; Harris, M.; 
Hignett, G. J.; Scopes, D. I. C.; Wilson, N. D. V. Indole and Biogenetically Related Alkaloids; Phillipson, J. 
D.; Zenk, M. H., Eds; Academic: London, 1980, pp. 229–247. (e) For biological activity sustaining the 
pharmacophore of the indole moiety, see: El-Subbagh, H.; Wittig, T.; Decker, M.; Elz, S.; Nieger, M.; 
Lehmann, J. Archiv der Pharmazie 2002, 9, 443-448. 
 
12  (a) Bennasar, M.-L.; Zulaica, E.; Solé, D.; Alonso, S. Chemical Communications 2009, 23, 3372-3374. 
(b) Bennasar, M.-L.; Zulaica, E.; Solé, D.; Toca, T.; García-Diaz, D.; Alonso, S. Journal of Organic 
Chemistry 2009, 74, 8359-8368. 
 
13  Suzuki, K.; Takayama, H. Organic Letters 2006, 8, 4605-4608. 
 
14 Gao, P.; Liu, Y.; Zhang, L.; Xu, P.-F.; Wang, S.; Lu, Y.; He, M.; Zhai, H. Journal of Organic Chemistry 




 1.2.1 (±)-subincanadine E    
 
The synthesis of (±)-subincanadine E was published very recently by Zhai and 
coworkers10 and consisted of a Ni(COD)2-mediated intramolecular Michael addition as 
the key assembly, originally employed in the group’s synthesis of (±)-subincanadine C.15  
The retrosynthetic analysis is shown in Scheme 1.1.  A final zinc-mediated fragmentation 
reaction of 15 installed the final 1-azabicyclo[5.2.2]undecane ring system to furnish the 
natural product.  Kobayashi previously suggested intermediate 5a could be 
biosynthetically derived from 3 and the authors were the first to provide evidence that 3 
could be a synthetic precursor to 5a through radical intermediate 20 (Scheme 1.2).2 
 
 
Scheme 1.1 Retrosynthesis of Zhai’s total synthesis of (±)-subincanadine E. 
 
 
                                                






































This sequence was the first to demonstrate a zinc-mediated fragmentation 
reaction of a quaternary ammonium salt utilized during the total synthesis of an alkaloid.  
Pentacyclic 15 was accessed through a double bromination and intramolecular 
ammonium formation of diol 16, where both diastereomers were taken through the 
sequence independently in a one-pot, three-step process.  Interestingly, utilizing CBr4 
/PPh3/NEt3 as brominating reagents instead of LiBr only furnished the desired ammonium 
salt when using the cis-diastereomer of 16 and did not deliver the pentacylic ammonium 
when employing the trans-adduct under the same conditions.  Intramolecular Michael 
addition of ester 17 using Ni(COD)2 provided the tetracyclic framework, which can be 
generated through a Pictet-Spengler condensation of tryptamine salt 18a with 19 prior to 
alkylation and further manipulation of the two ester functionalities.  This synthetic 
sequence provided (±)-subincanadine E in ten operations from tryptamine hydrochloride 
in overall high yields.  In addition to the use of nearly 5 equivalents of Ni(COD)2, a 
major drawback of this synthesis is an almost 1:1 dr resulting from the Michael addition 
that necessitates proceeding through the final series of transformations independently, 
only to lead to a racemic mixture.  The authors are currently investigating an asymmetric 






                                                
16 For synthetic details, see scheme in reference 15 in: Tian, J.; Du, Q.; Guo, R.; Li, Y.; Cheng, B.; Zhai, H. 
Organic Letters 2014, 16, 3173"3175. 
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1.2.2 Synthesis of (+)-, (")-, and (±)-conolidine 
 
Conolidine was isolated in 200417 from the flowering tropical plant 
Tabernaemonta divaricata and has been used extensively in traditional medicine for the 
treatment of fever and pain.18  Due to its scarcity within the plant, no medicinal 
evaluations were conducted on conolidine, though more abundant alkaloids common to 
this species had implicated analgesic activity.19  Micalizio and coworkers were motivated 
by its drug-like structure and devised a total synthesis that ultimately discovered its 
efficacy as a non-opioid analgesic in an in vivo model (Scheme 1.3).20   
 
                                                
17 Kam, T.-S.; Pand, H.-S.; Choo, Y.-M.; Komiyama, K. Chemistry and Biodiversity 2004, 1, 646–656. 
 
18 Pratchayasakul, W.; Pongchaidecha, A.; Chattipakorn, N.; Chattipakorn, S. Indian Journal of Medical 
Research 2008, 127, 317–335. 
 
19 Ingkaninan, K.; Ijzerman, A. P.; Taesotikul, T.; Verpoorte, R. Journal of Pharmacy and Pharmacology 
1999, 51, 1441. 
 
20 Tarselli, M. A.; Raehal, K. M.; Brasher, A. K.; Streicher, J. M.; Groer, C. E.; Cameron, M. D.; Bohn, L. 



















This synthesis was based on the reported biosynthetic pathway from 
stemmadenine to vallesamine put forth by Kutney21 and later realized in vitro by Scott 
(see Section 1.3 for biomimetic details).22  In a similar fashion, the imminium ion was 
generated with paraformaldehyde and underwent cylization of the more stable conformer 
22a through minimization of A-1,3 strain.  Precursor 23, kinetically stabilized from the 
stereochemistry of the exo-olefin, was accessed through protecting group removal and 
                                                
21 Kutney, J. P. Heterocycles 1976, 4, 429-451. 
 













































oxidation of 24.  This stereoisomeric mixture of alcohols was obtained through oxidation 
of 27 and addition of organolithium reagent 25.  A [2,3]-Wittig rearrangement from the 
conversion of allylic alcohol 28 to its corresponding stannylmethyl ether with subsequent 
expose to n-BuLi, favoring formation of the desired (E)-olefin.  The sequence originated 
from pyridine 29 after N-alkylation and hydride reduction, concluding the route after 8 
steps with an 18% yield overall.   
Following the successful preparation of racemic conolidine, the group sought to 
complete an asymmetric synthesis from optical enrichment of 28 (Scheme 1.4).  
Commercially available lipases furnished the enriched substrates 28a and 28b (both with 
>90% ee).  Either enantiomer of conolidine was delivered and required only a 
modification of the original route to a Parikh-Doering oxidation on carbinol 24 to prevent 
racemization.   
Since this compound was determined to possess pharmacological activity and is 
structurally similar to subincanadine E, we believe a biomimetic relationship could exist 
between the two.  Despite the fact that they were isolated in separate species, Scheme 
1.14 in Section 1.3 (page 27) outlines our proposal for the formation of conolidine from 















1.2.3 Synthesis of  (±)-, and (+)-subincanadine F 
     
The first reported total synthesis of (±)-subincanadine F was completed by Zhai 
and coworkers.  The route was a six step sequence that involved a SmI2-mediated ring 
opening to a bridge-containing tetracyclic core followed by an acid-mediated Mannich 
reaction (Scheme 1.3).11  Full deprotection of 30 to arrive at subincanadine F proved a 
laborious endeavor.  It was anticipated that a Lewis acid, oxidant, or base would remove 
the PMB group, however the desired product was only obtained in the presence of HCl to 
simultaneously N-deprotect and decarboxylate in an optimized 28% yield.  The (E)-
ethenyl appendage was introduced on 31 in hopes that the pendant protecting groups 
























of 10:1.  Skeletal rearrangement required introduction of a 1-carbon linker to form the 
tetracycle, which was accessed through SmI2-mediated disconnection of the C/D ring 
junction.  Intermediate 33 was efficiently constructed in a 1-step process via a Pictet-
Spengler cyclization following tryptamine condensation with the requisite ketoester 34.  
 
 





Three years later, a protecting-group-free total synthesis was reported by Li and 
coworkers in 7 steps from commercially available tryptamine in a 33% overall yield 
(Scheme 1.6).23  Similar to the previous synthesis, a late-stage (E)-ethenyl addition was 
promoted by using TiCl4 with i-Pr2NEt as the base which gave none of the (Z)-isomer.  
Using two equivalents of t-BuOK, a chemoselective Dieckmann condensation of 36 
                                                














































ensued prior to deesterification of 35, taking advantage of steric control since the 
alternative condensation would demand the generation of a sterically congested 
quaternary center.  Tricyclic compound 37 underwent a Michael addition with methyl 
acrylate and was readily assembled from the skeletal rearrangement of 38 followed by a 
subsequent reduction.  An initial Pictet-Spengler condensation of tryptamine and 
bromopyruvate began their synthetic route.  This route provided an advantageous 
incorporation of the 1-carbon linker at C14 without the need to break and reform a ring 
and avoided the inefficient protecting group removal seen in Zhai’s synthesis.    
 
 














































A more recent asymmetric approach by the Li group assigned absolute 
stereochemistry of (+)-subincanadine F (Scheme 1.5).24  Comparable to their previous 
route, an initial double N-conjugate addition on (+)-tryptophan and a Dieckmann 
condensation afforded 42.  Following benzyl ester formation, a number of oxidative 
conditions were screened, anticipating that the ester group would control 
stereoselectivity.  The uncommon 7-endo-trig ring closure resulted with Cp2FePF6 and t-
BuOK (favored due to the radical-stabilizing effect of the phenyl group)25 without the 
need of a protecting group on the indole nitrogen and with no evidence of 6-exo-trig 
cyclization.  Cleavage of the two ester groups was achieved in the usual manner, though 
employment of a methyl group in place of a benzyl group on compound 41 led to 
decomposition, presumably through enhanced electrophilicity of the ketone due to ring 
strain.  The authors utilized an identical ethylenation as their racemic route to produce the 








                                                
24 Chen, P.; Cao, L.; Tian, W.; Wang, X.; Li, C. Chemical Communications 2010, 46, 8436-8438. 
 
25 (a) Liu, F.; Liu, K.; Yuan, X.; Li, C. Journal of Organic Chemistry 2007, 72, 10231-10234. (b) Chen, P.; 









Finally, the Waters group published the most current total synthesis of (±)-
subincanadine F in 2010 (Scheme 1.6).26  Use of a titanium-mediated intramolecular 
nucleophilic acyl substitution strategy offered the natural product in 7 steps (Scheme 1.6).  
A 6-exo-trig ring closure between the organotitanium moiety and the neighboring ester 
functionality of intermediate 45 provided the requisite (E)-geometry.  The group has 
described an in situ generation of the titanacyclopropene species from Ti(Oi-Pr)4 and 2 
equivalents of i-PrMgCl with alkyne 46 to directly furnish the exo-ethenyl appendage and 
therefore obviated the need for a late-stage installation (as seen in corresponding 
syntheses carried out by both Zhai11 and Li13,14).  The titanium chemistry originated from 
                                                
















































Kulinkovich27 and was later applied to the construction of several N-heterocyclic 
compounds, described by Sato.28  The Nb-butynyl derivative of indoloazepine 46 was 
conveniently obtained from a modification of Kuehne’s protocol from tryptamine, methyl 
chloropyruvate, and butynyl mesylate in 4 steps (See reference 16 and those therein).  
Distinct from previous syntheses, this route efficiently closed the bridged-fused ring 
system with concurrent installment of the olefin moiety.  This avoided an E/Z mixture 
and prevented further functional group manipulation.  
 
 





                                                
27 For reviews, see: (a) Kulinkovich, O. G. Pure and Applied Chemistry 2000, 72, 1715–1719. (b) 
Kulinkovich, O. G.; de Meijere, A. Chemical Reviews 2000, 100, 2789–2834.  
 
28 (a) Okamoto, S.; Iwakubo, M.; Kobayashi, K.; Sato, F. Journal of the American Chemical Society 1997, 
119, 6984–6990. (b) Okamoto, S.; Kasatkin, A.; Zubaidha, P. K.; Sato, F. Journal of the American 




































1.2.4 Synthesis of (")-subincanadine A and B 
    
 Zhai was the first to construct the main framework of (±)-subincanadine B8a by a 
route that featured similar methods as Li’s synthesis of (±)-subincanadine F (shown in 
Scheme 1.4).  Shortly after this, Takayama and coworkers reported the total synthesis of 
(")-subincanadine B as well as (")-subincanadine A from (S)-malic acid.10  Although 
Zhai achieved the core in only 4 steps, Takayama’s asymmetric synthesis required 16 
steps for both A and B with an overall 2.7% and 6.8% yield, respectively.  The synthesis 
hinged upon a concluding intramolecular Nozaki-Hiyama-Kishi coupling of enantiomer 
51 using NiCl2 and CrCl2 to furnish diastereomers 50 in and 49 in a 2:3 ratio.29  Each 
compound was taken on independently through a deprotection and mesylation to close 
the final ring, affording each respective natural product target as the chloride salt.  All 
spectroscopic and optical properties were identical to the isolated of (")-subincanadine A.  
Spectroscopic data was identical for subincanadine B, but optical rotation was opposite 
and thus provided the enantiomer of natural subincanadine B.  This route also featured a 
diastereoselective Pictet-Spengler reaction using TMSCl as a Lewis acid to form a 9:1 
mixture of diastereomers that was recrystallized to isolate 54 as a single diastereomer.  
Selectivity was presumed to occur through an intermediate acylimminium intermediate 
where the indole is presumed to attack the less hindered face (anti to the side chain).  The 
heavy use of protecting-group transformations is one undesirable element throughout this 
synthesis as well as the excessive number of steps (7) to obtain hydroxyl ketone 56.         
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1.2.5 Synthesis of (±)-apparicine 
 
 
Finally, the Alonso group synthesized (±)-apparicine in the most concise route 
of all the total syntheses described (Scheme 1.10).11a  It was first isolated30 from four 
separate Aspidosperma species (A. olivaceum, A. eburneum, A. multiflorum, and A. 
gomezianum) and the enantiomeric (+)-apparicine from a fifth (A. Dasycarpon).31  Its 
core skeleton was constructed in the late 1970s by Joule and coworkers11b-c (void of the 
ethylidene appendage), but proved unsuitable to generate the complete alkaloid.  
Alonso’s 6-step sequence highlighted a final intramolecular Heck reaction which was the 
first example of an (aza)cylooctene ring construction that generated a strained bridge 
system.  Starting material was recovered during all screened conditions and required the 
presence of Ag2CO3 in addition to Pd(OAc)2, PPh3, in 1:1 toluene:NEt3 to obtain the 
desired product, albeit in only a 15% yield.  Attempts to improve the yield through indole 
nitrogen protection were unsuccessful.  The 8-membered ring 60 was envisioned to arise 
from diene 3 through a RCM and subsequent olefin isomerization.  Unfortunately, this 
led to dimeric products as a result of intermolecular metathesis, isomerization of the 
terminal double bond, or ring-contraction to 67 through coupling of isomerized olefin 66 
to liberate propene (Figure 1.4).   
 
                                                
30 (a) Part XLVII, Ohashi, M.; Joule, J. A.; Gilbert, B.; Djerassi, C. Experientia 1964, 20, 363-364. (b) 
Gilbert, B.; Duarte, A. P.; Nakagawa, Y.; Joule, J. A.; Flores, S. E.; Brissolese, J. A.; Campello, J.; 
Carrazoni, E. P.; Owellon, R. J.; Blossy, E. C.; Brown Jr., K. S.; Djerassi, C. Tetrahedron 1965, 21, 1141-
1166. (c) Van Der Heijden, R.; Lamping, P. J.; Out, P. P.; Wijnsma, R.; Verpoorte, R. Journal of 
Chromatography 1987, 396, 287-295. 
 









The problematic terminal alkene was avoided by employing the less crowded 
diene 63, which was easily obtained from a Friedel-Crafts formylation, reductive 
amination, and protection of 1-(phenylsulfonyl)indole.  Grubbs’ second-generation 
catalyst cleanly furnished the desired RCM product 62, and upon t-BuOK exposure, 
isomerization of the double bond and deprotection of the indole nitrogen occurred in one 




































Figure 1.4 Resultant RCM products of compound 61. 
 
 
Due to complications with protecting group manipulation and coupling 
conditions, the group published a more thorough discussion of apparicine’s total 
synthesis several months later.11b  They outlined the inflexibility of the protecting group 
on 60, noting that Boc and Ts would lead to decomposition under most deprotecting 
conditions, eventually relying on a mild Boc removal using 1.2 M HCl.  An alternative 
route to 60 installed the trisubstituted double bond required for the Heck reaction from a 
ketone handle (Scheme 1.9).  They originally examined dehydration conditions of the 
tertiary alcohol 71 from MOM-protected substrate 72.  Less than a 10% yield of 60 
resulted, conceivably from competitive indole deprotection.  A more efficient approach 
was routed through the free indole 70 to arrive at 60 in a 26% yield over four steps.  
























1.3 Biomimetic extension to other natural products 
 
Kutney was the first to suggest a biosynthetic relationship between 
stemmadinine and its 5-nor-indole derivatives, vallesamine and apparicine.19  He 
provided evidence in feeding studies that tritium-labeled tryptophan was a precursor to 
apparicine and discovered that C5 of tryptophan was lost while C6 was retained (Scheme 
1.3.1).32  
                                                
32 (a) Kutney, J. P.; Nelson, V. R.; Wigfield, D. C. Journal of the American Chemical Society 1969, 91, 
4278-4279. (b) Kutney, J. P.; Nelson, V. R.; Wigfield, D. C. Journal of the American Chemical Society 


















































A biogenetic pathway from stemmadinine to apparicine was suggested by Potier 
and coworkers, featuring a Potier-Polonovski fragmentation of the N-oxide precursor.33  
Scott and coworkers provided strong evidence for this proposal through the 
transformation of stemmadenine to vallesamine.21  Kutney observed that 
decarboxylation or deformylation to the imminium must occur synchronously with 
fragmentation, since secodine was converted to apparicine with no loss of the 
                                                
33 Potier, P. In Indole and Biogenetically Related Alkaloids; Phillipson, J. D., Zenk, M. H., Eds; Academic 








































methoxycarbonyl group at C16.20  Contrary to this, Scott proved decarboxylation or 
deformylation participation did not need to occur for the fragmentation to take place.  
Furthermore, support for this model was rationalized by the conversion of 
subincanadine E (isolated from K. arborea and assumed to arise from stemmadenine) 
to its respective C5 nor-alkaloid apparicine (Scheme 1.3.2).5  Alternative cleavage of 
the N-oxide to imminium 7 existed in equilibrium with valpericine under protic 
conditions and could be reverted back to subincanadine E through trapping with 
NaBH4.  Morever, this imminium could be trapped with a number of nucleophiles, as 






















Based on the biomimetic routes established, it is proposed that 17-oxo-
subincanadine E (obtained through a retrosynthesis of this work, see compound 5cin 
Scheme 2.2.2) could be a precursor to the related natural products conolobine A and B, 
as well as 17-oxo-valpericine (Scheme 1.3.3).  The imminium (17-oxo-valpericine 8c) 
could be similarly trapped to generate a number of unnatural and potential biologically 
active targets worthy of investigation.  Not only could a number of unique structures 
and related natural products be constructed from subincanadine E, but also further 
















































these indole alkaloid compounds.  Consequently, the extensive in vivo and in vitro 
evidence involving subincanadine E throughout these biomimetic transformations 
proves a sensible pursuit.     
 
 
Scheme 1.14 Proposed biomimetic transformation of 17-oxo-subincanadine E to other 

















































1.4 Retrosynthetic Analysis 
 
 While previous total syntheses of subincanadine type natural products 
demonstrated success and presented noteworthy transformations, each route suffered 
from a combination of low yields, heavy protecting group use, or undesired byproducts.  
Particularly, the only previous total synthesis of (±)-subincanadine E required 10 steps 
and involved a late-stage transformation necessitating the separation of diastereomers, 
only to lead to a racemic mixture of the natural product.  We aimed to provide a more 
efficient approach that pre-installed the ethylidene appendage in the desired E-
geometry while maximizing atom economy through the least number of steps.  Our 
initial investigations explored the utility of an intramolecular Pd-catalyzed coupling 
reaction as an alternative approach to construct the aza-bicylic ring system.  Three such 
sequences have been investigated to date, each showcasing this chemistry while 
differing in the structure of their cross-coupling precursor.   
Herein we report studies toward the first-generation total synthesis of (±)-
subincanadine E.  The retrosynthetic plan outlined in Scheme 1.15 would give rise to 
the natural product in 6 overall steps from tryptamine, providing the shortest total 
synthesis if accomplished.  The major disconnections focused on fragmentation of a 6-5 
fused ring system 91 to the larger 9-membered ring 90 and subsequent closure to a 
[5.2.2]bicycle.  We envisioned a final Pd-catalyzed cross-coupling reaction that would 
appropriately install the external olefin through #-hydride elimination.  We anticipated 
that the requisite internal olefin would be set in the previous step from a ring 
 29 
 
fragmentation reaction of 91.  A Pictet-Spengler reaction and lactam reduction would 
assemble the cyclic amide 92 from commercially available starting materials.  
 
 






1.5 Forward Route 
 
The first-generation synthesis began with the Pictet-Spengler condensation of 
tryptamine and levulinic acid to provide 92 (Scheme 1.16) in a 74% yield after only 
four hours under reflux.  Subsequent reduction using LiAlH4 provided the tetracyclic 
amine framework necessary for an electrophile-induced fragmentation.34   No 
                                                






































purification was required for either step and yields were consistent with literature 
precedence.35        
 
 





Since the pioneering work done by Dolby and Sakai in the early 1960’s, a 
number of reports have been published concerning ring cleavage of tetra- or pentacyclic 






                                                
35 (a) Allin, S. M.; Thomas, C. I.; Allard, J. E.; Duncton, M.; Elsegood, M. R. J.; Edgar, M. Tetrahedron 
Letters 2003, 44, 2335-2337. (b) Ardeo, A.; García, E.; Arrasate, S.; Lete, E.; Sotomayor, N. Tetrahedron 
Letters 2003, 44, 8445-8448. 
 
36 Dolby, L. J.; Sakai, S. Journal of the American Chemical Society 1964, 86, 5362-5363. (b) Wan, A. S. 



























Magnus and coworkers conducted a similar ring opening on a carboxy-
substituted system during the total synthesis of vinblastine and strychnine, encouraging 
the possibility of fragmentation on our methyl-substituted skeleton.37   According to a 
more recent paper published by the Bonjoch group, a similar breakage could be 
accomplished through use of a nucleophilic hydroxide (Scheme 1.18).38  It was 
recognized that the resultant intermediate 96 could then be subjected to elimination 





                                                
37 (a) Magnus, P.; Stamford, A.; Ladlow.; M. Journal of the American Chemical Society 1990, 112, 8210-
8212. (b) Magnus. P.; Giles, M.; Bonnert, R.; Johnson, G.; McQuire, L.; Deluca, M.; Merritt, A.; Kim, C. 
S.; Vicker, N. Journal of the American Chemical Society 1993, 112, 8116-8129. 
 










X = (CH2)n 















Considering the aforementioned strategies, a detailed procedure adapted from 
Bonjoch was conducted.  All trials were unsuccessful in developing either intermediate 
96 or the desired elimination product 90a.  The starting material, however, transformed 
into something new.  Although the more substituted internal olefin was expected to 
form considering kinetic and thermodynamic arguments, in fact the ring-expanded 
external olefin was observed (Scheme 1.19).  A range of additional conditions and 
electrophilic species were screened, including acetic anhydride, trifluoroacetic 
anhydride, and Boc anhydride; all of which produced the undesired external olefin 97a 
(as high as 52%) with no detection of the initial olefin.  It was decided to move away 
































1.5.1 Isomerization efforts 
 
Several references discuss the difficulties encountered on forming the internal 
olefin, concluding that 9-membered rings often possess elevated ring strain and can cause 
formation of exocyclic adducts.39   Exocyclic methylene isomers of various ring size were 
shown to be just as stable as their endocyclic homologues (a thermodynamic argument), 
but in a few cases, they are slightly more stable.40  It was decided that all means of 
forcing the molecule open were exhausted and conformational properties of the ring were 
responsible for its exo-olefin preference.  
                                                
39 Schriesheim, A.; Muller, R. J.; Rowe Jr., C. A. Journal of the American Chemical Society. 1962, 84, 
3164-3168. 
 
40 Mlinari$-Majerski, K.; Vinkovi$, M.; Fry, J. Journal of Organic Chemistry 1994, 59, 664-667. 
 
Na2CO3, CbzCl, THF,




















Because the system exhibited a tendency for promoting the improper olefinated 
compound, it was decided to take advantage of such a clean conversion and successively 
expose the system to isomerization conditions.41  Data supplied on alkylidenecycloalkane 
isomerization specified that maximum %-overlap was required and the isomerization rate 
was highly dependent on this.42  %-overlap, in turn, was a function of ring size, which was 
much greater in large rings, making rehybridization less difficult.38  Therefore, it was 
anticipated that contact with acid might isomerize 97 towards the theoretically more 
stable internal olefin (Scheme 1.20).  Pressing onward, the purified exocyclic isomer 
(with either a Cbz, Boc, or Troc protection group) was then subjected to a number of 
acidic conditions based on comparable literature (p-TsOH, HCl, H2SO4, etc.), but no 
obvious signs of conversion were detected.43    
 
 





                                                
41 For papers on olefin isomerizations, see: (a) Hubert, A. J.; Reimlinger, H. Synthesis. 1969, 97-112. (b) 
Marcos-Escribano, A.; Bermejo, F. A.; Bonde-Larsen, A. L.; Retuerto, J. I.; Sierra, I. H. Tetrahedron, 
2009, 65, 7587-7590. (c) Lim, H. J.; Smith, C. R.; RajanBabu, T. V. Journal of Organic Chemistry 2009, 
74, 4565-4572. (d) Ohta, T.; Ikegami, H.; Miyake, T.; Takaya, H. Journal of Organometallic Chemistry 
1995, 502, 169-176.  
 












Despite these results, an interesting product was consistently formed upon each 
isomerization trial.   The resultant 1H NMR spectrum of every isomerization attempt 
(varying the N-protecting group on the starting material and the identity of the acid 
employed) produced the same spectrum after deprotection (Figure 1.5).  Further 
investigation utilizing LC-MS concluded a molecular (M+1) ion that was twice the 
molecular weight of the desired product.  
 
 
Figure 1.5 1H NMR spectrum of attempted acid-induced isomerization of 97a. 
 
 
This result suggested the formation of a dimer species, potentially resulting from 
an intermolecular cycloaddition (Scheme 1.21).  The indole nitrogen could be protonated 
at C7 to form an S-cis diene 97c primed for intermolecular [4+2] cyclization with the 
external olefin diene 97a to form spiro-centered dimer 98.  The Diels-Alder reaction is a 
documented means of dimeric natural product formation and has been portrayed as a 
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mechanism of their biosynthesis in various cases.44  Additionally, bisindoles often exhibit 
more potent biological activity co mpared to their monomeric counterpart.45  
 
 





An alternative approach was required, void of an external methyl group in the 
starting cycloadduct that consistently would form an external olefin, and consequently 
react to form a dimer complex.  Chapter 2 will detail a second-generation synthesis that 
circumvents this problem through use of harmicine, a tetrahydro-#-carboline that omits 
the troublesome methyl group.  
 
                                                
44 Ichihara, A.; Oikawa, H. Current Organic Chemistry 1998, 2, 365-3954. 
 
45 (a) Wright, C. W.; Allen, D.; Cai, Y.; Phillipson, J. D.; Said, I. M.; Kirby, G. C.; Warhurst, D. C. 
Phytotherapy Research 1992, 6, 121-124. (b) Keawpradub, N.; Kirby, G. C.; Steele, J. C. P.; Houghton, P. 
J. Planta Medica 1999, 65, 690-694. For an indole alkaloid dimerization via oxidation, see: (c) Ishikawa, 





















Chapter 2: Second-Generation Synthesis: Exploration of an Enolate-Driven Pd-
Catalyzed Coupling Reaction  
 
2.1 Retrosynthetic analysis 
 
A second-generation synthesis was proposed, avoiding all problematic 
functionalities through a more reliable means to subincanadine E (Scheme 2.22).  A 
similar disconnect as the previous retrosynthesis was envisioned, in which a variant of 
the palladium-catalyzed intramolecular coupling would prepare the aza-bicycle through 
use of a ketone handle (intermediate 99).  Utilizing an analogous ring opening strategy 
as the first-generation sequence, harmicine 101, a known natural product, could be 
functionalized with the requisite pre-coupling moieties.  Such a material could be 
assembled from a similar condensation of tryptamine with &-butryrolactone.  This 
strategy would install the necessary tetracyclic amine lacking a methyl group from 

















2.2 Forward route 
 
Formation of the starting tetracyclic amine ((±)-harmacine) is a known process 
and proceeded without complication.46  Combining tryptamine with lactone 104 provided 
the amido-alcohol 103 in a 64% yield from which a Bischler-Napieralski reaction was 
concluded (Scheme 2.23).  This step involved a modified exposure of POCl3 as a solvent 
                                                
46 (a) Bremner, J. B.; Winzenberg, K. N. Australian Journal of Chemistry 1984, 37, 1203-1215. (b) 
Szawkalo, J.; Czarnocki, S. J.; Zawadzka, A.; Wojtasiewicz, K.; Leniewski, A.; Maurin, J. K.; Czarnocki, 


















































and a reagent to fuse a 6,5-imminium intermediate.  The solvent was carefully removed 









Given that ring opening procedures are well documented for compounds 
containing a tetrahydro-#-carboline unit (see Chapter 1, Scheme 1.17), the successive 
fragmentation step occurred readily.  Bonjoch’s method was directly applied, treating 
harmacine 101 with benzyl chloroformate and base followed by water to yield the 
protected alcohol 100a (Scheme 2.24).  Exposure to Pd/C and hydrogen gas furnished the 
unprotected amino-alcohol 106.  Ethanol or ethyl acetate must be used as the solvent 































(though this was easily removed in the presence of aqueous acid).47  It was interesting to 
note than although ammonium formate was used for operational ease during smaller-
scale experiments, the substrate did not undergo complete deprotection upon scale-up.  
 
 






Analogous to previous reports, the alkylation step was achieved with (Z)-2-
iodobut-2-enyl methanesulfonate 111, converting the amino-alcohol 106 to its iodo-olefin 
counterpart 112 (Scheme 2.25).48  The alkylating species was prepared separately in three 
steps from crotonaldehyde, whose stereoselectivity was recently improved by Kraft and 
                                                
47 For examples of similar occurrences in the literature, see: (a) Büchi, G.; Manning, R. E. Journal of the 
American Chemical Society 1966, 88, 2532-2535. (b) Büchi, G.; Kulsa, P.; Ogasawara, K.; Rosati, R. L. 
Journal of the American Chemical Society 1970, 92, 999-1005. (c) Gauvin-Hussenet, C.; Séraphin, D.; 
Cartier, D.; Laronze, J.-Y.; Lévy, J. Tetrahedron, 1993, 34, 465-468. 
 
48 Wanner, M. J.; Boots, R. N. A.; Eradus, B.; de Gelder, R.; Van Maarseveen, J. H.; Hiemstra, H. Organic 














0 oC to rt, 1 h, 
then H2O, reflux, 6 h
(71%)













coworkers.49  !-Iodination and NaBH4 reduction50 followed by mesylation provided the 
mesylated (Z)-olefin 11 in excellent yields.51   
 
 





Dess-Martin periodinane was initially prepared and used for oxidation of 112, 
but the reaction was low yielding and a significant amount of the starting material 
remained.  Unsatisfied, an alternative means of oxidation was desired.  Manganese (II) 
dioxide was employed by James Cook to oxidize a similar indole alkaloid scaffold 
                                                
49 See supporting information in: Krafft, M. E.; Cran, J. W. Synthetic Letters 2005, 8, 1263-1266. 
 
50 Loh, T.-P.; Cao, G.-Q.; Pei, J. Tetrahedron Letters 1998, 39, 1453-1456. 
 













1. DMAP, K2CO3, I2,H2O, THF, rt, 3 h109
(45%)
2. NaBH4, MeOH,
0 oC, 3 h
110
(59%)
3. MsCl, NEt3, CH2Cl2,
0 oC, 3 h
(94%)






towards the synthesis of affinine.52  Gratifyingly, employment of this reagent supplied 
the target amino-ketone 99 in a respectable yield (Scheme 2.26). 
 
 





The coupling precursor was completed after a Na-protection using Boc 
anhydride (Scheme 2.27).  Although there was literature precedent for such 
transformations to occur without indole N-protection, precautions were taken at this 
stage in the synthesis to prevent undesired Pd complexation with the secondary amine. 
 
 
Scheme 2.27 Protection of 99. 
 
 
                                                
52 (a) Yang, J.; Rallapalli, S. K.; Cook, J. M. Tetrahedron Letters 2010, 51, 815-817. (b) Stahl, R.; Galli, 




























2.2.1 Enolate-mediated Pd-catalyzed cross-coupling precedent 
 
Presently, there are only a handful of documented applications of the Pd-
catalyzed intramolecular coupling of vinyl halides and ketone enolates completed; the 
most recent concerning indole alkaloid systems.53  The first was performed by Piers, 
who transformed an enone functionality into a methylenecyclopentane fragment 
(Scheme 2.28).54    
 
 
Scheme 2.28 Piers’ ring annulation using a novel Pd-catalyzed vinyl iodide and enolate 





                                                
53 For examples of Pd coupling of vinyl halides and ketones, see: (a) Cao, H.; Yu, J.; Wearing, X. Z.; 
Zhang, C.; Liu, X.; Deschamps, J.; Cook, J. M. Tetrahedron Letters 2003, 44, 8013-8017. (b) Bonjoch, J.; 
Diaba, F.; Puigbó, G.; Peidró, E.; Solé, D. Tetrahedron Letters 2003, 44, 8837-8390. (c) Zhao, S.; Liao, X.; 
Cook, J. M. Organic Letters 2002, 4, 687-690. (d) Zhou, H.; Liao, X.; Yin, W.; Ma, J.; Cook, M. A. 
Journal of Organic Chemistry 2006, 71, 251-259. (e) Zhang, H.; Boonsombat, J.; Padwa, A. Organic 
Letters 2007, 9, 279-282. (f) Boonsombat, J.; Zhang, H.; Chughtai, M. J.; Hartung, J. Padwa, A. Journal of 
Organic Chemistry 2008, 73, 3539-3550. (g) Shen, L.; Zhang, M.; Wu, Y.; Qin, Y. Angewandte Chemie 
International Edition 2008 47, 3618-3621. (h) Solé, D.; Urbaneja, X.; Bonjoch, J. Organic Letters 2005, 7, 
5461-5464. 
 
54 (a) Piers, E.; Marais, P. C. Journal of Organic Chemistry 1990, 55, 3454-3455. (b) Piers, E.; Oballa, R. 














Slow addition of base to a solution of the enone in THF and a Pd(0) source 
initiated formation of the enolate in situ via proton abstraction (see Scheme 1.31 for 
mechanistic details).  Piers was able to demonstrate this cyclization on a range of other 
enone species, including its later application to the total synthesis of (±)-crinipellin B.55  
In 2000, a similar coupling was reported on amino-tethered vinyl halides with 
ketone enolates, creating a bridged framework found in several classes of indole alkaloids 
(Scheme 2.29 depicts optimized conditions).56  A survey of different ligands, bases, and 
solvents was conducted, proving its utility among the formation of nitrogen heterocycles, 









                                                
55 Piers, E.; Renaud, J. Journal of Organic Chemistry 1993, 58, 11-13. 
 
56 (a) Solé, D.; Peidró, E.; Bonjoch, J. Organic Letters 2000, 2, 2225-2228. (b) Solé, D.; Diaba, F.; 
Bonjoch, J. Journal of Organic Chemistry 2003, 68, 5746-5749. (c) Solé, D.; Vallverdú, L.; Solans, X.; 




















The same year, Cook showcased this methodology toward the construction of 
several natural products.  He demonstrated its utility in the first enantioselective total 
synthesis of 3-oxegenated sarpagine indole alkaloids affinine, 16-epiaffinine, 
vobasinediol, and 16-epivobasinediol through a common intermediate 121.46,57  The 
same intermediate was later exploited to generate (+)-vellosimine 123 (Scheme 2.30).58  















                                                
57 Yu, J.; Wang, T.; Liu, X.; Deschamps, J.; Flippen-Anderson, J.; Liao, X.; Cook, J. M. Journal of Organic 
Chemistry 2003, 68, 7565-7581. 
 
58 Wang, T.; Cook, J. M. Organic Letters 2000, 2, 2057-2059.  
 
59 Yin, W.; Kabir, M. S.; Wang, Z.; Rallapalli, S. K.; Ma, J.; Cook, J. M. Journal of Organic Chemistry 
2010, 75, 3339-3349. 
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Cook provided a detailed mechanism50 (Scheme 2.31) for the intramolecular 
enolate-driven cross-coupling reaction in accordance with the neutral pathway,60 
though an anionic pathway would describe the catalytic cycle appropriately.61  As the 
!-vinylation of ketones had only been utilized in a handful of reports compared to !-
arylation, there was little mechanistic information known.  However, it was believed 
that oxidative addition of Pd(0) to the vinyl halide preceded an equilibrium between 
                                                
60 Heck, R. F. Palladium-catalyzed vinylation of organic halides; Dauben, W. G.; Boswell, G. A.; 
Danishefsky, S.; Gschwend, H. W.; Heck, R. F.; Hirshmann, R. F.; Kende, A. S., Paquette, L. A.; Posner, 
G. H., Eds; John Wiley & Sons: New York, 1982, Vol. 27, pp 345-390. 
 














5 mol % 
Pd2(dba)3, 6 mol % 
DPEphos, NaOt-Bu,

















120a R1 = CH2OH, R2 = Haffinine
120b R1 = H, R2 = CH2OH16-epiaffinine
R2
122a R1 = CH2OH, R2 = Hvobasinediol
122b R1 = H, R2 = CH2OH16-epivobasinediol
1. Pd(OAc)2, PPh3, 
TBAB, K2CO3, 
DMF-H2O (9:1),
70 oC, 5 h
(71%)
2. H3COCH2PPh3, 
KOt-Bu, PhH, rt, 24 h; 













124 and its enolate to generate Pd(II) species 125.62  Intramolecular coordination of the 
Pd to the enolate followed by formation of a palladocycle underwent reductive 
elimination to furnish cyclic ketone 121.   
 
 





                                                
62 This differs from Buchwald’s mechanistic proposal during !-arylation in which the ketone first 
coordinates to the Pd center prior to deprotonation.  This increases the acidity of the proton !- to the 
ketone, allowing for employment of weaker bases.  See Scheme 1 therein: (a) Fox, J. M.; Huang, X.; 
Chieffi, A.; Buchwald, S. L Journal of the American Chemical Society 2000, 122, 1360-1370.  Also, see 
Scheme 2 in: (b) Palucki, M.; Buchwald, S. L.; Journal of the American Chemical Society 1997, 119, 































































Analogous studies conducted on the vinyl bromide equivalent of 119, resulted in 
recovered starting material.  Cook proposed that oxidative addition was more facile into 
the C-I bond and slower addition (as compared to the bromine substrate) would lead to 
complexation of Pd(0) with the indole, thus removing it from the catalytic cycle.  
However, no protecting groups strategies were employed on the electron-rich indole to 
decrease catalyst interaction.63  
An improved synthesis toward (+)-macroline and alstonerine published one year 
later revealed more details for the same mechanism.64  If the nucleophilic addition of 
the iodine by the enolate was relatively slow, this would allow time for E2 elimination 
to transpire, providing an alkyne.65  Moreover, (Z)-alkylidenes are oftentimes 
incompatible since #-elimination can occur.52a  After Cook’s initial studies,66 it was 
later revealed that bidentate ligands would provide the highest chance of success due to 
their ability to suppress #-elimination and facilitate reductive elimination.67  These 
conditions also supress the potential intramolecular attack of the vinyl halide on the 
adjacent carbonyl group.   
 
                                                
63 Cook utilized a methyl protection on the indole nitrogen when coupling an iodobutenyl unit only; (a) Yu, 
J.; Wearing, X.; Cook, J. M. Journal of Organic Chemistry 2005, 70, 3963-3979. (b) Zhai, H.; Liao, X.; 
Cook, J. M. Organic Letters 2004, 6, 249-252. 
 
64 Liao, X.; Zhou, H.; Yu, J.; Cook, J. M. Journal of Organic Chemistry 2006, 71, 8884-8890. 
 
65 This can only occur on the (Z)-ethylidene and is prohibited on the (E)-ethylidene since there is no 
hydrogen anti to the iodide. 
 
66 See references 61 and 56-58. 
 





2.3 Coupling results 
 
Built upon the foundation set by Cook, confidence was placed in the ability of 
this method to functionally align with the synthesis of subincanadine E (Scheme 2.32).  
Considerable effort was spent preparing a literature survey of various combinations to 
perform.  Precautions were taken to avoid known side reactions, preventing possible 
dealkylation, elimination, isomerization byproducts, or coordination to the free indole 
nitrogen.   
 
 





A variety of both Pd(II) and Pd(0) sources were employed, with and without the 
use of an external ligand.  The enolizing base was explored in both its strength and the 
identity of the counterion.  Solvents were also varied and additives were tested without 
effectively providing the coupled product.  Table 1.1 summarizes a small sample of the 



















Table 2.1: Highlighted conditions applied to 113. 




1 KOt-Bu Pd2(dba)3 xantphos THF 4 h 130, 83% 
2 NaOt-Bu Pd2(dba)3 BINAP THF 3 h 130, 27% 
3 PhOK Pd2(dba)3 - THF 20 h 130, 60% 
4 PhOK Pd2(dba)3 xantphos THF 20 h 130, 50% 




DMF 12 h 130, 90% 
Conditions B 




DMF 12 h 132, 43% 
Conditions C 
7 NaOt-Bu Pd2(dba)3 xantphos THF 4 h 131, 71% 
8 LHMDS Pd2(dba)3 BINAP THF 3 h 131, 54% 
9 PhOK Pd(PPh3)4 dppe THF 3 h 131, 26% 
Conditions D 
10 KOt-Bu Pd2(dba)3 xantphos THF 4 h 133, 83% 
11 PhOK Pd2(dba)3 - THF 20 h 133, 60% 
12 PhOK Pd(PPh3)4 - THF 12 h 133, 50% 

























Scheme 2.33 illustrates the products that resulted.  Initially, 113 was subjected 
to a combination of each palladium source and base listed in Table 2.1 without the use of 
an external ligand.  This resulted in either recovered starting material or its deprotected 
congener 130.  Solvents were briefly explored, since Cook could only promote coupling 
in a mixture of DMF and H2O.52c  All entries were conducted in this solvent system with 
no evidence of coupling, thus a typical organic solvent with a moderate boiling point was 
commissioned.   
The addition of a ligand was deemed necessary in most related cases in the 
literature and therefore attention was next directed at exploring all possible combinations 
with the ligand and Pd sources in hand.  Deprotected starting material 130 (entries 1-5) or 
dehydrohalogenation (132 or 133, entries 6, and 10-12, respectively) resulted in most 
cases.  However, when xantphos (a large bite angle bidentate ligand) was employed with 
Pd2(dba)3, a coupled product was observed.  After 2D NMR analysis, it was determined 
that a 5-membered aza-bicycle 131 was formed rather than the desired 6-membered ring 
129 (Scheme 2.33).  Additionally, using a smaller bite angle ligand (Scheme 2.34) led to 
a corresponding decrease in the yield of 131 (entries 7-9).  This was true when using 














Interestingly, the identity of some bases employed was important.  Comparing 
entries 7 and 10, NaOt-Bu provided the coupled product 131 whereas KOt-Bu did not 
when all other conditions were held constant, suggesting a possible metal cation effect.   
Surprisingly, milder bases such as PhOK in combination with Pd2(dba)3 (entries 11-12) 
were able to produce alkyne 133.   
Numerous studies also provided insights regarding the sensitivity of the reaction 
to the ratio of Pd to ligand.69  Excess ligand relative to Pd is known to decrease the 
amount of active Pd(0)L2 species present, which would inhibit the oxidative addition 
step.62  A slower reaction rate would lead to more dehydrohalogenation byproduct and 
                                                
68 For reviews on bite angles, see: (a) Birkholz (née Gensow), M. N.; Freixab, Z.; van Leeuwen, P. W. N. 
M. Chemical Society Reviews 2009, 38, 1099–1118. (b) Van Leeuwen, P. W. N. M.; Kamer, P. C. J.; Reek, 
J. N. H. Pure and Applied Chemistry 1999, 71, 1443-1452.  
 
69 For reviews on Pd sources and ligands, see: (a) Tsuji, J. Chapter 1 The Basic Chemistry of 
Organopalladium Compounds in Palladium Reagents and Catalysts: New Prospectives for the 21st 
Century, Tsuji, J., John Wiley & Sons, Inc.: 2004; Vol.1, pp. 1-26. (b) Choueiry, D.; Negishi, E. Chapter 
II.2.3 Pd(0) and Pd(II) Complexes Containing Phosphorous and Other Group 15 Atom Ligands in 
Handbook of Organopalladium Chemistry for Organic Synthesis, Negishi, E., John Wiley & Sons, Inc,: 















a lower yield of the coupled product.  Counterintuitive to this, Cook found that a large 
excess of phosphine was necessary when using a Pd(II) species and the exact mol % 
was substrate dependent.58  The reaction took much longer (3 days) but the amount of 
byproducts was significantly decreased.   
Experimental exploration of varying Pd(0)/ligand ratios on our substrate did not 
affect the yield of 131 to a significant extent (performed on entry 7, Table 2.1).  The 
optimal catalyst loading was found to be 20 mol % Pd2(dba)3 with 15 mol % xantphos 
before the yield began to consistently degrade.      
Lastly, a new method70 reported on a copper-mediated preparation of vinyl 
sulfides encouraged Cook and coworkers to attempt the coupling conditions on system 
119.71  A handful of conditions were attempted, which led to either deprotected starting 
material (Table 2.1, entry 5) or deprotected alkyne (Table 2.1, entry 6).     
To demonstrate viability of the final steps toward subincanadine E, compound 
131 was carried through a deprotection and a concluding Wittig reaction (Scheme 2.35).72  






                                                
70 Kabir, M. S.; Van Linn, M. L.; Monte, A.; Cook, J. M. Organic Letters 2008, 10, 3363-3366. 
 
71 See reference 58 and the mechanism therein. 
 
72 For an example of a Wittig reaction conducted on a similar scaffold, see Scheme 3 in: Srirama Sarma, P. 
V. V.; Cook, J. M. Organic Letters, 2006, 8, 1017-1020 and Yu, J.; Wang, T.; Wearing, X. Z.; Ma, J.; 
Cook, J. M. Journal of Organic Chemistry 2003, 68, 5852-5859. 
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2.3.1 Control experiments 
 
To further probe the nature of the enolate-driven cross-coupling reaction, a 
number of control reactions were considered (Table 2.2).  The reaction was run with only 
base present, which afforded no 5-membered coupled product 131 (entries 1-3) nor was 
formation of alkyne 133 detected.  Exposure to only a Pd source provided full recovery of 
the starting material (entries 4-5).  Finally, entry 6 and 7 also resulted in starting material 
exclusively.  This indicated no 5-membered ring could be produced without the collective 


















THF, 0 oC, 1 h,




Table 2.2: Control experiment conditions. 
Entry Base Catalyst Ligand  Solvent Time Product 
1 KOt-Bu - - THF 18 h 113  
2 NaOt-Bu - - THF 18 h 113 
3 PhOK - - THF 18 h 113 
4 - Pd2(dba)3 - THF 18 h 113 
5 - Pd(PPh3)4 - THF 18 h 113 
6 - Pd2(dba)3 xantphos THF 18 h 113 
7 NaOt-Bu Pd2(dba)3 - THF 18 h 113 
* All temperatures were at a reflux respective to the solvent. 
 
 
 To ensure the enolate was indeed generated during the course of the catalytic 
cycle, a silyl enol ether was synthesized and exposed to equivalent conditions listed in 
Table 1.1 (Scheme 2.36).  The results exactly mirrored its ketone predecessor, differing 
only in the addition of TBAF.73  The same control experiments were completed on 139 
and 139a as well, providing parallel conclusions.  This indicated formation of the enolate 







                                                
73 See reference 55a for an example of a Pd-catalyzed alkenylation with a silyl enol ether as well as: (a) 
Kuwajima, I.; Urabe, H. Journal of the American Chemical Society 1982, 104, 6831-6833. (b) Tsukano, C.; 
Zhao, L.; Takemoto, Y.; Hirama, M. European Journal of Organic Chemistry 2010, 22, 4198-4200. (c) 
Deiters, A.; Chen, K.; Eary, C. T.; Martin, S. F. Journal of Organic Chemistry 2003, 125, 4541-4550. (d) 









 To guarantee all Pd sources were reactive, both Pd2(dba)3 and Pd(PPh3)4 were 
freshly prepared and employed in entries 1, 7, and 9 of Table 1.1.74  Furthermore, the 
purchased reagents were tested in the aforementioned entries using a glove box.  Each 
reaction was reproducible in yield and product identity to the previous tested conditions 




2.3.2 Proposal of mechanism 
 
 Research of the literature revealed that similar transformations failed to undergo 
the desired cyclization.  Bonjoch and coworkers were able to promote coupling of a 
                                                
74 (a) Coulson, D. R. Chapter 4.23 Tetrakis(triphenylphosphine)Palladium(0) in Inorganic Syntheses, 
Cotton, F. A., McGraw-Hill, Inc,: 1972; Vol. 13, pp. 121-124. (b) Backväll, J.-E.; Nyström, J.-E.; 
Nordberg, R. E. Journal of the American Chemical Society 1985, 107, 3676-3686. (c) Zalesskiy, S. S.; 















vinyl iodide and ketone enolate on a model study towards the synthesis of 
strychnopivotine, though the required system for completion of the natural product did 
not support a parallel coupling (Scheme 2.37).75  
 
 





Furthermore, intramolecular cyclization of 9-membered rings was documented 
to be sluggish and prone to side reactions, such as dehalogenation or dimerization 
(neither of which were isolated for this system) and forcing an internalized 6-membered 
ring may have a higher degree of strain than its more precedented 8-membered 
counterpart.76  Additionally, 9-membered rings possess the highest ring strain (12.6 
kcal/mol) of all ring sizes from 5 to 16.77  Since the same iodo-ethylidene appendage 
                                                
75 (a) Solé, D.; Urbaneja, X.; Cordero-Vargas, A.; Bonjoch, J. Advanced Synthetic Catalysis 2004, 346, 
1646-1650. (b) Solé, D.; Urbaneja, X.; Cordero-Vargas, A.; Bonjoch, J. Tetrahedron 2007, 63, 10177-
10184. 
 
76 Ma, S.; Negishi, E. Journal of the American Chemical Society 1995, 117, 6345-6357. 
 
77 Anslyn, E. V.; Dennis A. D. Chapter 2 Strain and Stability in Modern Physical Organic Chemistry, 














has been utilized in analogous transformations, it was believed that the ring size prior to 
bicycle formation imparts geometric constraints that are not present in other systems 




Figure 2.6 Conformation of 113, 119, 142, and their respective enolates. 
 
 
 It was for these reasons that the desired bicycle 129 was regarded as unable to 
form, allowing for a different reaction pathway to ensue.  The undesired bicycle 131 was 
proposed to materialize according to Scheme 2.38.  After standard oxidative addition and 
base-induced enolate formation, #-hydride elimination could occur to generate an 
allene.78  Protonation at this site would provide an imminium, equipped to undergo a 
Mannich reaction with the pendant enolate to provide the undesired 131 as a racemic 
                                                
78 Allenes are known intermediates in many Pd-catalyzed reactions.  See: (a) Asari, A.; Angelov, P.; Auty, 
J. M.; Hayes, C. J. Tetrahedron Letters 2007, 48, 2631-2634. (b) Shigehisa, H.; Jikihara, T.; Takizawa, O.; 







































mixture.        
 
 





 This mechanism rationalizes the formation of the 5-membered ring through 
which a Pd catalyst and a base was required, supporting the control study results (see 
Table 2.2).  However, addition of an external ligand was also necessary and this result 
opposed the presumption (based on literature precedent) that large bite angle ligands 
suppress #-hydride elimination.  In fact, our results indicated larger bite angle ligands 












































obtained in the presence of a larger bite angle ligand.  The control experiments also rule 
out the possibility of alkyne isomerization since base alone does not produce any 
alkyne.  Additionally, the catalytic cycles does not seem to require a strong base for 
enolization but a specific salt indicating a cationic metal effect, since NaOt-Bu 
provided the coupled product and KOt-Bu did not.  This was in accordance with the 
literature where KOt-Bu and a Pd source with or without ligand frequently led to 




2.4 Further Studies 
 
An alternative cyclization was envisioned to mask the seemingly activated 
methylene linker and prevent #-hydride elimination from occurring, allowing a Pd-
catalyzed coupling to transpire.  Inserting a carbonyl at this position would be 
attainable synthetically and inhibit the undesired cyclized product from forming 






                                                









Rotational restrictions about the amide bond may impart the necessary 
geometric conformation such that orbital alignment and therefore coupling would 
ensue.  Both inter- and intramolecular Pd-catalyzed !-arylation of amides is known,80 
though it is mostly limited to lactams or intramolecular couplings of acyclic amides, 
with a few exceptions.81  Intermolecular Pd-catalyzed !-vinylation of amide enolates 
has only been demonstrated on oxindoles and in only one case to date.82  On the 
contrary, intramolecular coupling of a ketone enolate with an amido-vinylhalide has not 
been documented.83 
 
                                                
80  (a) Deppermann, N.; Thomanek, H.; Prenzel, A. H. G. P.; Maison, W. Journal of Organic Chemistry 
2010, 75, 5994-6000. See reference 11 therein. (b) Okita, T.; Osobe, M. Tetrahedron 1994, 50, 11143-
11152. (c) Shaughnessy, K. H.; Hamann, B. C.; Hartwig, J. F. Journal of Organic Chemistry 1998, 63, 
6546-6553.  
 
81 Hama, T.; Culkin, D. A.; Hartwig, J. F. Journal of the American Chemical Society 2006, 128, 4976-4985. 
 
82 Taylor, A. M.; Altman, R. A.; Buchwald, S. L. Journal of the American Chemical Society 2009, 131, 
9900–9901.  
 
83 For an example of an alkene coupled to an amido-vinylbromide, see: Birman, V. B.; Rawal, V. H. 














2.4.1 Amide synthesis 
 
 The proposed amide 147 was formed via ring opening of the common 
intermediate 101 with anhydride 149, providing amido-alcohol 150 in a respectable 
91% yield (Scheme 2.40).  The anhydride was readily synthesized in three steps from 
crotonaldehyde using known procedures (Scheme 2.41).84  Indolylic oxidation and 
protection afforded the coupling precursor 147.   
 
 






                                                
84 Iodination: (a) see reference 48. Pinnick oxidation; Dalcanale, E. Journal of Organic Chemistry 1986, 51, 
















Na2CO3, THF, 0 oC to rt, 
2 h then H2O, reflux, 18 h
(91%)
MnO2, CH2Cl2, rt, 36 h
(91%)
Boc2O, CH2Cl2, 




















All entries listed in Table 2.1 were applied to the amide variant in addition to 
other combinations described in Table 2.3 (Scheme 2.42).  Each attempt resulted in 
either recovery of starting material (entries 1-4) or dehydrohalogenation product 154 
(entry 5).  
 
 














1. I2, DMAP, K2CO3, H2O/THF, rt, 3 h(92%)
2. NaClO2, NaH2PO4, 2-methyl-2-butene,




























Table 2.3 A sample of cross-coupling conditions applied to 147 and 153. 
Entry Base Catalyst Ligand Additive Solvent Product & Yield 





2*  LHMDS Pd2(dba)3 BINAP - THF 
154, 
99% 
3* PhOK Pd2(dba)3 - - THF 
147, 
70% 
4*  NaOt-Bu Pd2(OAc)2 P(t-Bu)3 - THF 
147, 
97% 
5** PhOK Pd(PPh3)2Cl2 - TBACl THF 
154, 
80% 
* Using 147 as the starting material.  ** Using 153 as the starting material. 
  
 
Moreover, the TES-enol ether 153 was synthesized and subjected to a number of 
equivalent conditions, parallel to the amine version 139 in Scheme 2.36 above.  Again, 
the results were consistent with their ketone congener and no evidence of the desired 6-




2.4.2 Conjugate addition 
 
 It was decided to explore other coupling chemistries that could be applied to our 
substrate and accomplish the identical carbon-carbon bond formation.  Switching the 
original electronics of the coupling precursor would impart nucleophilicity to the 
iodocarbon instead.  An intramolecular Michael reaction could occur between a vinyl 
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organometallic species and a tethered !,#-unsaturated ester.  Additionally, such a 
substrate would allow for investigations of %-allyl reductive Heck coupling conditions.   
Fortunately, the known intermediate 158 could be extended to obtain the desired 
functionalities required for a 1,4-conjugate addition to proceed.85  Scheme 2.43 outlines 
the forward route, which was subjected to Bonjoch’s ring opening strategy using 
TrocCl as the electrophile.37  Protecting group removal, alkylation, and indole nitrogen 
protection successfully produced the conjugate addition precursor 160.  t-BuLi 
mediated iodine-lithium exchange followed by the addition of MnCl2 and CuCl would 
convert ester 160 to [5.2.2]-azabicycle 162.  All efforts led to decomposition of the 













                                                
85 (a) Fokas, D.; Wang, Z. Synthetic Communications 2008, 38, 3816-3822. (b) Magnus, P.; Giles, M.; 
Tetrahedron Letters 1993, 34, 6355-6358. 
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The conjugate addition was next attempted on amide 164 to determine if the 
methylene linker was once again problematic (Scheme 2.44).  Tetrahydro-#-carboline 
158 was modified to undergo ring opening directly with anhydride 160 (see Scheme 
2.41 for its synthesis).  Exposure to the copper-mediated coupling conditions provided 
only recovery of starting material and with more equivalents if t-BuLi, a complex 




































9-BBN, THF, 65 oC, 1 h
then diluted in MeOH,
2 M HCl in Et2O, 1 h
(72%)
Na2CO3, TrocCl, THF, 
0 oC, to rt, 1h
then H2O, reflux, 20 h
(50%)




2. K2CO3, THF,rt, 5 h
(96%)
1. Boc2O, CH2Cl2, 
DMAP, rt, 3 h
(71%)
2. t-BuLi, -78 oC, 1 h
3. MnCl2, CuCl2, 


















Other researchers have encountered similar difficulties in their attempts to form 
the C15-C20 bond.  Scheme 2.45 outlines Stork’s system in which closure of the 
piperidine ring proceeded in poor yields and was susceptible to a number of side 
reactions, including HI elimination, loss of the iodobutenyl side chain, and 
deiodination.86  Utilizing greater amounts of lithium not surprisingly provided a 
complex mixture of products.   
 
 
                                                
86 (a) Eichberg, M. J.; Dorta, R. L.; Grotjahn, D. B.; Lamottke, K.; Schmidt, M.; Vollhardt, K. P. C. 
Journal of the American Chemical Society 2001, 123, 9324-9337. (b) Bonjoch, J.; Solé, D. 
Chemical Reviews 2000, 100, 3455-3482. (c) Martin, D. B. C.; Nguyen, L.; Vanderwal, C. D. Journal of 















K2CO3, THF,rt, 5 h
(76%)
Boc2O, CH2Cl2, 
DMAP, rt, 3 h
(98%)
1. t-BuLi, -78 oC, 1 h
2. MnCl2, CuCl2, 

























Toward the total synthesis of vincorine, Qin struggled to form a similar bond 
(Scheme 2.46).87  The group was able to isolate only the amine starting material with 
loss of the side chain by use of either n-BuLi or t-BuLi with CuCN/LiCl88 or TMSCl89 
in THF or HMPA at varying temperature.  They even attempted a Pd-catalyzed Heck 
coupling (with Pd2(OAc)2, PPh3, TBACl, and HCO2Na, NEt3, or piperidine), as well as 
a radical cyclization (initiated with Bu3SnH, AIBN), and a Ni-catalyzed addition.90  All 
resulted in deiodinated product.      
 
                                                
87 Zhang, M.; Huang, H.; Shen. L.; Qin, Y. Journal of the American Chemical Society 2009, 131, 6013-
6020.  
 
88 Dieter, R. K.; Oba, G.; Chandupatla, K. R.; Topping, C. M.; Lu, K.; Watson, R. T. Journal of Organic 
Chemistry 2004, 69, 3076-3086.  
 
89 Piers, E.; Harrison, C. L.; Zetina-Rocha, C. Organic Letters 2001, 3, 3245-3247. 
 
90 For examples of Ni-catalyzed couplings, see references 56-57 and: Yu, S.; Berner, O. M.; Cook, J. M 
Journal of the American Chemical Society 2000, 122, 7827-7828.  For examples of radical additions, see 







1. t-BuLi, -78 oC
















It was originally proposed that %-allyl/Heck coupling could be investigated via 
the sequence outlined in Scheme 2.47.  This was abandoned after a significant portion 






























Another option was to attempt the coupling on an alkene such that the external 
olefin at C16 could be directly accessed (Scheme 2.48).  Reduction of the !,#-
unsaturated ester and acetylation or mesylation would generate an adduct prepped for 
cuperate-mediated cyclization by the same means as above, with expulsion of the 
leaving group.  Additionally, this route could be explored with the amide version 165, 
necessitating a selective reductant in the first step.  This approach was abandoned as 
well since generating a nucleophilic carbon at C20 has proved problematic under the 




































2.4.3 Intramolecular enolate addition to 2-oxobutanamide 
 
Though a coupling reaction would create a new carbon-carbon bond and furnish 
the requisite (E)-ethylidene appendage, addition of an enolate to an electrophilic center 
bearing by a leaving group would accomplish the same result.  However this alternative 
route is less appealing because alkene geometry would not be set.  Interested in a final 
effort to create the challenging C15-C20 bond, we investigated methods toward such a 


























R = H2 161  or O 165
16
R = H2 170  or O 173
R = H2 174  or O 175
R = H2 172  or O 176
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Modeled after work done by Harley-Mason (Scheme 2.49), alkene isomers were readily 
separable after an enolate addition and methoxide elimination of 177.91  
 
 





In lieu of repeating his work, we sought a 2-oxobutanoyl group to decorate the 
Nb-tryptamine that could furnish a mixture of the (E) and (Z) appendage upon 
elimination of water (Scheme 2.50).  The desired (E) isomer could readily be 







                                                
91 (a) Harley-Mason, J. Pure and Applied Chemistry 1975, 41, 167-174.  Dadson, B. A.; Harley-Mason, J.; 
Foster, G. H. Chemical Communications 1968, 1233. (c) Crawley, G. C.; Harley-Mason, J. Chemical 
























Initial efforts toward synthesizing the unassuming acid chloride from !-
ketobutyric acid were unrewarding (Scheme 2.51).  Neither thionyl chloride nor oxalyl 
chloride were capable of providing the desired 179.  Construction of its anhydride also 
proved fruitless.  Inspection of the literature revealed few claims of its construction,92 
though more recent manuscripts disclosed 2-oxobutanoyl chloride was inaccessible 




                                                
92 (a) Chen, J.-H.; Venkatesham, U.; Lee, L.-C.; Chen, K. Tetrahedron 2006, 62, 887-893. (b) Ayitou, A. 
J.-L.; and Sivaguru, J. Chemical Communications 2001, 47, 2568-2570. 
 
 
93 !,!-dichloromethyl methyl ether has been used to synthesize 179, though this reagent was not available 
at the time of this work. See: (a) Pansare, S. V.; Ravi, R. G.; Jain, R. P. Journal of Organic Chemistry 
1998, 63, 4120-4124. (b) Ottenheijm, H. C. J.; Tijhuis, M. W. Organic Syntheses 1983, 61, 1-4. (c) Snider, 
B. B.; Song, F.; Foxman, B. M. Journal of Organic Chemistry 2000, 65, 793-800. (d) Otttenheijm, H. C. J.; 
De Man, J. H. M. Synthesis 1975, 3, 163-164.  Trichloroisocyanuric acid can also accomplish this 
transformation and was also unavailable at the time of this work.  See: (e) Rodrigues, R. C.; Barros, I. M. 
A.; Lima, E. L. S. Tetrahedron Letters 2005, 46, 5945-5947.  This could also be accomplished via N-






















Table 2.4 Conditions for the acid chloride or anhydride formation. 
Entry Conditions Desired Product 
1 SOCl2, CH2Cl2, reflux, 18 h 179 
2 (COCl)2, CH2Cl2, reflux, 18 h 179 
3 SOCl2, reflux, 18 h 179 
4 (COCl)2, reflux, 18 h 179 
5 (COCl)2, reflux, DMF/ H2Cl2, 18 h 179 
5 SOCl2, K2CO3, CH2Cl2, dibenzylamine TFA salt, 0 oC to reflux, 5 h 182 
6 P2O5, CH2Cl2, 45 oC, 45 min 182 
7 DCC, CH2Cl2, 0 oC to rt, 18 h then 45 oC, 2 h 182 
 
 
Sensibly, standard peptide coupling conditions were tried next on amino-alcohol 
106 (see Scheme 2.24 for its synthesis).  No amide bond was formed, even using other 





                                                
94 Reference 92e can be used to directly access the desired amide for the in situ generation of the acid 























As a proof-of-concept, the benzylamine was exposed to the same coupling 
conditions (Scheme 2.53).  This seemingly simple procedure did not afford the desired 
amide and produced an inseparable mixture of multiple products that was un-
interpretable by 1H or 13C NMR.  
 
 



































2.4.4 Intramolecular enolate addition to ethyl-2-oxoacetate  
 
Instead, our attention was directed toward an ethyl 2-oxoacetate moiety as the 
electrophile (Scheme 2.54).95  This could displace an ethoxide group in which the more 
electrophilic carbonyl would be attacked for subsequent functional group manipulation.  
The three carbonyl groups would need to be differentiated for an amide reduction and 
two separate Wittig reactions at a later stage.  Though less attractive than the original 
electrophile, the desired aza-bicycle was expected to form with ease.  Employing typical 
ring opening conditions, the di-oxoacetate 186 was constructed and exposed to conditions 
that orthogonally saponified the ester over the amide.  All efforts led to elimination of the 











                                                
95 For synthesis of ethyl-2-chloro-2-oxoacetate 185, see: (a) Zhao, Y.; Wang, G.; Li, Y.; Wang, S.; Li, Z. 
Chinese Journal of Chemistry 2010, 28, 475-479. The anhydride is also known; (b) Plusquellec, D.; 
Roulleau, F.; Lefeuvre, M. Tetrahedron Letters 1988, 44, 2471-2476. 
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 The alkenyl intermediate offered an opportunity to undergo selective hydration, 
affording the alcohol 188 through either hydroboration or oxymercuration,96 dependent 
on the electronic behavior of the double bond.  Both were attempted and each failed to 
provide the desired alcohol (Scheme 2.55).  
 
 
                                                





















Na2CO3, 0 oC to rt, 
 










































A comparable system was found to undergo hydroboration-oxidation at the 
desired C16 position to complete allocriptopine (Scheme 2.56).97   Regioselectivity was 
rationalized based on a dative N-B complex, which undergoes intramolecular 
hydroboration with one of two possible intermediates; a [5.3.1]bicycle 195 (consisting 
of a fused 8 and 6-membered ring) or a [4.4.1]bicycle 196 (two fused 7-membered 




                                                
97 Valpuesta, M.; Díaz, A.; Suau, R.; Torres, G. European Journal of Organic Chemistry 2006, 4, 964-971. 
 





















Na2CO3,  rt, 1 h, 








1 M BH3  THF,rt, 45 min 
or








THF/H2O, 0 oC to rt, 24 h
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 Our system would prepare either a [5.31]-bicycle (a fused 7 and 6-membered 
ring) or a [5.2.1]-bicycle (a fused 8 and 5-membered ring), in which the former was 
presumed to be more stable (Figure 2.7).  However, the indole nitrogen was also 
available for dative bonding and could form a 5-membered ring with the undesired 
regioisomer (the 4-membered ring would be too strained).  It’s also possible that the 
ethyl 2-oxoacetate moiety was complexing with the borane.  Since the lone pairs on 
both Na and Nb are delocalized through conjugation, it was plausible that regiocontrol 
through dative bonding could not be achieved.  Furthermore, prior evidence suggesting 
conformational flexibility of the 9-membered 187 may have prevented any possible 
dative bond selectivity from occurring.  This could enable orbital alignment of the C15-
C16 olefin such that conjugation with the indole was possible, substantially lowering its 













1. 1 M BH3  THF,rt, 30 min 
(42%)
2. H2O2, phosphatebuffer (pH = 8), 




























Figure 2.7 Predicted intermediates resulting from the hydroboration of compound 187. 
 
 
Experimentally, no boranyl derivative was isolated nor was starting material 
recovered, suggesting hydration through this method was not probable on our scaffold 
(excess borane was used to circumvent exclusive complexation).  Failure to promote 




2.4.5 Intermolecular enolate-driven Pd-catalyzed cross-coupling 
 
At this stage, all approaches to place an electrophilic fragment on the Nb atom 





































means.99   
Scheme 2.57 outlines a pathway by which Pd-catalyazed enolate-driven 
coupling of 142 would proceed with fragment 205 or 206.  Liberation of 207 to the free 
alcohol followed by mesylation and Nb-deprotection presents an intermediate arranged 
for SN2 displacement to afford 209.  This method ensures the olefin’s geometry as our 
endeavors originally intended.  
 
 




                                                
99 For precedent on intermolecular vinylation of ketone enolates, see: (a) Chieffi, A.; Kamikawa, K.; 
Åhman, J.; Fox, J. M.; Buchwald, S. L. Organic Letters 2001, 3, 1897-1900. (b) Cosner, C. C.; Helquist, P. 
Organic Letters 2011, 13, 3563-3567. (c) Cosner, C. C.; Bhaskara Reddy Iska, V.a; Chatterjee, A.; 
Markiewicz, J. T.; Corden, S. J.; Loefstedt, J.; Ankner, T.; Richer, J.; Hulett, T.; Schauer, D. J.; Wiest, O.; 





















1. MnO2, CH2Cl2, 
reflux, 36 h
(86%)
2. Boc2O, CH2Cl2, 

















R = TES 205











The forward direction recycled previously synthesized amino-alcohol 106 as 
well as iodo-butenol 110 (Scheme 2.25) which was silyl protected to generate the 
requisite intermolecular coupling partner.  Exposure to selected coupling conditions 
(Table 2.1, entries 7, 2 and Table 2.3, entry 4) with an increased concentration led to Na 
deprotection of the Boc group exclusively.  The TMS-enol ether of 142 was also 
generated and exposed to identical conditions, resulting in starting material once again.  
Any new methine peak corresponding to the desired product was not isolated in a 




2.4.6 Control reactions 
 
To discredit operational complications and demonstrate that the various 
conditions employed were sound, a model substrate was studied (Scheme 2.58).  Aryl 
bromide indeed coupled to tetralone100 substantiating its feasibility, providing both the 
mono-coupled product (low catalyst loading) and the di-coupled product (high catalyst 
                                                
100 For other examples of !-arylation of ketone enolates, see: (a) Marion, N.; Ecarnot, E. C.; Navarro, O.; 
Amoroso, D.; Bell, A.; Nolan, S. P. Journal of Organic Chemistry 2006, 71, 3816-3821.  (b) Lessi, M.; 
Masini, T.; Nucara, L.; Bellina, F.; Rossi, R. Advanced Synthesis and Catalysis 2011, 353, 501-507. (c) 
Viciu, M. S.; Germaneau, R. F.; Nolan, S. P. Organic Letters 2002, 4, 4053-4056. (d) Hamanda T.; Chieffi, 
A.; Åhman, J.; Buchwald, S. L. Journal of Organic Chemistry 2002, 124, 1261-1268. (e) Muratake, H.; 
Natsume, M. Tetrahedron Letters 1997, 38, 7581-7582. (f) Åhman, J.; Wolfe, J. P.; Troutman, M. V.; 
Palucki, M.; Buchwald, S. L. Journal of the American Chemical Society 1998, 120, 1918-1919. (g) Satoh, 
T.; Kametani, Y.; Terao, Y.; Miura, M.; Nomura, M. Tetrahedron Letters 1999, 40, 5345-5348. (h) Liao, 




loading).101  However, utilizing the silyl-protected iodobutene 205 or 206 with tetralone 
did not deliver a clean product, even with very low catalyst loading.   
Ni(COD)2-mediated vinylation was also attempted in place of Pd (again, 
utilizing a bidentate ligand), resulting in only recovered starting material.102  Multiple 
new alkene peaks were detected (presumably due to di-coupling, isomerization, or 
enolate addition to the carbonyl) and a mono-coupled product was not isolable under 
any chromatography conditions applied.  As the reaction is known to be ligand-
dependent, comprehensive screening of a number of conditions would be needed to 
uncover an optimal system.  
 
 




                                                
101 '-arylation was performed based on ease of operation and possession of materials and a similar !-
vinylation was conceded to occur under parallel conditions in accordance with the literature.  
 
102 Ge, S.; Hartwig, J. F. Journal of the American Chemical Society 2011, 133, 16330-16333. 
O O
Pd2(dba)3, BINAP,






O O ORPd2(dba)3, BINAP,










Additionally, !-vinylation often required the use of zinc enolates (ZnCl2 and 
LiTMP) to decrease basicity and avoid side reactions.93b-c  Precedent was established on 
aryl ketone 215 with an alkenyl bromide, and the authors made no mention of attempts 
without the use of Zn, suggesting its requirement (Scheme 2.57).  Only electron-rich 
sterically-demanding phosphanes supported coupling (such as t-Bu3P) while the use of 
arylphosphines failed completely (PPh3 or dppe).  Such conditions were not explored 
and it was decided attention was better directed on a more advantageous route. 
 
 





At this point, all conditions thought to accomplish formation of the desired C15-
C20 bond were exhausted and efforts were put forth to devise a new route in which this 
bond was already intact.  Focus was directed to install the aza-bicycle prior to 
introduction of the indole moiety, avoiding potential geometric constraints when fused 
















Chapter 3: Third-Generation Synthesis: Enantioselective Synthesis from (S)-





 A more elegant route to subincanadine E was inspired by Neil Garg’s total 
synthesis of (±)-aspidophylline A (see Scheme 3.57).103  A late stage 
rearrangement/cyclization cascade (termed the interrupted Fisher indolization) prepared 
the densely substituted cyclohexyl amine skeleton 222, the product of an intramolecular 
Heck coupling.  This stimulated us to consider assembly of the bicycle prior to 
introduction of the planar indole moiety.  An alternative disconnect to circumvent C15-
C20 bond formation would avoid former complications and provide an approach 
predominantly unexplored in any total synthesis of the pericine type alkaloids (see 







                                                
103 Zu, L.; Boal, B. W.; Garg, N. K. Journal of the American Chemical Society 2011, 133, 8877-8879. 
 
104 Conolidine was the only related natural product that was assembled without a tryptamine precursor via 
introduction of a lithiated indole.  See Chapter 1, Section 1.2.2.  
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 The convergent enantioselective route toward dihydrocleavamine (containing a 
tacaman or pseudo-aspidosperma skeleton) served as additional motivation that such a 
disconnect of an aza-bicyclic indole alkaloid was achievable.105  Assembly of the 
central 9-membered ring played the key role, realized through either: (A) a C2-C16 
Pictet-Spengler-like coupling between tryptophol and piperidine 226 followed by N4-
C5 intramolecular alkylation, or (B) N4-C5 formation via indoleacetic acid coupling 
with 229 and a subsequent intramolecular Friedel-Crafts acylation (Scheme 3.61).  
Introduction of the indole nucleus and a fused aza-bicycle was accomplished during the 
final stages, providing evidence that a 9-membered ring as the base of a bridged 
                                                















































framework was accessible without the need to linearly construct the molecule from a 
tryptamine core.   
 
 






3.2 Retrosynthetic analysis 
  
With these bond disconnections in mind, a modern approach was envisioned to 
expand beyond the aforementioned routes discussed in Chapter 1 and 2 such that a final 
C15-C20 bond coupling would be evaded and new bond connectivity would facilitate 
an enantioselective total synthesis.  Scheme 3.62 depicts the retrosynthetic analysis 
anticipated to furnish (15S)-subincanadine E.  Instead of attempting to close a 6-
membered ring within a 9-membered framework, the conformationally more robust 
valpericine 8 could be employed as the final precursor to subincanadine E through an 
























225 226 227 228 229
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biomimetic conversion of subincanadine E to valpericine, suggesting its compatibility 
with such a transformation (see Scheme 1.13 for biomimetic details).  Intermediate 230 
would arrive from N-alkylation of 231 after indolization about the ketone handle.  The 
enone intermediate 232 would be generated from a more illustrious intramolecular 
Heck coupling process than attempted in retrosynthesis 1 and 2 (see Scheme 1.15, 
transformation 89 to 5 and Scheme 2.22, 99 to 5c), effectively setting the desired olefin 
geometry.  Synthon 233 was possible by way of a Beckmann rearrangement of oxime 
234, stemming from a reduced version of enantiopure carvone. 
 
 




















































Our proposed route is only the third approach using carvone to generate an 
indole alkaloid-containing natural product.  The first was led by Phil Baran’s entry to 
the hapalindole and fischerindole families in 2004106 trailed by Neil Garg’s 
construction of N-methylwelwitindolinone C isocyanate in 2011 (see Section 3.3.1 and 




3.3 Previous employment of carvone 
 
Carvone is extremely inexpensive ($23.70/5 mL for (S)-(+)-carvone and $32/5 
mL (R)-(")-carvone)108 and each enantiomer is used industrially for different means; (S)-
carvone is used for the prevention of potato sprouting and (R)-carvone is used 
commercially as mosquito repellant.   
 
                                                
106 (a) Baran, P. S.; Richter, J. M. Journal of the American Chemical Society 2004, 126, 7450-7451. (b) 
Entry to only one other nitrogen-containing natural product, nominine, was initiated from carvone to form a 
common enone intermediate, though the proposed synthesis was never completed.  For synthesis of the 
enone intermediate from carvone, see: de Groot, A.; Jenniskens, L. H. D. Tetrahedron 1998, 54, 5617-
5622. (c) de Groot, A.; Verstegen-Haaksma, A. A.; Swarts, H. J.; Jansen, B. J. M. Tetrahedron 1994, 50, 
10073-10082. (d) For the proposed synthesis of nominine, see: Yee Lee Goh, W. (2013) Studies Directed 
Towards the Natural Product Nominine. Unpublished doctoral dissertation, University of Southhampton, 
Southhampton, England.  
 
107 Hunter, A. D.; Quasdorf, K. W.; Styduhar, E. D.; Garg, N. K. Journal of the American Chemical Society 
2011, 133, 15797–15799. 
 




Carvone has a rich history of use among several complex natural products, most recently 
including the total synthesis of cyperolone,109 kainic acid,110 and cyrneine A111 (Figure 
3.8).112  Specifically, Section 3.3.1 and 3.3.2 will focus on the only total syntheses to date 
utilizing carvone as a starting material toward indole alkaloid natural products.  Section 
3.3.3 will outline the derivitization of carvone into a series of useful ligands.   
 
 
Figure 3.8 Recent natural products synthesized from carvone. 
                                                
109  Klahn, P.; Duschek, A.; Liébert, C.; Kirsch, S. F. Organic Letters 2012, 14, 1250–1253. 
 
110 Takita, S.; Yokoshima, S.; Fukuyama, T. Organic Letters 2011, 13, 2068-2070. 
 
111 Elamparuthi, E.; Fellay, C.; Neuburger, M.; Gademann, K. Angewandte Chemie Internation Edition 
2012, 51, 4071-4073. 
 
112 For other natural products initiated from carvone, see: (a) Omphadiol: Liu, G.; Romo, D. Angewandte 
Chemie Internation Edition 2011, 50, 7537-7550. (b) Platensimycin: Yun, S. Y.; Zheng, J.-C.; Lee, D. 
Journal of the American Chemical Society  2009, 131, 8413-8415. (c) Peribysin E: Angeles, A. R.; Waters, 
S. P.; Danishefsky, S. J. Journal of the American Chemical Society 2008, 130, 13765-13770. (d) 
Guanacastepene E: Shipe, W. D.; Sorensen, E. J. Journal of the American Chemical Society 2006, 128, 
7025-7035. (e) Samaderine Y: Shing, T. K. M.; Yeung, Y. Y. Angewandte Chemie Internation Edition 
2005, 44, 7981-7984. (f) Briarellins E and F: Corminboeuf, O.; Overman, L. E.; Pennington, L. D. Journal 
of the American Chemical Society 2003, 125, 6650–6652. (g) Thapsigargins: Oliver, S. F.; Högenauer, K.; 
Simic, O.; Antonello, A.; Smith, M. D.; Ley, S. V. Angewandte Chemie Internation Edition 2003, 42, 
5996-6000. (h) Picrotoxin and corianin: Trost, B.; Krische, M. J. Journal of the American Chemical 
Society 1999, 121, 6131–6141. (i) Cladantholide: Lee, E.; Lim, J. W.; Yoon, C. H.; Sung, Y.; Kim, Y. K. 
Journal of the American Chemical Society 1997, 119, 8391-8392. (j) Salsolene oxide: Paquette, L. A.; Sun, 
L.-Q.; Watson, T. J. N.; Friedrich, D.; Freeman, B. T. Journal of the American Chemical Society 1997, 119, 
2767-2768. (k) 7-deacetoxyalcyonin acetate: MacMillan, D. W. C.; Overman, L. E. Journal of the 
American Chemical Society 1995, 117, 10391–10392. (l) Upial: Taschner, M. J.; Shahripour, A. Journal of 
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3.3.1 Total synthesis of hapalindole Q and (")-12-epi-fischerindole U 
isothiocyanate 
 
The hapalindoles were originally isolated in 1987113 from the blue-green alga 
Hapalosiphon fontinalis whose extracts revealed anti-algal and antimycotic activity, 
recently found to be a direct result of RNA-polymerase inhibition.114  The 
fischerindoles were isolated in 1992115 and possess similar activity.116  The Baran group 
devised a direct coupling of indole with carvone through oxidation of their 
corresponding anions to radicals 249 and 250 (Scheme 3.63).  After LHMDS 
deprotonation, they found that Cu(II)2-ethylhexanoate-mediated coupling when indolic 
radical 250 was used in 2-fold excess afforded an optimized yield of 53% (70% based 
on recovered starting material).  Adduct 248 was carried on to indole 245, which served 
as the synthon for divergence to either natural product.  Hapalindole Q was obtained 
after direct reductive amination and succeeding isocyanate formation of 246.  The 
fischerindole 242 was derived from identical steps after initial biomimetic ring closure 
of 245 using TMSOTf.  Diversification of the common intermediate 245 accomplished 
                                                
113 Moore, R. E.; Cheuk, C.; Yang, X.-Q. G.; Patterson, G. M. L.; Bonjouklian, R.; Smitka, T. A.; 
Mynderse, J. S.; Foster, R. S.; Jones, N. D.; Swartzendruber, J. K.; Deeter, J. B. Journal of Organic 
Chemistry 1987, 52, 1036–1043. 
 
114 (a) Doan, N. T.; Rickards, R. W.; Rothschild, J. M.; Smith, G. D. Journal of Applied Phycology 2000, 
12, 409-416. (b) Doan, N. T.; Stewart, P. R.; Smith, G. D. Microbiology Letters 2001, 196, 135-139. 
 
115 Park, A.; Moore, R. E.; Patterson, G. M. L. Tetrahedron Letters 1992, 33, 3257–3260. 
 
116 For biological activity of the hapalindoles, fischerindoles, and related natural products, see references 
therein: Richter, J. M.; Ishihara, Y.; Masuda, T.; Whitefield, B. W.; Llamas, T.; Pohjakallio, A.; Baran, P. 
S. Journal of the American Chemical Society 2008, 130, 17938–17954. 
 92 
 


































































3.3.2 Total synthesis of N-methylwelwitindolinone C isocyanate 
 
 The Garg group utilized (S)-carvone in the first enantiospecific 17-step route to 
N-methylwelwitindolinone C isocyanate (Scheme 3.64).  This compound was found to 
reverse P-glycoprotein-mediated multiple drug resistance to a number of anti-cancer 
drugs, proving to be a promising lead for drug-resistant tumor formation.117  Highlights 
from this synthesis include a nitrene insertion reaction to functionalize the sterically 
congested C11 bridgehead carbon as well as an indolyne cyclization that assembled the 
[4.3.1]-bicycle (transformation 254 to 253), endorsing this intermediate’s use in total 
synthesis.  Enone 257 was a known intermediate reported by Natsume118 and resulted 
from a 7-step elaboration of (S)-carvone.  Though the heaviest number of steps was 
required to modify 236 to 253 (13 steps), the greatest synthetic utility was sequestered 
from use of indolyne 254 which formed at ambient temperatures and proceeded to 253 







                                                
117 (a) Smith, C. D.; Zilfou, J. T.; Stratmann, K.; Patterson, G. M. L.; Moore, R. E. Molecular 
Pharmacology 1995, 47, 241–247. (b) Zhang, X.; Smith, C. D. Molecular Pharmacology 1996, 49, 288–
294. 
 










3.3.3 Chiral [2.2.2] dienes from carvone 
 
Carvone has also been diversified into several chiral diene ligands for use in 
Rh(I)-catalyzed conjugate addition reactions (Scheme 3.65).119  A sequence of seven 
steps converted either enantiomer of carvone and allowed for diversity-oriented synthesis 
of the ligand scaffold.   
                                                
119 (a) Defieber, C.; Paquin, J.-F.; Serna, S.; Carreira, E. M. Organic Letters 2004, 6, 3873–3876. (b) 
Fischer, C.; Defieber, C.; Suzuki, T.; Carreira, E. M. Journal of the American Chemical Society 2004, 126, 
1628-1629. (c) Hickmann, V.; Alcarazo, M.; Fürstner, A. Journal of the American Chemical 






















































Interestingly, saturation between carbon 2 and 3 of ligand 261 provided less than a 10% 
conversion of 260 to 263.  
 
 






3.4 Forward route: oxidation of carvone 
 
  The forward route required preliminary efforts to determine if regioselective 




















2. LiNEt2, PhNTf23. [Pd], HCO2H









would diminish the number of overall steps and prevent unnecessary redox changes to 
the enone that would be needed for later manipulation.   
Prior to these objectives, investigations of the direct oxidation from carvone to 
diketone 264 was required (Scheme 3.66).  Oxidative cleavage of the double bond 
under standard literature conditions (OsO4/NaIO4)120 was sluggish and over-oxidation 
products were visible.121  Even with the use of 2,6-lutidine as an additive, suppression 
of oxidative degradation products was minimal and starting material was always 
recovered.  Furthermore, powdered K2CO3 and pyridine122 were separately added to 
reduce the formation of 265 to no avail.      
 
 




                                                
120 Pappo, R.; Alen, D. S. Jr.; Lemieux, R. U.; Johnson, W. S. Journal of Organic Chemistry 1956, 21, 478-
479. 
 
121 Aldehydic peaks were also present in the crude NMR, presumably from the cleavage of the internal 
double bond.  Others have reported the presence of over-oxidation and only a few have reported an !-
hydroxy ketone side product.  See: Yu, W.; Mei, Y.; Kang, Y.; Hua, Z.; Jin, Z. Organic Letters 2004, 19, 
3217-3219. 
 
122 Pyridine was tested although it is known to accelerate epimerization via enolization of the resultant 














 Although carvone was known to undergo oxidation directly to diketone 264, the 
harsh conditions (non-catalytic amounts of nitrous oxide between 50-70 atm for 12 
hours at 250 °C) initiated us to pursue other options.123  Using a more consistent two-
step procedure, the diketone was furnished in high yields (Scheme 3.67).124  
Epoxidation using mCPBA125 successfully prepared intermediate 264.  This reaction 
was completely regioselective though not stereoselective, which was adequate for our 
purposes.  Liberation to the vicinal diol in the presence of periodic acid followed by 
further oxidation provided 264 in gram quantities. 
 
 






                                                
123 Romanenko, E. P.; Starokon, E. V.; Panov, G. I.; Tkachev, A. V. Russian Chemical Bulletin, Internation 
Edition 2007, 56, 1239-1243.  The cyclopropane homo-derivative was reported as a major byproduct of this 
reaction, resulting from cyclopropanation of the double bond.  See Scheme 3 therein.   
 
124 (a) Torosyan, S. A.; Gimalova, F. A.; Valeev, R. F.; Miftakhov, M. S. Russian Journal of Organic 
Chemistry 2011, 47, 682-686. (b) Baldwin, J. E.; Broline, B. M. Journal of the American Chemical Society 
1982, 104, 2857-2865. 
 
125 Employing H2O2 would epoxidize the enone double bond.  See: Hatakeyama, S.; Numata, H.; Osanai, 






CH2Cl2, 0 oC, 2.5 h
(96%)
HIO4  H2O,




3.5 Regioselective oxime formation 
 
 Regioselective oxime formation was next explored using different bases during 
exposure of diketone 264 to hydroxylamine hydrochloride in ethanol (Scheme 3.68).  
Though oxime formation is a routine transformation, there is no literature on 
regioselectivity regarding ketone versus enone functionalities.  It was hypothesized that 
the ketone would be more electrophilic and thus prefer 1,2-addition here.  To our 
surprise, all trials led to exclusive 1,2-addition of the enone carbonyl or di-oxime 
formation (Table 3.5).125  
 
 
























Table 3.5 Conditions applied to the regioselective oxime formation of 267. 
Entry Base Temperature Time Product 
1 - rt 18 h 268, 90% 
2 pyridine rt 18 h 268, 81% 
3 NaOH rt 18 h 268, 77% 
4 NaOAc!3H2O rt 2 d 
268, 46% +  
269, 15% 





3.6 Exploration of protecting group strategies 
 
These results substantiated the need for protection group chemistry of the enone 
such that the desired oxime could be acquired.  It was anticipated that electronic 
differences would enable regioselective protection of one carbonyl over the other, 
ideally 1,4-protection over 1,2-protection.126  A cyclic protecting group was chosen to 
more clearly understand the di-carbonyl reactivity in this system.  Initial attempts with 
ethylene glycol protected only the ketone in high yields (Scheme 3.69).  Alternative 





                                                
126 This reaction was attempted despite the fact that most ketones have a faster reaction rate than enones. 
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Employment of the softer dithioacetal protecting group was next considered 
(Scheme 3.70).  Selected conditions are outlined in Table 3.6.  A number of different acid 
catalysts were tested with varying solvents and temperatures.127  Entries 1-4 produced the 
desired enone-protected product, however this did not go to completion.  Increasing the 
equivalents of dithioethane higher than 1.1 produced a significant amount of the di-
protected species.  Attempts to optimize the conditions led to substantial starting material 
recovery, while driving the reaction to completion did not allow for thorough separation 
                                                
127 See the following references for dithioacetal protecting group conditions employed in Table 3.5. (a) 
Using iodine: Firouzabadi, H.; Iranpoor, N.; Hazarkhani, H. Journal of Organic Chemistry 2001, 66, 7527-
7529. (b) Using SnCl2!H2O, see Table 1, entry 15: Bez, G.; Gogoi, D. Tetrahedron Letters 2006, 47, 5155-
5157. (c) Using ZnCl2: Lerner, D. B.; Kearns, D. R. Journal of the American Chemical Society 1980, 102, 
7612-7613. (d) Using BF3!OEt2: see reference 111c. (e) Using p-TsOH and silica gel: Ali, M. H.; Gomes, 




1.1 equiv ethylene glycol, p-TsOH,













of di-protected 272 from mono-protected 273.128  It is possible that the steric hindrance of 
the enone imposed by the neighboring methyl group has decreased selectivity at that 
position, thus permitting ketone protection as well.    
 
 





Table 3.6 Conditions applied to the regioselective protection to provide 273. 
Entry Acid Solvent Temperature Time Product 
1 I2 CHCl3 rt 2 d 272 + 273 
2 SnCl2!H2O Et2O µW, 100 W 3 min 272 + 273 
3 ZnCl2 CH2Cl2 -78 °C to 0 °C 1 h 272 + 273 
4 BF3!OEt2 MeOH -78 °C to 0 °C 5 h 272 + 273 
5 silica gel, p-TsOH CH2Cl2 reflux 12 h 272  
                                                
















Furthermore, it was reported that Michael adduct 276 was the main product on a 
similar system (piperitone 274) under certain acid-catalyzed conditions (Scheme 3.71).129  
The authors mentioned that carvone showed a similar tendency.  Supplementary literature 
disclosed evidence of Michael product formation when attempting to protect a range of 
enones and the scope was not limited to one acid catalyst in specific.130  
 
 





 Lastly, analysis of regioselective protection of a diol intermediate was 
investigated.  Though simple acetal protection of carvone occurs readily,131 electronic 
discrepancies between the two olefins of 277 no longer exist for later oxidation 
                                                
129 Corey, E. J.; Shimoji, K. Tetrahedron Letters 1983, 24, 169-172.  
 
130 For other examples of selective monothioketalization that exhibit carbonyl differention, see: (a) Evans, 
D. A.; Truesdale, L. K.; Grimm, K. G.; Nesbitt, S. L. Journal of the American Chemical Society 1977, 99, 
5009-5017. (b) Sato, T.; Otera, J.; Nozaki, H. Journal of Organic Chemistry 1993, 58, 4971-4978.  
 
131 However, employment of PPTS as the acid catalyst in a higher boiling solvent leads to p-cymene x 
exclusively (Scheme 3.72).  For comparable protection procedures, see: (a) Greene, T. W. Protecting 
Groups in Organic Synthesis, John Wiley & Sons, Inc., New York, 1981. (b) Nomura, M.; Hisatomi, S.; 
Fujhiara, Y.; Shibata, M.; Takagi, S.; Sugiura, M. Nihon Yukagakkaishi 1996, 45, 865-870. (c) Use of CdI2 
under µW irradiation accelerates the reaction.   See:  Laskar, D. D.; Prajapati, D.; Sandhu, J. S. Chemistry 










(Scheme 3.72).  However, halting the oxidation at the diol would allow for further 
manipulation of the enone.  
 
 





After epoxidation of (S)-carvone, sulfuric acid in water cleanly prepared the 
ring-opened diol (Scheme 3.73).132  Both ethylene glycol and dithioethane protecting 
groups were used with various acid catalysts (Table 3.7).  Attempted formation of 280 
resulted in mostly starting material recovered and in only one case (entry 4) desired 
product was formed, albeit in a low yield.  Efforts to form the sulfur congener resulted in 
decomposition of the starting material with no identifiable products.  It was postulated 
that protonation of the ketone allowed for intramolecular attack by either pendant 
alcohol, arranging a 5 or 6-membered ring.  This may also occur in the intermolecular 
fashion, propagating multiple cyclic ether products.  
 
 
                                                
132 Engel, W.; Journal of Agriculture and Food Chemistry 2001, 49, 4069-4075.   
O
ethylene glycol, p-TsOH,
toluene, reflux, 18 h
(88%)
O O ethylene glycol, PPTS,









Table 3.7 Conditions applied to the protection of diol 279. 
Entry Protecting Group Acid Solvent Temperature Time 
1 ethylene glycol p-TsOH toluene reflux 22 h 
2 dithioethane BF3!OEt2 MeOH 0 °C 1.5 h 
3 ethylene glycol p-TsOH benzene reflux 8 h 


















CH2Cl2, 0 oC, 2.5 h
(96%)
H2SO4, H2O,





X = O 270







3.7 Oxime formation via reduction of the enone 
 
 As direct access to the oxime precursor and regioselective protection were 
achievable, a lengthier procedure was adopted.  Though other protecting group 
strategies exist,133 we directed our attention on the carbonyl reduction of carvone 
followed by subsequent silyl protection.  This would circumvent the need for 
regioselective chemistries and enable succeeding oxidation of the isopropenyl unit to 
ensue.  The formerly prepared epoxide 266 was subjected to NaBH4 in the presence of 
sucrose as a ‘reactant transfer’ agent to prevent formation of the saturated alcohol from 
1,4-addition (Scheme 3.74).134  The Luche reduction (CeCl3, MeOH)135 indeed 
furnished the desired chemoselective 1,2-addition product according to the literature, 
but reportedly was accompanied by intramolecular acid-catalyzed cyclization and 






                                                
133 Carvone can be transformed into its TMS-protected cyanohydrin.  Cabirol, F. L.; Lim, A. E. C.; 
Hanefeld, U.; Sheldon, R. A.; Lyapkal, I. M. Journal of Organic Chemistry 2008, 73, 2446-2449.  
 
134 For details on sucrose used as a reactant transfer agent in the chemoselective reduction of !,#-
unsaturated aldehydes and ketones, see: Denis, C.; Laignel, B.; Plusquellec, D.; Le Marouille, J.-Y.; Botrel, 
A. Tetrahedron Letters, 1996, 37, 53-56. 
 
135 Gemal, A. L.; Luche, J.-L. Journal of the American Chemical Society 1981, 103, 5454-5459. 
 
136 Smitt, O.; Högberg, H.-E. Tetrahedron 2002, 58, 7691-7700.  Synthetic details toward x can be found in 
this work.  
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The unstable epoxy allylic alcohol 281 was immediately protected with the more 
robust TBDPS group to prevent intramolecular cyclization to previously characterized 
bottrospicatols 283 and 284 (Scheme 3.75).137  Use of TBDMS or TMS resulted in a 
sizable amount of these products that proved difficult to separate from the desired silyl 
ethers (both syn and anti diastereomers of 235a).  Oxidative periodic acid cleavage of 
epoxide 282 furnished siloxyketone 235a as the dominant diastereomer, though both 




                                                
137 (a) Noma, Y.; Nishimura, H.; Hiramoto, S.; Iwami, M.; Tatsumi, C. Agricultural and Biological 
Chemistry 1983, 46, 2871-2872. (b) Nishimura, H.; Hiramoto, S.; Mizutani, J.; Noma, Y.; Furusaki, A.; 








0 oC to rt, 18 h
(96%)
NaBH4, sucrose,
0 oC, 1 h
TBDPSCl, DMAP, 
Imidazole, rt, 18 h
(62%)
 over two steps
HIO4  H2O
CH2Cl2, 0 oC, 1.5 h
(79%)









Scheme 3.75 Byproducts of the intramolecular Lewis acid catalyzed cyclization of 281. 




 The oxime was next prepared which efficiently supplied a mixture of (E) and (Z) 
isomers (ratio of 5:4, respectively) in a collective 85% yield (Scheme 3.76).  Though 
the geometric isomers were easily separable by chromatography, thermodynamic 
isomerization occurs during the Beckmann rearrangement in the presence of a protic 
acid such that only the (E) isomer will rearrange.138  The skeleton was now prepared for 
exploration of rearrangement conditions.   
 
 




                                                
138 Gawley, R. E. Chapter 1 The Beckmann Reactions: Rearrangements, Elimination-Additions, 
Fragmentation, and Rearrangement-Cyclizations.  In Organic Reactions, Kende, A. S., John Wiley & 











2.5 M NH2OH  HCl,
 








3.8 Beckmann rearrangement 
 
 Prior to establishing the use of only TBDPS as a protecting group, the more 
hydrolysable TBS was employed (synthesized in accordance with Scheme 3.74 in 
comparable yields).  Exposure of this oxime derivative to MsCl and AcOH after 
aqueous workup delightfully underwent rearrangement (Scheme 3.77).  However, the 
TBS group was readily cleaved in acidic medium.  This permitted O-acetylation by 
means of a stable allylic carbocation intermediate at which all optical activity was lost 
due to its C2-symmetric nature (Scheme 3.78).  
 
 































 Moreover, this was the first entry toward 5-aminocyclohexenol derivatives to be 
documented.  Such a small molecule was surprisingly unknown in the literature and our 
route readily delivered access to such structures in a succinct manner.  
 
 





Interestingly, a second acetylation product was identified as the N-mesylated 
adduct 288.  Only a few examples in the literature mention the appearance of such a 
product using typical Beckmann conditions, which occurs from trapping the nitrillium 

































This mechanism is reminiscent of the Chapman rearrangement, though most N-
substituted amides result under refluxing conditions.  Scheme 3.80 provides three 
examples noted in the literature.  In the last example (reaction 3), benzophenone oxime 
301 undergoes esterification, rearrangement to benzoyl imidate 302, and further 
rearrangement to produce N-substituted benzanilide 303.  The authors of reaction 2 also 





                                                
139 (a) Reaction 1 of Scheme 3.80: Huisgen, H.; Witte, J.; Ugi, I Chemische Berichte 1957, 90, 1844-1849.  
(b) Reaction 2: Schulenberg, J. W.; Archer, S. Organic Reactions 1965, 14, 1-51.  (c) Reaction 3: Bittner, 


































The less labile TBDPS-protected siloxyoxime 234a was instead subjected to the 
Beckmann conditions (Scheme 3.81).  It was discovered that the secondary addition of 
acid was not necessary for rearrangement to occur, thus avoiding potential silyl 
deprotection.  The rearrangement proceeded with at an optimal ratio of 1:1.2 of N-
mesylated 304 to non-mesylated 233a using a small volume of water added at a rapid 
stirring speed to the organic solution.  A slight excess of MsCl was therefore required 






































instead provided a higher ratio of the mesylated adduct (7:1 of N-mesylated to non-
mesylated, not shown).       
 
 





N-mesylated or O-acetylated material (Scheme 3.82, either 288 or 287) was 
easily cleaved under basic conditions forming amido-alcohol 305.  Furthermore, any O-
silyl protected 304 would lose the protecting group at high temperatures to produce 305 
as well, supporting the opportunity for a one-pot process.  Since the enone functionality 
was eventually desired, the alcohol could be oxidized after alkylation.  This provided 










 MsCl, NEt3, CH2Cl2,
1 drop water,






















 Acetamide 233a was expected to undergo alkylation using the previously 
employed mesylate 111 (see Chapter 2, Scheme 2.25 for its synthesis).  A strong base 
was required to deprotonate the amide, which consistently reacted with the alkyl 
mesylate instead. Adding 15-crown-ether-5 to solvate the sodium cation salt resulting 
from amide deprotonation (Table 3.8, entry 2) did not change the outcome.  Regardless 
of the base employed, starting material was recovered quantitatively and only some of 































Table 3.8 Conditions applied to the alkylation of 233a. 
Entry Base Solvent Temperature Time 
1 NaH THF 70 °C 17 h 
2 NaH 15-crown-ether-5, benzene  70 °C 2 h 
3 KHMDS THF 70 °C 17 h 
4 n-BuLi THF 70 °C 4 h 
 
 
A control reaction void of the acetamide proved that the base quickly eliminated 
the mesylate, rendering it useless for alkylation purposes (Scheme 3.84).  Other amide 
alkylations did not possess a reagent able to undergo facile E2’ elimination and 
therefore Sn2 alkylation was not possible for our system.140 
 
                                                
140 For examples of amide N-alkylation see: (a) Fones, W. S. Journal of Organic Chemistry 1949, 14, 1099-
1102. (b) Park, J. D.; Englert, R. D.; Meek, J. S. Journal of the American Chemical Society 1952, 74, 1010-
1012. (c) Bogdal, D. Molecules 1999, 3, 333-337. (d) Kasuga, J.; Hashimoto, Y.; Miyachi, H. Bioorganic 
& Medicinal Chemistry Letters 2006, 16, 771–774. (e) Rao, S. N.; Babu, K. S. Organic Communications 























3.10 Deacetylation  
 
 Since the use of strong base was not possible with our requisite alkylating agent, 
it was decided to remove the acetyl group such that a more feasible alkylation of an 
amine over an amide could occur.  To prevent over-alkylation, reductive amination 
between amine 306 and aldehyde 108 (the precursor to mesylate 111) could occur 
(Scheme 3.85).  Deacetylation of an amide requires more rigorous conditions than its 
ester counterpart; nonetheless this transformation is documented in the literature.141  
However, all conditions applied resulted in quantitative recovery of starting material or 
loss of the silyl protecting group to form amido-alcohol 305.  Even removal by way of 
methylation with triethyloxyoxonium tetrafluoroborate (Meerwein’s salt, entry 8) that  
 
                                                
141 For examples of N-deacetylation conditions, see: (a) Barger, G.; Schlittler, E. Helvetica Chimica Acta 
1932, 15, 381-394. (b) Cao, Y.; Du, D.; Yang, X.; Xu, X.; Song, F.; Xu, Y. Agricultural Science and 
Technology 2012, 13, 1-3. (c) Li, G.-Q.; Gao, H.; Keene, C.; Devonas, M.; Ess, D. E.; Kürti, L. Journal of 








was employed for stubborn acetamide removal did not prove fruitful.142 
 
 





Table 3.9 Conditions attempted to deacetylate 233a. 
Entry Acid or Base Solvent Temperature Time Product 
1 tetramethyl guanidine MeOH rt 18 h 233a 
2 HCl EtOH rt 18 h 305 
3 SOCl2, pyridine CH2Cl2 rt 2 d 305 
4 NaOH EtOH reflux 18 h 305 
5 KOH EtOH reflux 18 h 305 
6 hydrazine hydrate MeOH rt 2 d 233a 




CH2Cl2 rt 15 h 305 
 
                                                
142 (a) Kozikowski, A. P.; Ishida, H. Journal of the American Chemical Society 1980, 102, 4265-4267. (b) 
Kishi, Y.; Fukuyama, T.; Nakatsubo, A. F.; Goto, T.; Inoue, S.; Tanino, H.; Suguira, S.; Kakoi, H.  Journal 


























   Deacetylation conditions were tested on sulfonimide 304, a byproduct from the 
Beckmann rearrangement (Scheme 3.81), since sulfonimides are more susceptible to 
cleavage than an N-acetyl group (Scheme 3.86).143  Comparably, a literature example 
illustrating the cleavage of the sulfonamide N-methanesulfonylpiperidine proved to be 
inert to sodium naphthalene cleavage, suggesting aliphatic amines are inherently 
robust.144  It was rationalized that the weaker sulfonimide, through lone pair dual-
delocalization, would be more inclined to cleavage than the sulfonamide example.  
Conditions in Table 3.8 were applied (entries 4-5), resulting in N-mesyl and O-silyl 
deprotection (product 305).   
 
 




Taking advantage of another intermediate more receptive to deacetylation was 
envisioned through Boc protection of acetamide 233a to form an acid-labile carbamate 
                                                
143 Searles, S.; Nukina, S. Chemical Reviews 1959, 59, 1077-1103. 
 
144 Ji, S.; Gortler, L. B.; Waring, A.; Battisti, A.; Bank, S.; Closson, W. D. Journal of the American 


















(Scheme 3.87).  Exhaustive efforts to Boc protect did not proceed to the desired 
carbamate 309.  Excess DMAP was even used to ensure the acetamide nitrogen was 
kept nucleophilic.  Literature examples once again indicate that aliphatic and/or 
sterically hindered amines are resistant to such a reaction.145  It was plausible that the 
secondary nature of the amine as well as steric bulkiness of the neighboring tertiary 
carbon on the pseudo-chair would cause interference with nucleophilic attack of the 
nitrogen.          
   
 







                                                
145 (a) Grehn, L.; Gunnarsson, K.; Ragnarsson, U. Journal of the Chemical Society, Chemical 
Communications 1985, 1317-1318. (b) Grehn, L.; Gunnarsson, K.; Ragnarsson, U. Acta Chemica 






























3.11 Reduction to ethylamine and reductive amination 
 
 To drive the synthesis forward and focus on condition optimization for the 
ensuing intramolecular Heck coupling, it was decided to reduce the acetamide to its 
corresponding ethylamine derivative 311 (Scheme 3.88) for utility as a model system.  
Original attempts in refluxing THF results in O-deprotected material only, speaking to 
its inherent robustness.146  Increasing the energy to refluxing 1,4-dioxane provided the 
desired ethylamine 311 in which the silyl protecting group was unavoidably removed 
under such forceful conditions.  This assisted in step economy since the protecting 
group was no longer necessary for the remainder of the synthesis.      
 
 





                                                
146 Reduction using excess Red-Al in THF was also employed but did not provide the desired ethylamine.  
For precedence, see: Voight, E. A.; Bodenstein, M. S.; Ikemoto, N.; Kress, M. H. Tetrahedron Letters, 















 Reductive amination was first performed using iodo-crotonaldehyde 108 with or 
without Ti(OiPr)4 in the presence of NaCNBH3 (Scheme 3.89).147  This led to a mixture 
of products, ostensibly from Michael addition to 313 followed by a second addition of 
the amine to aldehyde 108 and subsequent sodium cyanohydride reduction (since the 
pH was kept above 6, reduction of the intermediate aldehyde should not occur).  This 













                                                
147 (a) For reductive amination of ketones and aldehydes, see: Abdel-Magid, A. F.; Carson, K. G.; Harris, 
B. D.; Maryanoff, C. A.; Shah, R. D. Journal of Organic Chemistry 1996, 61, 3849-3862. (b) Borch, R. F. 
Organic Syntheses 1972, 52, 124-127. (c) For a review on sodium cyanoborodydride utility, see: Hutchins, 
R. O.; Natale, N. R. Organic Preparations and Procedures International 1979, 11, 201-246. (c) Lane, C. F. 
Synthesis 1985, 135-146. (d) For reduction aminations using Ti(OiPr)4 as a Lewis acid catalyst, see: 
Mattson, R. L.; Pham, K. M.; Leuck , D. J.; Cowen, K. A. Journal of the American Chemical Society 1990, 
55, 2552-2554. 
 









 Finally, alkylation149 was accomplished with the original mesylate 111 in 
reasonable yields and subsequent allylic oxidation occurred with satisfaction (Scheme 






                                                
149 No O-alkylation was seen under these conditions.  For O- versus N-alkylation, see: Mijin, D. Z.; Mi(i$-
Vukovi$, M. M.; Petrovi$, S. D. Journal of the Serbian Chemical Society 2004, 69, 711–736. 
 
150 Oxidation also worked with PCC as demonstrated on acetamide x (Scheme 3.86), but was much lower 


















































3.12 Pd-Catalyzed Coupling 
 
 A model substrate was now in hand for optimization of Pd-catalyzed 
intramolecular coupling (Scheme 3.91).  Several catalysts with and without ligands 
were tested and the base and solvent were also surveyed (Table 3.10).  Entries 1-4 
provided recovery of starting material.  Delightfully, evidence of the coupled product 
was visible under the conditions outlined in entry 5, albeit in less than a 15% yield after 
15 h.  Efforts are currently being made to optimize this reaction as well uncovering an 































Table 3.10 Conditions attempted for the intramolecular Heck coupling of 316. 
Entry Base Catalyst Ligand Solvent Temperature Time 
1 K2CO3 Pd(PPh3)4 - THF 70 °C 10 h 
2 Ag2CO3 Pd(OAc)2 PPh3 DMF 110 °C 15 h 
3 K2CO3 Pd2(dba)3 xantphos THF 70 °C 18 h 
4 Na2CO3 Pd2(dba)3 BINAP toluene 110 °C 16 h 
5 NEt3  (20 equiv) 
Pd(OAc)2  




3.13 End-game strategy 
 
 Following optimization of the Heck coupling, the final natural product can be 
realized in 5 transformations (Scheme 3.92).  The desired secondary amine 318 void of 
the ethyl group is required for further functionalization of the molecule.  After N-
deacetylation conditions of 233a (Scheme 3.88) is resolved, it was originally planned 












enolate with o-iodonitrobenzene followed by nitro reduction to introduce the indole 
ring (simple Fisher indole synthesis is not possible with !,#-unsaturated ketones).  
However, this may couple with the external olefin, producing a mixture of coupled 
products.  Regiocontrol of the indole synthesis was optimized by Rawal and coworkers 
using an unsymmetrical nitrophenylating reagent 320 that can be readily prepared in 
two steps from o-iodonitrobenzene.151  An alkylative cyclization protocol adopted by 
the same group would provide 322 in a two-step manner.152  The final step to open 
valpericine 8 can be accomplished with sodium cyanoborohydride in acidic medium to 
furnish subincanadine E.  This procedure would furnish the natural product in 16 linear 










                                                
151 For precedence of this step, see Scheme 12 in: Kozmin, S. A.; Iwama, T.; Huang, Y.; Rawal, V. Journal 
of the American Chemical Society 2002, 124, 4628-4641. 
 
152 A 1-step procedure is known, but Rawal and coworkers found that cyclization induced by tosylation 
competed with tosylation of the indole nitrogen.  For the one step protocol, see: Rubiralta, M. Diez, A. 
Bosch, J.; Solans, S. Journal of Organic Chemistry 1989, 54, 5591-5597.  For the 2-step protocol, see 
reference 147.  Note that the transformation from x to x after step 1 would probably isolate the chloroamine 
rather than the O-mesylated amine as reported in this paper.  
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 Efforts toward the second total synthesis of (±)-subincanadine E have been put 
forth from tryptamine as well as efforts toward the first total asymmetric synthesis of 
(15S)-subincanadine Efrom (S)-carvone.  Several retrosyntheses have been discussed 
concerning the asymmetric route, with highlights including undesired intramolecular 
Diels-Alder cyclization, formation of 17-oxo-subincanadine E via intramolecular 
enolate-driven Pd-catalyzed coupling, and copper-mediated 1,4-addition attempts to 
form the challenging C15-C20 bond.  The asymmetric retrosynthesis features a novel 
route toward a 5-aminocyclohexenol and 5-aminocyclohexenone building blocks 
unprecedented in the literature by means of a Beckmann rearrangement.  An 
intramolecular Heck reaction proceeded and efforts are currently being made toward its 
optimization as well as cleavage of a robust N-acetamide.  To date, 10 out of 16 total 











CHAPTER 4: EXPERIMENTAL PROCEDURES 
 
4.1 Methods and materials 
Unless otherwise stated, all non-aqueous reactions were carried out under an 
atmosphere of dry nitrogen in either oven-dried or flame-dried glassware.  
Tetrahydrofuran, dichloromethane, diethyl ether, benzene, and toluene were dried using 
a Glass Contour solvent purification system by SG H2O USA, LLC.  All commercially 
available starting materials were purchased from Aldrich, Fischer Scientific, or Acros 
Organics, and used as received.  Analytical TLC was performed on a Whatman Partisil 
KF6 0.255 mm silica gel plates with UV indicator.  Visualization was accomplished by 
irradiation under a 254 nm UV lamp or stained with either an aqueous solution of 
CAM, KMnO4, iodine, or vanillin.  Flash chromatography was performed using a 
forced flow of the indicated solvent system on EM Reagents Silica Gel 60 (230-400 
mesh).  Removal of solvents was accomplished on a Büchi R-210 rotary evaporator and 
compounds were further dried under a Fischer Scientific Maxima C-Plus vacuum line. 
All 1H data was conducted at ambient temperatures and recorded on a Varian 
UnityInova (500 MHz), Bruker ARX (500 MHz), or Bruker AscendTM (125 MHz) 
spectrometer.  13C NMR spectra were recorded on a Bruker ARX (125 MHz) or a 
! 128 
Bruker AscendTM (500 MHz).  Chemical shifts are reported relative to either 
chloroform (! 7.24) or methanol (! 3.31) for 1H spectra and either chloroform (! 77.2) 
or methanol (! 49.15) for 13C spectra.  Data are reported as follows: chemical shift, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, br = broad, m = 
multiplet), coupling constants (Hz), and number of protons.  IR spectra were recorded 
on a Thermo Nicolet FT200 FT-IR spectrometer with attenuated total reflectance 
(ATR) head.  High-resolution mass spectra (HRMS) in CI mode were obtained on a 
Waterss GC-TOF mass spectrometer (GCTPremier) employing a direct insertion probe 
and methane as the reagent gas.  Heptacosa was used as the internal reference.  Samples 
were dissolved in CH2Cl2 and introduced using a direct insertion probe.  Data analysis 
was performed in automated fashion using Waters software.  For ESI mode, HRMS 
were obtained on a Waterss LC-TOF mass spectrometer (LCT-XE Premier) using 
electrospray ionization in positive mode.  Samples were prepared in 100% CH2Cl2 and 
introduced using flow injection through Water Alliance separation module 2695 using a 
mobile phase of 100% MeOH (0.1mL/minute).  Leucine Enkephaline (Waterss MS kit) 
was used as an internal reference (2 ng/ul in acetonitrile/ H2O, 1:1 V/V, was mixed 
with 1% acetic acid acetonitrile/ H2O 1% V/V) and introduced by infusion.  Standard 
settings were used for all other parameters including drying gas, nebulizer flow, and 
! 129 
cone voltage.  The dry gas temperature was default value of 300 °C.  Solvents used 
were all Optima grade from Fisher. 
 
 
4.2 Experimental procedures for the first-generation synthesis 
 
 
11b-methyl-5,6,11,11b-tetrahydro-1H-indolizino[8,7-b]indol-3(2H)-one (92).  To a 
stirred solution of tryptamine 18 (0.1674 g, 1.0 mmol, 1 equiv) in xylenes (8 mL) was 
added levulinic acid (0.21 mL, 2 mmol, 2 equiv) via syringe.  The reaction flask was 
equipped with a Dean-Stark trap and condenser, placed under a stream of nitrogen, and 
heated to reflux.  After 4 h, the solvent was removed and the remaining brown oil was 
diluted in chloroform (8 mL), washed with 1 M HCl (1 x 10 mL), 1 M NaOH (1 x 10 
mL) and H2O (2 x 10 mL).   The combined organic layers were dried over MgSO4 and 
concentrated under reduced pressure.  The dark brown solid was recrystallized in 
benzene yielding 0.1770 g (74%) of a light brown solid.  Rf  = 0.33 (100% EtOAc).  1H 






1H), 7.17 (td, J = 7.0, 1.2 Hz, 1H), 7.12 (td J = 1.1, 6.9 Hz, 1H), 4.46 (ddd, J = 1.5, 5.8, 
13.3 Hz, 1H), 3.08 (td, J = 5.5, 11.0 Hz, 1H), 2.72 – 2.86 (m, 2H), 2.62 – 2.71 (m, 1H) 
2.46 (dd, J = 2.3, 9.7 Hz, 1H), 2.27 (ddd, J = 2.2, 8.9, 12.1 Hz, 1H), 2.13 – 2.20 (m, 
1H), 1.58 (s, 3H).  13C NMR (125 MHz, CDCl3) ! 172.7, 137.6, 136.1, 126.7, 122.2, 
119.8, 118.5, 111.0, 106.9, 35.0, 32.8, 30.7, 25.6, 25.4, 21.2. 
 
 
11b-methyl-2,3,5,6,11,11b-hexahydro-1H-indolizino[8,7-b]indole (91).  To an oven-
dried round-bottom flask purged with nitrogen was added lactam 92 (0.9604 g, 4 mmol, 
1 equiv) in dry THF (68 mL).  LiAlH4 (0.3410 g, 14.4 mmol, 3.6 equiv) was slowly 
added to the stirred mixture and brought to a reflux for 4 h under nitrogen.  Upon 
cooling, the solution was quenched with H2O (0.6 mL) via slow pipette addition 
followed by 1 M NaOH (0.6 mL) and more H2O (1.8 mL).  The resultant solution was 
filtered and placed under reduced pressure to provide 0.760 g (84%) of 91 as a light 
brown solid.  Rf  = 0.46 (streak in 85:15:1 CH2Cl2:MeOH:NH4OH).  1H NMR (500 
MHz, CDCl3) ! 7.78 (s, 1H), 7.46 (d, J  = 7.7 Hz, 1H), 7.31 (d, J = 8.1 Hz, 1H), 7.14 






3.22 – 3.31 (m, 2H), 3.08 (ddd, J = 4.0, 9.1, 17.0  Hz, 1H), 2.89 – 2.99 (m, 2H), 2.56 
(dd, J = 4.3, 16.9 Hz, 1H), 2.12 – 2.17 (m, 1H), 2.02-2.07 (m, 1H), 1.83 – 1.94 (m, 2H), 
1.55 (s, 3H).  13C NMR (125 MHz, CDCl3) ! 138.8, 135.9, 127.1, 121.3, 119.2, 118.1, 




carboxylate (97b).  To a solution of amine 91 (0.1147 g, 0.51 mmol, 1 equiv) in dry 
toluene (5 mL) was added Boc anhydride (0.1743 g, 0.75 mmol, 1.5 equiv) and allowed 
to stir at rt for 1 h.  The reaction mixture was heated to 110 °C in an oil bath for 21 h.  
The crude solution was concentrated to yield 0.2245 g of a red oil.  Purification was 
accomplished by flash chromatography (2:1 hexanes:EtOAc) affording 0.0208 g (12%) 
of the protected external olefin 97b.  Rf  = 0.80 (2:1 hexanes:EtOAc).    1H NMR (500 
MHz, CDCl3) ! 7.90 (s, 1H), 7.50 (dd, J = 7.8, 3.2 Hz, 1H), 7.28 (d, J = 8.0 Hz, 1H), 
7.16 (ddd, J = 8.4, 5.9, 2.1 Hz, 1H), 7.07 (m, 1H), 5.26 – 5.03 (m, 2H), 3.63 – 3.51 (m, 
1H), 3.42 (t, J = 5.2 Hz, 1H), 3.23 (t, J = 5.9 Hz, 1H), 3.12 (ddt, J = 20.5, 10.8, 5.7 Hz, 






(s, 4H).  13C NMR (125 MHz, CDCl3) ! 156.1, 155.3, 143.1, 143.0, 135.7, 135.6, 
135.0, 129.2, 129.2, 122.7, 122.5, 119.5, 119.3, 118.5, 118.3, 112.7, 111.9, 110.6, 




(97a).  To a solution of amine 91 (0.5533 g, 2.4 mmol, 1 equiv) in dry THF (60 mL) 
was added NaHCO3 (1.8132 g, 11 mmol, 4.6 equiv).  After cooling to 0 °C, benzyl 
chloroformate (1.0 mL, 6.7 mmol, 2.8 equiv) was added drop-wise and allowed to 
warm to rt over 1 h.  H2O was then added (5.4 mL, 293 mmol, 122 equiv) and the 
reaction mixture was heated to 50 °C in an oil bath.  After 3 h, additional benzyl 
chloroformate and H2O was added and continued to stir for 20 h.  Once cooled to rt, the 
red solution was washed with 2 M NaOH (1 x 30 mL), brine (1 x 30 mL), dried over 
Na2SO4, and concentrated to yield 1.6064 g of an orange oil.  Purification was 
accomplished by flash chromatography (95:5 CH2Cl2:EtOAc) affording 0.46 g (52%) 
of the protected external olefin 97a.  Rf  = 0.55 (2:1 hexanes:EtOAc).  1H NMR (500 







7.15 – 7.21 (m, 3H), 7.09 (td, J = 3.9, 8.0 Hz, 1H), 6.97 (d, J = 7.0 Hz, 1H), 5.28 
(CH2Cl2), 5.03 – 5.16 (m, 3H), 4.91 (s, 1H), 4.10 (EtOAc), 3.62 – 3.64 (m, 1H), 3.54 – 
3.56 (m, 1H), 3.32 (t, J = 6.3 Hz, 1H), 3.25 (t, J = 6.5 Hz, 1H), 3.10 – 3.16 (m, 2H), 
2.62 – 2.67 (m, 2H), 2.03 (EtOAc), 1.93 – 1.97 (m, 1H), 1.78 – 1.83 (m, 1H), 1.24 
(EtOAc).  13C NMR (125 MHz, CDCl3) ! 171.4 (EtOAc), 156.5, 155.6, 142.8, 136.8, 
135.2, 128.9, 128.4, 28.2, 128.0, 127.5, 122.5, 119.3, 118.0, 112.6, 112.2, 111.5, 110.5, 
66.6, 60.5 (EtOAc), 48.4, 47.1, 31.7, 28.5, 24.4, 21.2 (EtOAc), 14.4 (EtOAc). 
 
 
1-(7-methylene-1,2,4,5,6,7-hexahydroazonino[5,4-b]indol-3(8H)-yl)ethanone (97c).  
See procedure for 97a.  1H NMR (500 MHz, CDCl3) ! 8.02 (s, 1H), 7.52 (d, J = 7.9 Hz, 
1H), 7.30 (d, J = 8.1 Hz, 1H), 7.21 – 7.15 (m, 1H), 7.12 – 7.06 (m, 1H), 5.25 (s, 1H), 
5.11 (s, 1H), 3.49 – 3.41 (m, 2H), 3.41 – 3.30 (m, 2H), 3.23 – 3.10 (dt, J = 8.5, 3.3 Hz, 
2H), 2.61 (dd, J = 7.6, 4.2 Hz, 2H), 2.17 – 1.94 (m, 4H), 1.52 (H2O), 1.49 (s, 3H).  13C 
NMR (125 MHz, CDCl3) ! 171.1, 142.7, 135.8, 135.7, 129.0, 122.9, 119.6, 118.0, 









7,9'-azonino[6,5,4-hi]benzo[b]indolizine]-3,3'(2H,2'H)-dicarboxylate (98).  To a 
solution of the external olefin 97a (0.1123 g, 0.31 mmol, 1 equiv) in dry toluene (14 
mL) was added p-TsOH (0.0969 g, 0.51 mmol, 1.6 equiv) and heated to 50 °C in an oil 
bath.  After 4 h, the reaction solution was washed with saturated Na2CO3 (2 x 15 mL), 
brine (1 x 15 mL), dried over Na2SO4, and concentrated to an orange foam.  
Purification was accomplished by flash chromatography (2:1 hexanes:EtOAc) affording 
0.1141 g (51%) of dimer 98.  Rf  = 0.38 (3:1 hexanes:EtOAc).  1H NMR (500 MHz, 
CDCl3) ! 7.59 – 7.43 (m, 2H), 7.39 – 7.33 (q, J = 4.5, 4.1 Hz, 2H), 7.33 – 7.25 (m, 4H), 
7.20 – 6.97 (m, 5H), 5.29 – 4.89 (m, 2H), 4.52 – 4.27 (m, 1H), 4.10 (EtOAc), 3.95 – 
3.76 (s, 1H), 3.71 – 3.21 (m, 3H), 3.21 – 2.47 (m, 6H), 2.36 – 2.14 (m, 2H), 2.14 – 1.83 
(m, 3H), 1.37 – 1.17 (td, J = 6.8, 3.9 Hz, 2H), 1.17 – 1.03 (d, J = 22.8 Hz, 1H), 1.03 – 
0.91 (m, 2H), 0.91 – 0.75 (m, 1H).  13C NMR (125 MHz, CDCl3) ! 157.1, 157.0, 156.8, 









133.9, 133.9, 133.4, 133.1, 133.0, 132.9, 131.7, 131.6, 131.5, 131.4, 129.8, 129.4, 
128.7, 128.6, 128.5, 128.1, 128.0, 127.9, 127.7, 127.1, 122.0, 121.8, 121.7, 121.5, 
121.4, 121.0, 119.8, 119.7, 118.6, 118.5, 118.1, 118.0, 117.9, 111.9, 111.8, 111.7, 
111.2, 111.1, 109.2, 109.0, 104.5, 104.2, 103.6, 67.3, 67.2, 67.0, 66.9, 66.7, 66.3, 66.2, 
66.1, 65.4, 49.1, 48.6, 48.3, 47.8, 47.6, 47.5, 46.7, 40.9, 40.8, 40.3, 40.2, 39.1, 38.6, 




4.3 Experimental procedures for the second-generation synthesis 
 
 
N-(2-(1H-indol-3-yl)ethyl)-4-hydroxybutanamide (103).  To a stirred solution of 
tryptamine 18 (3.2131 g, 20 mmol, 1 equiv) in dry toluene (30 mL) was added !-
butryrolactone (1.7 mL, 22 mmol, 1.4 equiv) via syringe.  After addition of p-TsOH 
(catalytic), the reaction mixture was heated at a reflux for 7 h.  Once cooled, toluene 
was removed by rotary evaporation, the residue was re-dissolved in ethyl acetate (15 
mL), and placed in the freezer overnight.  Filtration provided 3.3210 g (64%) of a 
yellow/white solid.  Rf  = 0.57 (85:15:1 CH2Cl2:MeOH:NH4OH).  1H NMR (500 MHz, 
CDCl3) " 8.19 (s, 1H), 7.58 (d, J = 8.5 Hz, 1H), 7.36 (d, J = 7.9 Hz, 1H), 7.19 (td, J = 
1.1, 8.1 Hz, 1H), 7.20 (td, J = 1.0, 7.8 Hz, 1H), 7.01 (d, J = 0.6, 8.0 Hz, 1H), 5.67 (bs, 
1H), 3.58 – 3.62 (m, 4H), 2.96 (t, J = 7.7 Hz, 2H), 2.84, (bs, 1H), 2.24 (t, J = 7.4 Hz, 
2H), 1.80 (p, J = 6.5 Hz, 2H).  13C NMR (125 MHz, CDCl3) " 195.7, 175.9, 138.2, 









2,3,5,6,11,11b-hexahydro-1H-indolizino[8,7-b]indole ((±)-harmacine) (101).  Under 
an atmosphere of nitrogen, amido-alcohol 103 (4.61 g, 17.7 mmol, 1 equiv) was 
dissolved in POCl3 (50 mL, 567 mmol, 32 equiv) and heated at reflux for 5 h.  Once 
cooled to rt, POCl3 was removed in vacuo and the residue was re-dissolved in CH2Cl2 
(3 x 40 mL) to ensure complete removal of this reagent.  After drying overnight under 
vacuum, the lime green foam (crude weight of 4.70 g, 17.4 mmol, 1 equiv) was 
exposed to MeOH (350 mL) and cooled to 0 °C.  NaBH4 (13.250 g, 350 mmol, 20 
equiv) was slowly added over a period of 1 h.  The stirred mixture was allowed to 
warm to rt.  After 2 h, MeOH was removed in vacuo, the resultant crude material was 
diluted with diethyl ether (150 mL), washed with H2O (1 x 150 mL), dried over 
Na2SO4, and concentrated under reduced pressure to yield 3.35 g (89% over 2 steps) of 
a yellow solid.  Rf = 0.26 (85:15:1 in CH2Cl2:MeOH:NH4OH).  1H NMR (500 MHz, 
CDCl3) ! 8.22 (s, 1H), 7.47 (d, J = 8.2 Hz, 1H), 7.23 (d, J = 8.0 Hz, 1H), 7.07 – 7.14 
(m, 2H), 4.23 (td, J = 2.3, 7.3 Hz, 1H), 3.44 (s, MeOH), 3.31 (ddd, J = 2.5, 5.4, 13.0 






– 2.31 (m, 1H), 1.78 – 1.94 (m, 3H). 13C NMR (125 MHz, CDCl3) ! 136.2, 136.6, 




(101a).  To a stirred solution of harmacine 101 (0.0508 g, 0.24 mmol, 1 equiv) in dry 
CH2Cl2 (4 mL) was added DMAP (0.0291 g, 0.24 mmol, 1 equiv) and Boc anhydride 
(0.1001 g, 0.46 mmol, 1.9 equiv).  After 3 h, the solution was concentrated to a light 
brown foam.  Purification was performed by flash chromatography (100% EtOAc to 
85:15:1 CH2Cl2:MeOH:NH4OH) yielding 0.0338 g (67%) of a white foam.  Rf= 0.79 
(2:1 hexanes:EtOAc).  1H NMR (500 MHz, CDCl3) ! 8.01 (d, J = 8.3, 1H), 7.40 (d, J = 
7.7, 1H), 7.30 (t, J = 8.3, 1H), 7.23 (t, J = 7.6, 1H), 5.30 (t, J = 7.1, 1H), 3.68 – 3.74 (m, 
1H), 3.47 – 3.52 (m, 1H), 3.36 – 3.40 (m, 1H), 3.13 – 3.20 (m, 2H), 2.83 – 2.96 (m, 
2H), 2.15 – 2.25 (m, 1H), 1.94 – 2.05 (m, 2H), 1.65 (s, 9H).  13C NMR (125 MHz, 
CDCl3) ! 159.6, 136.0, 130.4, 127.6, 125.3, 123.3, 118.4, 115.7, 113.2, 85.2, 59.6, 









(100a).  To a stirred solution of harmacine 101 (0.6180 g, 2.9 mmol, 1 equiv) in dry 
THF (60 mL) was added Na2CO3 (1.4451 g, 13.1 mmol, 4.5 equiv).  After cooling to 0 
°C under nitrogen, benzyl chloroformate (1.2 mL, 8.1 mmol, 2.8 equiv) was added 
drop-wise.  The cloudy lime green solution was allowed to stir at rt for 1 h.  A reflux 
condenser was added and the reaction mixture was brought to 50 °C in an oil bath.  
After 25 min, H2O (6.3 mL, 349.2 mmol, 120 equiv) was added and continued to heat 
for 3 h, after which the solution turned dark brown.  An additional equivalent of the 
chloroformate (1.2 mL) and H2O (6.3 mL) was added and allowed to stir at this 
temperature for 2 h more.   The solvent was removed and the residue was diluted with 
chloroform (30 mL), washed with 2 M NaOH (1 x 30 mL), rinsed with brine (1 x 30 
mL), dried over Na2SO4, and concentrated under reduced pressure to yield a lime green 
oil.  Purification was performed by flash chromatography (85:15:1 
CH2Cl2:MeOH:NH4OH) yielding 0.748 g (71%) of 100a.  A benzyl alcohol impurity 
was present, providing 53% of the desired product (Calculated from 1H NMR 








CDCl3) ! 8.89 (d, J = 7.4 Hz, 1H), 7.55 (t, J = 6.8 Hz, 1H), 7.38 – 7.42 (m, 6H), 7.21 (t, 
J = 7.5 Hz, 1H), 7.16 (t, J = 7.5 Hz, 1H), 5.07 – 5.22 (m, 2H), 4.67 (s, benzyl alcohol) 
3.96 – 4.09 (m, 2H), 3.51 – 3.61 (m, 1H), 2.94 – 3.17 (m, 2H), 2.54 – 2.67 (m, 2H), 
2.11 – 2.23 (m, 1H), 1.79 – 1.86 (m, 1H), 1.34 (d, J = 14.4 Hz, 1H), 0.78 – 0.86 (m, 
1H).  13C NMR (125 MHz, CDCl3) ! 156.2, 136.6, 136.4, 135.5, 135.4, 128.4, 127.9, 




1,2,3,4,5,6,7,8-octahydroazonino[5,4-b]indol-7-ol (106).  To the protected amine 
100a (0.100 g, 0.27 mmol, 1 equiv) stirred in EtOH (4 mL) was added 10% Pd/C 
(0.010 g, cat.) and ammonium formate (0.085 g, 1.35 mmol, 5 equiv) at rt.  After 
stirring for 18 h the solution was filtered through a plug of Celite and concentrated to 
produce 0.0984 g of a bright yellow oil.  Purification was performed by flash 
chromatography (85:15:1 CH2Cl2:MeOH:NH4OH) yielding 0.0465 g (75%) of a white 
solid.  Rf  = 0.25 (85:15:1 CH2Cl2:MeOH:NH4OH).  1H NMR (500 MHz, CDCl3) ! 8.25 







7.1 Hz, 2H), 5.08 (dd, J = 2.90 4.7 Hz, 1H), 3.32 (ddd, J = 2.3, 4.6, 14.0 Hz, 1H), 3.05 
(ddd, J = 2.2, 11.7, 15.0 Hz, 1H), 2.91 (dd, J = 3.9, 14.7 Hz, 1H), 2.58 – 2.62 (m, 2H), 
2.34 – 2.41 (m, 1H), 2.00 – 2.05 (m, 1H), 1.75 – 1.81 (m, 1H), 1.24 – 1.33 (m, 2H), 
1.06 – 1.15 (m, 1H).   13C NMR (125 MHz, CDCl3) ! 136.3, 134.5, 128.5, 120.7, 118.4, 
117.0, 110.2, 110.2, 68.0, 48.2, 48.1, 37.1, 25.4, 22.8. 
 
 
(Z)-2-iodobut-2-enal (109).  To a stirred solution of crotonaldehyde 108 (4.2 mL, 56.7 
mmol, 1 equiv) in 1:1 THF/H2O (250 mL) was added K2CO3 (8.3076 g, 68.1 mmol, 1.2 
equiv), I2 (19.3347 g, 868 mmol, 15.3 equiv), and DMAP (1.2344 g, 10.1 mmol, cat.) 
successively.  After 3 h of stirring at rt, the black solution was diluted with EtOAc (200 
mL), washed with Na2S2O3 (1 x 100 mL), 0.1 M HCl (1 x 200 mL), dried over MgSO4, 
and concentrated yielding 4.500 g (45%) of a black oil.  Rf  = 0.80 (2:1 
hexanes:EtOAc).  1H NMR (500 MHz, CDCl3) 8.67 (s, 1H), 7.28 (q, J = 6.7 Hz, 1H), 
4.01 (q, EtOAc), 2.18 (d, J = 6.8 Hz, 3H), 1.98 (s, EtOAc), 1.13 (t, EtOAc).  13C NMR 






(Z)-2-iodobut-2-en-1-ol (110).  To a solution of the aldehyde 109 (4.500 g, 22.96 
mmol, 1 equiv) in MeOH (100 mL) cooled to 0 °C was added NaBH4 (1.7391 g, 34.4 
mmol, 1.5 equiv) portion-wise and continued to stir for 3 h.  Methanol was removed in 
vacuo and the residue was dissolved in EtOAc (150 mL), washed with 1 M NaOH (2 x 
150 mL), dried over Na2SO4, and concentrated.  Further removal of solvent in vacuo 
for 2 h yielded 2.690 g (59%) of an orange oil.  Rf  = 0.45 (2:1 hexanes:EtOAc).  1H 
NMR (500 MHz, CDCl3) ! 5.95 (qt, J = 1.2, 6.5 Hz, 1H), 4.23 (s, 2H), 1.78 (dt, J = 1.1, 
6.4 Hz, 3H), 1.51 (s, H2O). 
 
 
(Z)-2-iodobut-2-enyl methanesulfonate (111).  To a stirred solution of buten-ol 110 in 
dry CH2Cl2 (50 mL) wad added NEt3 (2.3 mL, 16 mmol, 1.2 equiv).  The reaction 
mixture was cooled to 0 °C and MsCl (1.2 mL, 15 mmol, 1.1 equiv) was added drop-
wise and continued to stir for 3 h.  The bright yellow solution was washed with water (1 
x 50 mL), NaHCO3 (1 x 50 mL), dried over Na2SO4, and concentrated under reduced 








NMR (500 MHz, CDCl3) ! 6.17 (q, J = 0.9, 6.4 Hz, 1H), 4.87 (q, J =1.0 Hz, 2H), 3.04 




(Z)-3-(2-iodobut-2-enyl)-1,2,3,4,5,6,7,8-octahydroazonino[5,4-b]indol-7-ol (112).  
To a tarred round-bottom flask was added mesylate 111 (0.085 g, 0.31 mmol, 1.4 
equiv) in dry THF (2 mL), K2CO3 (0.0655 g, 0.44 mmol, 2.0 equiv), NEt3 (0.048 mL, 
0.33 mmol, 1.5 equiv), and amino-alcohol 106 (0.0518 g, 0.22 mmol, 1 equiv).  The 
reaction mixture was stirred under nitrogen at rt for 21 h.  The solvent was removed in 
vacuo, the residue was diluted with CH2Cl2 (3 mL), washed with H2O (1 x 3 mL), brine 
(1 x 3 mL), dried over Na2SO4, and concentrated under reduced pressure.  Purification 
was performed by flash chromatography (85:15:1 CH2Cl2:MeOH:NH4OH) yielding 
0.081 g (90%) of a light brown foam.  Rf  = 0.70 (85:15:1 CH2Cl2:MeOH:NH4OH).  1H 
NMR (500 MHz, CDCl3) ! 8.04 (s, 1H), 7.47 (d, J = 7.9 Hz, 1H), 7.29 (d, J = 8.0 Hz, 
1H), 7.12 (td, J = 1.1, 7.2 Hz, 1H), 7.06 (td, J = 1.0, 8.0 Hz, 1H), 5.85 (q, J = 6.3 Hz, 








2.98 (m, 1H), 2.77 – 2.82 (m, 1H), 2.60 – 2.67 (m, 2H), 2.38 – 2.50 (m, 2H), 1.96 – 
2.03 (m, 2H), 1.82 (d, J = 6.5 Hz, 3H), 1.30 – 1.35 (m, 1H), 1.11 – 1.19 (m, 1H).  13C 
NMR (125 MHz, CDCl3) ! 137.2, 135.0, 134.0, 128.7, 121.3, 119.0, 118.8, 117.7, 




b]indole (112a).  The alkylation procedure was the same as for compound 112.  The 
hydrogenation used the same procedure as 106 with the exception of using MeOH as 
the solvent instead.  Rf  = 0.65 (95:5:1 CH2Cl2:MeOH:NH4OH).  1H NMR (500 MHz, 
CDCl3) ! 8.66 (bs, 1H), 7.54 (d, J = 7.9 Hz, 1H), 7.38 (d, J = 8.0 Hz, 1H), 7.12 (t, J = 
7.1, 15.0 Hz, 1H), 7.14 – 7.06 (t, J = 7.8, 14.9 Hz, 1H), 6.01 (dd, J = 11.0, 5.7 Hz, 1H), 
5.83 (q, J = 6.2 Hz, 1H), 3.55 (s, 2H), 3.34 (s, 3H), 2.99 – 2.86 (m, 1H), 2.86 – 2.69 (m, 
2H), 2.56 – 2.43 (m, 1H), 2.43 – 2.28 (m, 2H), 2.11 – 1.97 (m, 1H), 1.95 – 1.73 (m, 
5H), 1.38 – 1.20 (m, 1H), 1.03 – 0.84 (m, 1H).  13C NMR (125 MHz, CDCl3) ! 135.70, 
135.37, 132.92, 128.41, 121.46, 118.85, 117.94, 114.75, 110.88, 110.17, 71.85, 56.86, 









(Z)-3-(2-iodobut-2-enyl)-1,2,3,4,5,6-hexahydroazonino[5,4-b]indol-7(8H)-one (99).  
Manganese(II) dioxide (0.2332 g, 2.7 mmol, 24 equiv) was added to the alkylated 
amino-alcohol 112 (0.0440 g, 0.11 mmol, 1 equiv) and suspended in dry CH2Cl2 (3 
mL).  The suspension was heated to a reflux and allowed to stir for 21 h.  Once cooled, 
the solids were filtered through a Celite plug producing a light yellow solution that was 
concentrated under reduced pressure to yield 0.0352 g (86%) of the desired amino-
ketone 99.  Rf  = 0.83 (85:15:1 CH2Cl2:MeOH:NH4OH).  No purification was 
necessary. 1H NMR (500 MHz, CDCl3) ! 8.86 (s, 1H), 7.67 (d, J = 7.4 Hz, 1H), 7.36 
(d, J = 8.2 Hz, 1H), 7.29 (t, J = 6.9 Hz, 1H), 7.11 (t, J = 6.7 Hz, 1H), 5.46 (q, J = 6.9 
Hz, 1H), 5.24 (s, CH2Cl2) 3.16 (s, 2H), 3.05 (s, 2H), 2.68 – 2.32 (m, 6H), 2.00 (bs, 2H), 
1.61 (d, J = 6.3 Hz, 3H). 13C NMR (125 MHz, CDCl3) ! 195.8, 135.7, 135.6, 131.4, 














b]indole-8(1H)-carboxylate (113).  To a stirring solution of ketone 112 (0.0455 g, 
0.11 mmol, 1 eqiuv) in CH2Cl2 (1 mL) under nitrogen was added DMAP (0.0039 g, 
0.02 mmol, 0.2 equiv) followed by Boc anhydride (0.567 g, 0.17 mmol, 1.7 equiv).  
The solution was allowed to stir at rt for 4 h before the solvent was removed in vacuo to 
produce 0.0487 g of a dark brown oil.  Purification was performed by flash 
chromatography (95:5:1 CH2Cl2:MeOH:NH4OH) yielding 0.0292 g (64%) of a light 
brown foam.  Rf = 0.87 (95:5:1 CH2Cl2:MeOH:NH4OH).  1H NMR (500 MHz, CDCl3) 
! 8.08 (d, J = 8.3 Hz, 1H), 7.56 (d, J = 7.8 Hz, 1H), 7.38 (t, J = 8.4, 16.7 Hz 1H), 7.25 
(t, J = 8.8, 16.9 Hz, 1H), 5.61 (q, J = 6.3 Hz, 1H), 3.15 (s, 2H), 2.98 – 2.65 (m, 7H), 
2.55 (t, J = 5.8 Hz, 2H), 2.11 – 1.85 (m, 2H), 1.85 – 1.73 (m, 5H), 1.73 – 1.63 (m, 
12H), 1.47 (s, 18H).  13C NMR (125 MHz, CDCl3) ! 193.2, 150.2, 137.3, 137.2, 132.2, 











3-(prop-1-ynyl)-1,2,3,4,5,6-hexahydroazonino[5,4-b]indol-7(8H)-one (132).  To an 
oven-dried Schlenk tube was added cis-1,2-cyclohexanediol (0.0028 g, 0.02 mmol, 1 
equiv), CuI (0.0059 g, 0.02 mmol, 1 equiv), and dry DMF (0.5 mL).  The tube was 
purged three times with nitrogen at rt using a vacuum line.  After 10 min of stirring, the 
Boc-protected amino-ketone 113 (0.0103 g, 0.02 mmol, 1 equiv) was added in dry 
DMF (1 mL) followed by KOt-Bu (0.0045 g, 0.04 mmol, 2 equiv).  The Schlenk tube 
was placed in a pre-heated 80 °C oil bath for 12 h.  Once cooled to rt, the black solution 
was filtered through a Celite plug and concentrated to 0.0311 g of a yellow foam.   
Purification was performed by flash chromatography (2:1 hexanes:EtOAc to 95:5:1 
CH2Cl2:MeOH:NH4OH) yielding 0.003 g (43%) of light brown solid.  Rf  = 0.62 (95:5:1 
CH2Cl2:MeOH:NH4OH).  1H NMR (500 MHz, CDCl3) ! 8.90 (s, 1H), 7.66 (d, J = 8.1 
Hz, 1H), 7.35, (d, J = 8.2 Hz, 1H), 7.26 (td, J = 1.0, 7.0 Hz, 1H), 7.11 (td, J = 0.9, 7.0 
Hz, 1H), 2.65 – 3.07 (m, 7H), 2.59 (m, 2H), 2.45 (bs, 1H), 2.03 (bs, 2H), 1.68 (t, J = 
2.3 Hz, 3H), 1.56 (s, H2O).  13C NMR (125 MHz, CDCl3) ! 195.5, 136.2, 135.1, 127.5, 








8(1H)-carboxylate (133).  To a dry round-bottom flask was added phenol (0.214 g, 2.3 
mmol, 23 equiv), KOt-Bu (0.0229 g, 0.2 mmol, 2 equiv) and dry THF (1 mL).  After 5 
min of stirring, Pd(PPh3) 4 (0.0073 g, 0.006 mmol, 0.06 equiv) and the alkylated ketone 
113 (0.0421 g, 0.1 mmol, 1 equiv) was added and the solution was degassed.  The 
reaction mixture was placed under a stream of nitrogen and added to a 75 °C pre-heated 
oil bath.  After 12 h of stirring, the brown solution was quenched with ice water (5 mL), 
extracted with ethyl acetate (3 x 5 mL), washed with brine (1 x 7 mL), dried over 
Na2SO4, concentrated, and placed under reduced pressure yielding 0.0435 g of a brown 
oil.  Purification was performed by flash chromatography (95:5:1 
CH2Cl2:MeOH:NH4OH) yielding 0.014 g (50%) of light brown solid.  1H NMR (500 
MHz, CDCl3) ! 8.11 – 8.02 (m, 1H), 7.61 – 7.52 (m, 1H), 7.47 – 7.36 (m, 1H), 7.28 
(dd, J = 14.7, 7.3 Hz, 1H), 3.67 – 3.56 (m, 1H), 3.55 – 3.45 (m, 1H), 3.35 (d, J = 5.9 






2H), 1.94 – 1.81 (m, 1H), 1.66 (s, 2H), 1.56 (s, 11H), 1.29 – 1.13 (m, 3H), 1.03 – 0.75 




methanoazonino[5,4-b]indole-8(2H)-carboxylate (131).  In a glovebox, Pd2(dba)3 
(0.1790 g, 0.18 mmol, 0.2 equiv), NaOt-Bu (0.1439 g, 1.35 mmol, 1.7 equiv), and 
xantphos (0.1422 g, 0.18 mmol, 0.2 equiv) was added to a Schlenk reaction vessel.  The 
Boc-protected ketone 113 (0.4571 g, 0.90 mmol, 1 equiv) in THF (1 mL) was added via 
syringe and further diluted with THF (1.5 mL).  The reaction vessel was capped, 
removed from the glovebox, and purged five times with nitrogen at -78 °C.  Once 
warmed to rt, the reaction vessel was placed in a pre-heated oil bath set at 70 °C.  After 
4 h, the solution was concentrated to produce 0.830 g of a brown foam.  Purification 
was performed by flash chromatography (1:1 hexanes:EtOAc to 95:5:1 
CH2Cl2:MeOH:NH4OH) yielding 0.180 g (71%) of light brown solid.  1H NMR (500 






7.24 (m, 1H), 5.67 – 5.53 (m, 1H), 5.53 – 5.35 (m, 2H), 5.24 (s, CH2Cl2), 4.35 (d, J = 
5.9 Hz, 1H), 3.48 – 3.00 (m, 12H), 3.00 – 2.66 (m, 4H), 2.42 – 2.27 (m, 2H), 2.27 – 
2.09 (m, 2H), 1.71 – 1.62 (m, 6H), 1.61 – 1.46 (m, 6H).  13C NMR (125 MHz, CDCl3) ! 
203.0, 149.4, 136.4, 134.1, 132.4, 128.7, 126.2, 125.2, 123.2, 120.7, 119.5, 115.3, 85.1, 




7(2H)-one (137).  To a stirring solution of the [5.2.1]bicycle 131 (0.0511 g, 0.13 mmol, 
1 equiv) in dry CH2Cl2 (1.5 mL, 23 mmol, 174 equiv) was added TFA (1.5 mL, 20 
mmol, 149 equiv) slowly under nitrogen.  After 1 h 45 min, the solution was diluted 
with CH2Cl2 (15 mL) and quenched with NaHCO3 (15 mL) at 0 °C.  The biphasic 
solution was separated and the organic layer was washed with 1 M NaOH (1 x 60 mL), 
brine (1 x 15 mL), dried over Na2SO4, and concentrated to a brown oil.  Purification 
was performed by flash chromatography (95:5:1 CH2Cl2:MeOH:NH4OH) yielding 






1H), 7.70 – 7.55 (m, 1H), 7.44 – 7.28 (m, 12H), 7.16 – 7.04 (m, 1H), 5.60 – 5.36 (m, 
2H), 5.24 (s, CH2Cl2), 4.30 – 4.16 (d, J = 6.5 Hz, 1H), 3.50 – 3.39 (m, 1H), 3.39 – 3.10 
(m, 4H), 3.10 – 2.97 (m, 1H), 2.64 – 2.46 (m, 1H), 2.46 – 2.31 (td, J = 13.2, 12.0, 7.7 
Hz, 1H), 1.74 – 1.46 (m, 5H).   
       
 
(Z)-7-methylene-13-(prop-1-en-1-yl)-2,4,5,6,7,8-hexahydro-1H-3,6-
methanoazonino[5,4-b]indole (138).  Formation of the ylide: To a stirring solution of 
CH3PPh3Br (0.5725 g, 1.60 mmol, 7.6 equiv) in dry THF (3 mL) at 0 °C under nitrogen 
was added drop-wise 1.3 M n-BuLi (2.1 mL, 0.47 mmol, 2.2 equiv) and continued to 
stir at 0 °C for 1 h 20 min.  Wittig reaction:  The ylide solution (2.1 mL) was added to a 
separate flask containing the Boc-deprotected ketone 137 (0.0593 g, 0.21 mmol, 1 
equiv) in dry THF (3 mL) at 0 °C.  After warming to rt for 4.5 h, the solution was 
diluted with CH2Cl2 (24 mL), washed with NH4OH (1 x 24 mL), dried over Na2SO4, 
and concentrated.  Purification was performed by flash chromatography (1:10 






desired product.  Rf = 0.67 (95:5:1 CH2Cl2:MeOH:NH4OH).  1H NMR (500 MHz, 
CDCl3) ! 8.35 – 8.18 (s, 1H), 1.57 – 1.41 (m, 1H), 7.55 – 7.44 (dd, J = 13.8, 6.0 Hz, 
1H), 7.40 – 7.29 (m, 1H), 7.22 – 7.15 (dd, J = 7.9, 6.4 Hz, 1H), 7.15 – 7.04 (m, 1H), 
5.78 – 5.47 (m, 2H), 5.43 – 5.16 (m, 3H), 5.24 (s, CH2Cl2), 4.18 – 3.90 (d, J = 7.6 Hz, 
1H), 3.58 – 3.40 (m, 1H), 3.40 – 3.10 (m, 5H), 3.10 – 2.87 (dtd, J = 14.0, 9.5, 5.7 Hz, 
2H), 2.58 – 2.36 (dtd, J = 14.0, 9.2, 4.5 Hz, 1H), 2.16 – 1.84 (m, 2H), 1.79 – 1.57 (m, 
5H), 1.37 – 1.10 (m, 3H).  13C NMR (125 MHz, CDCl3) ! 144.1, 135.5, 134.6, 134.5, 
133.8, 133.4, 130.7, 128.9, 123.1, 120.1, 120.1, 118.5, 115.8, 111.0, 109.7, 76.9, 69.4, 
68.1, 54.6 (CH2Cl2), 52.9, 52.8, 33.9, 25.8, 21.2, 17.9. 
   
 
(E)-tert-butyl 3-((Z)-2-iodobut-2-en-1-yl)-7-((trimethylsilyl)oxy)-2,3,4,5-
tetrahydroazonino[5,4-b]indole-8(1H)-carboxylate (139a).  To an oven-dried 
Schlenk tube brought to -78 °C was added the Boc-protected ketone 113 (0.0085 g, 







equiv), TMSCl (0.021 mL, 0.17 mmol, 10 equiv), and 1 M LHMDS (0.014 g, 0.085 
mmol, 5 equiv).   After stirring for 4 h 20 min, the solution was warmed to rt and 
diluted with CH2Cl2 (5 mL), added H2O (5 mL), separated, and rinsed with brine (1 x 5 
mL), dried over MgSO4, and concentrated to 0.0099 g (99%) of the desired product.  
The crude material was taken on to the next step.  1H NMR (500 MHz, CDCl3) ! 8.03 – 
7.93 (d, J = 8.3 Hz, 1H), 7.45 – 7.40 (m, 1H), 7.29 – 7.25 (m, 1H), 7.22 – 7.17 (m, 1H), 
7.17 – 7.12 (d, J = 7.7 Hz, 1H), 5.91 – 5.74 (q, J = 6.4 Hz, 1H), 5.08 – 4.92 (m, 1H), 
3.55 – 3.42 (s, 2H), 3.33 – 3.15 (q, J = 6.9, 5.8 Hz, 1H), 3.12 – 3.01 (q, J = 7.3 Hz, 3H), 
3.01 – 2.85 (t, J = 7.4 Hz, 6H), 2.85 – 2.70 (dd, J = 10.0, 3.3 Hz, 2H), 2.65 – 2.43 (m, 
2H), 2.13 – 1.96 (t, J = 6.7 Hz, 1H), 1.85 – 1.74 (m, 5H), 1.71 – 1.62 (d, J = 7.0 Hz, 
13H), 1.52 (H2O), 1.48 – 1.31 (t, J = 7.2 Hz, 6H), 0.39 – -0.13 (s, 38H). 
   
 
(E)-tert-butyl 3-((Z)-2-iodobut-2-en-1-yl)-7-((triethylsilyl)oxy)-2,3,4,5-
tetrahydroazonino[5,4-b]indole-8(1H)-carboxylate (139).  To an oven-dried Schlenk 







1 equiv) in dry THF (1.5 mL) followed by NEt3 (0.061 mL, 0.44 mmol, 20 equiv), 
TESCl (0.074 mL, 0.44 mmol, 20 equiv), and 1M LHMDS (0.033 mL, 0.33 mmol, 15 
equiv).  After stirring for 4 h 20 min, the solution was warmed to rt and diluted with 
CH2Cl2 (5 mL), added H2O (5 mL), separated, and rinsed with brine (1 x 5 mL), dried 
over MgSO4 and concentrated to 0.011 g (98%) of the desired product.  The crude 
material was taken on to the next step.  1H NMR (500 MHz, CDCl3) ! 7.99 – 7.94 (d, J 
= 8.3 Hz, 1H), 7.45 – 7.39 (d, J = 7.7 Hz, 1H), 7.29 – 7.25 (m, 1H), 7.21 – 7.16 (m, 
1H), 5.84 – 5.74 (m, 1H), 5.06 – 4.96 (dd, J = 10.3, 5.9 Hz, 1H), 3.54 – 3.42 (s, 2H), 
3.15 – 2.98 (m, 13H), 2.98 – 2.87 (m, 3H), 1.61 – 1.52 (m, 8H), 2.87 – 2.71 (m, 5H), 
2.64 – 2.45 (ddd, J = 24.0, 11.9, 5.8 Hz, 2H), 2.08 – 1.92 (dq, J = 14.9, 8.6, 7.5 Hz, 
2H), 1.85 – 1.74 (m, 4H), 1.72 – 1.61 (m, 11H), 1.46 – 1.31 (t, J = 7.3 Hz, 14H), 0.96 – 
0.78 (pd, J = 10.7, 10.3, 5.3 Hz, 17H), 0.67 – 0.53 (m, 13H).    
 
 
(Z)-2-iodobut-2-enoic acid (152).  To a stirring solution of iodo-crotonaldehyde 108 
(7.44 g, 38.0 mmol, 1 equiv) was added H2O (45 mL) and t-BuOH (60 mL).  The 






(13.8396 g, 152 mmol, 4 equiv) and 2 M 2-methyl-2-butene 60 mL, 113.9 mmol, 3 
equiv) were added.  The solution was warmed to rt over 30 min and continued to stir at 
rt for an additional 3.5 h.  The resultant crude material was acidified with concentrated 
HCl, diluted with CH2Cl2 (80 mL), separated, and the aqueous layer was washed with 
more CH2Cl2 (6 x 30 mL).  The combined organic layers were dried over MgSO4 and 
concentrated.  The crude material was recrystallized in hexane to produce 3.125 g 
(42%) of a white crystalline solid.  Rf  = 0.78 (1:1 hexanes:EtOAc).  1H NMR (500 
MHz, CDCl3) ! 7.50 (q, J = 6.7, 13.5 Hz, 1H), 2.03 (d, J = 6.7 Hz, 3H).  13C NMR (125 
MHz, CDCl3) ! 168.3, 151.9, 95.5, 23.2. 
 
 
(Z)-2-iodobut-2-enoic anhydride (149).  To a flame-dried round-bottom flask 
containing extra-pure Na2CO3 (1.1906 g, 10.5 mmol, 1 equiv) at 0 °C under nitrogen 
and added freshly distilled SOCl2 (0.8 mL, 10.5 mmol, 1 equiv) followed by iodo-
carboxylic acid 152 (1.0471 g, 10.5 mmol, 1 equiv) in 1:1 CH2Cl2:1,4-dioxane (60 
mL).  The solution was warmed to rt and brought to a reflux for 17 h.  Once cooled, the 






a brown oil.  The crude material was taken on to the next step.  1H NMR (500 MHz, 
CDCl3) ! 7.81 (q, J = 6.7, 13.5 Hz, 1H), 2.16 (d, J = 6.7 Hz, 3H).  13C NMR (125 MHz, 




en-1-one (150).  To a stirred solution of harmacine 101 (0.0528 g, 0.25 mmol, 1 equiv) 
in dry THF (3 mL) was added Na2CO3 (0.1297 g, 1.12 mmol, 4.5 equiv).  After cooling 
to 0 °C under nitrogen, a solution of anhydride 149 (0.25 mL, 0.63 mmol, 2.5 equiv) in 
THF (1.5 mL) was added drop-wise.  The dark brown solution was allowed to stir at 0 
°C for 1 h and then rt for 2 h.  Water (1.7 mL, 30 mmol, 120 equiv) was added along 
with additional anhydride 149 (0.25 mL, 0.63 mmol, 2.5 equiv) and the reaction 
mixture was brought to 65 °C in an oil bath for 20 h.  The solvent was removed in 
vacuo, diluted with CHCl3 (10 mL), washed with 2 N NaOH (1 x 10 mL), rinsed with 
brine (1 x 10 mL), dried over Na2SO4, and concentrated under reduced pressure to yield 









hexanes:EtOAc to 85:15:1 CH2Cl2:MeOH:NH4OH) yielding 0.0479 g (91%) of a light 
brown foam.  Rf= 0.19 (95:5:1 CH2Cl2:MeOH:NH4OH).  1H NMR (500 MHz, CDCl3) 
! 8.52 (s, 1H), 7.47 (d, J = 7.8 Hz, 1H), 7.29 (d, J = 7.9 Hz, 1H), 7.15 (t, J = 7.1 Hz, 
1H), 7.09 (t, J = 7.3 Hz, 1H), 5.94 (q, J = 6.3 Hz, 1H), 5.21 (dd, J = 5.9, 11.4 Hz, 1H), 
4.14 (dd, J = 4.0, 13.0 Hz, 1H), 3.72 (td, J = 2.5, 14.0 Hz, 1H), 3.29 (s, MeOH), 3.07 
(m, 1H), 2.96 (dd, J = 5.0, 15.9 Hz, 1H), 2.81 (dd, J = 14.2 Hz, 1H), 2.55 (t, J = 12.0 
Hz, 1H), 2.05 (m, 1H), 1.81 (d, J = 6.4 Hz, 3H), 1.37 (dd, J = 3.1, 15.7 Hz, 1H), 1.22 
(m, 1H), 0.91 (m, 1H).  13C NMR (125 MHz, CDCl3) ! 168.5, 136.1, 135.6, 134.7, 
127.7, 121.8, 119.2, 118.0, 111.6, 110.0, 95.6, 66.0, 51.8 (MeOH), 49.8, 36.0, 24.3, 




(151).  To a stirring solution of the amido-alcohol 150 (0.44 g, 1.04 mmmol, 1 equiv) 
dissolved in CH2Cl2 (10 mL) was added MnO2 (0.7542 g, 8.3 mmol, 8 equiv).  The 









and concentrated to produce 0.4114 g of a yellow foam.  Purification was performed by 
flash chromatography (85:15:1 CH2Cl2:MeOH:NH4OH) yielding 0.4037 g (91%) of a 
light yellow solid.  Rf = 0.3 (95:5:1 CH2Cl2:MeOH:NH4OH).  1H NMR (500 MHz, 
CDCl3) ! 9.65 (s, 1H), 7.75 (d, J = 8.1 Hz, 1H), 7.57 (d, J = 8.2 Hz, 1H), 7.49 (t, J = 
7.0 Hz, 1H), 7.28 (t, J = 7.7 Hz, 1H), 5.42 (s, 1H), 5.24 (s, CH2Cl2), 4.20 (bs, 2H), 3.65 
(bs, 3H), 3.56 (d, J = 5.2 Hz, 2H), 3.11 (bs, 2.5H), 2.50 (bs, 2H), 1.01 (bs, 2.5H).  13C 
NMR (125 MHz, CDCl3) ! 194.7, 168.5, 136.1, 133.7, 127.7, 120.6, 120.2, 118.4, 
112.3, 93.2, 52.0 (CH2Cl2), 49.3, 38.9, 26.3, 24.9, 20.1.      
      
 
(Z)-tert-butyl 3-(2-iodobut-2-enoyl)-7-oxo-2,3,4,5,6,7-hexahydroazonino[5,4-
b]indole-8(1H)-carboxylate (147).  To a stirring solution of amido-ketone 151 (0.0393 
g, 0.09 mmol, 1 equiv) in CH2Cl2 (1.5 mL) under nitrogen was added DMAP (0.0069 g, 
0.05 mmol, 0.5 equiv) followed by Boc anhydride (0.0372 g, 0.16 mmol, 1.7 equiv) and 
continued to stir at rt for 1.5 h.  The solution was diluted with CH2Cl2 (4 mL), washed 









under reduced pressure to yield 0.0596 g of a light brown foam.  Purification was 
performed by flash chromatography (1:1 hexanes:EtOAc to 95:5:1 
CH2Cl2:MeOH:NH4OH) yielding 0.045 g (92%) of a white foam.  Rf = 0.46 (95:5:1 
CH2Cl2:MeOH:NH4OH).  1H NMR (500 MHz, CDCl3) ! 8.02 (d, J = 8.4 Hz, 1H), 7.49 
(d, J = 7.9 Hz, 1H), 7.37 (t, J = 7.7 Hz, 1H), 7.22 (t, J = 6.2 Hz, 1H), 5.24 (s, CH2Cl2), 
4.51 (g, J = 6.2 Hz, 1H), 3.39 (m, 5H), 2.93 (s, 3H), 2.75 (t, J = 5.5 Hz, 2H), 2.33 (bs, 
2H), 1.51 (s, 11.5H), 0.86 (d, J = 6.3 Hz, 3H).  13C NMR (125 MHz, CDCl3) ! 195.5, 
168.1, 137.2, 137.0, 134.7, 127.7, 127.5, 123.1, 119.4, 114.7, 93.3, 53.4 (CH2Cl2), 51.3, 




carboxylate (154).  To an oven-dried Schlenk tube was added amido-ketone 147 
followed by 1 M LHMDS, Pd2(dba)2, BINAP, and dry THF.  The tube was capped, 
brought to -78 °C, and purged 5 times under vacuum refilling with nitrogen.  The 








for 2 h.  Once cooled to rt, the solution was concentrated to 0.0493 g of a brown foam.  
Purification was performed by flash chromatography (1:1 hexanes:EtOAc to 95:5:1 




3-(but-2-ynoyl)-1,2,3,4,5,6-hexahydroazonino[5,4-b]indol-7(8H)-one (155).  To a 
stirring solution of Boc-protected amide 147 (0.0118 g, 0.03 mmol, 1 equiv) in dry 
CH2Cl2 (0.288 mL, 4.5 mmol, 150 equiv) was added TFA (0.289 mL, 3.9 mmol, 130 
equiv) slowly under nitrogen.  After 1.5 h, the solution was diluted with CH2Cl2 (3 mL) 
and quenched with NaHCO3 (5 mL) at 0 °C.  The biphasic solution was separated and 
the organic layer was washed with 1 M NaOH (1 x 5 mL), brine (1 x 5 mL), dried over 
Na2SO4, and concentrated to a 0.007 g (59%) of a white solid.  Rf = 0.19 (1:1 
hexanes:EtOAc).!!1H NMR (500 MHz, CDCl3) ! 9.12 (s, 1H), 7.67 (d, J = 8.2 Hz, 1H), 
7.42 – 7.30 (m, 2H), 7.17 (t, J = 7.3 Hz, 1H), 3.81 – 3.20 (m, 6H), 3.03 – 2.80 (m, 2H), 








(m, 9H), 0.60 – 0.43 (m, 5H).  13C NMR (125 MHz, CDCl3) ! 194.6, 167.7, 136.3, 
136.2, 134.1, 127.0, 120.9, 120.4, 112.4, 99.5, 51.6, 38.5, 30.0, 27.9, 26.3, 25.9, 7.6, 




tetrahydroazonino[5,4-b]indole-8(1H)-carboxylate (153).  To an oven-dried Schlenk 
tube brought to -78 °C was added the amido-ketone 147 (0.0216 g, 0.04 mmol, 1 equiv) 
dry THF (3 mL) followed by NEt3 (0.112 mL, 0.8 mmol, 20 equiv), TESCl (0.134 mL, 
0.8 mmol, 20 equiv), and 1M LHMDS (0.6 mL, 0.62 mmol, 15 equiv).  After stirring 
for 3 h, the solution was warmed to rt and diluted with CH2Cl2 (3 mL), added H2O (3 
mL), separated, and rinsed with brine (1 x 3 mL), dried over MgSO4, and concentrated 
to 0.193 g (89%) of the desired product.  The crude material was taken on to the next 












dimethyl 2-oxopentanedioate (156).  To a stirring solution of !-ketoglutaric acid 
(5.0237 g) was added 5% HCl (6.7 mL) in dry MeOH (175 mL) under nitrogen.  The 
solution was heated to 45 °C for 2 h.  The solvent was removed in vacuo and further 
purified by vacuum distillation (collected at 162-165 °C) to produce 4.26 g (92%) of 
the desired 156.  1H NMR (500 MHz, CDCl3) ! 3.86 (s, 3H), 3.67(s, 3H), 3.14 (t, J = 
6.5 Hz, 2H), 2.67 (t, J = 6.5 Hz, 2H). ! 13C NMR (125 MHz, CDCl3) ! 192.4, 172.6, 
161.1, 53.2, 52.2, 34.4, 27.6.   
   
 
methyl 3-oxo-2,3,5,6,11,11b-hexahydro-1H-indolizino[8,7-b]indole-11b-
carboxylate (157).  A stirring solution of tryptamine 18 (3.0207 g, 18.9 mmol, 1 equiv) 
and !-ketoglutarate 156 (3.621 g, 20.79 mmol, 1.1 equiv), in acetic acid (57 mL) under 
nitrogen was heated at 120 °C for 4 h.  The solvent was removed in vacuo and the 














over Na2SO4, and concentrated to 5.58 g of a blue solid.  The crude material was 
recrystallized in t-butyl methyl ether yielding 4.442 g (83%) of a pale brown solid.  1H 
NMR (500 MHz, CDCl3) ! 8.54 – 8.43 (s, 1H), 7.51 – 7.46 (m, 1H), 7.39 – 7.34 (dt, J = 
8.2, 0.9 Hz, 1H), 7.23 – 7.17 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.14 – 7.08 (ddd, J = 7.9, 
7.1, 1.0 Hz, 1H), 4.63 – 4.47 (ddd, J = 13.3, 5.4, 1.9 Hz, 1H), 3.85 – 3.72 (s, 3H), 3.27 
– 3.14 (dddd, J = 13.3, 10.7, 6.2, 1.3 Hz, 1H), 2.91 – 2.73 (m, 3H), 2.68 – 2.53 (m, 1H), 
2.53 – 2.41 (m, 1H), 2.34 – 2.21 (ddd, J = 12.7, 11.5, 9.3 Hz, 1H).! ! 13C NMR (125 
MHz, CDCl3) ! 201.4, 173.28, 172.34, 142.3, 136.8, 130.6, 126.4, 123.0, 122.3, 120.1, 
118.9, 111.5, 109.8, 65.6, 53.4, 36.8, 32.3, 30.7, 21.0. 
          
 
methyl 2,3,5,6,11,11b-hexahydro-1H-indolizino[8,7-b]indole-11b-carboxylate 
(158).  A stirring solution of lactam 157 (0.5054 g, 1.78 mmol, 1 equiv) and 0.5 M 9-
BBN in THF (11 mL, 2.8 mmol, 3.2 equiv) was heated at 65 °C under nitrogen for 1 h.  
Once cooled to rt, MeOH (3 mL) and 2 M HCl in Et2O (3 mL) was added and 







mL) and washed with 3 M HCl (3 x 10 mL).  The combined organic layers were 
basified with Na2CO3 (7.37 g) and further extracted with EtOAc (2 x 10 mL), dried 
over Na2SO4, and concentrated to 0.348 g (72%) of a light brown foam.  The crude 
material was taken on to the next step.  1H NMR (500 MHz, CDCl3) ! 8.28 – 8.21 (s, 
3H), 7.51 – 7.46 (m, 3H), 7.35 – 7.30 (dt, J = 8.1, 0.9 Hz, 3H), 7.19 – 7.14 (ddd, J = 
8.2, 7.1, 1.2 Hz, 3H), 7.11 – 7.06 (ddd, J = 7.9, 7.1, 1.0 Hz, 3H), 4.10 (q, EtOAc), 3.81 
– 3.68 (s, 9H), 3.38 – 3.28 (m, 6H), 3.21 – 3.09 (ddd, J = 8.9, 7.4, 3.2 Hz, 3H), 3.01 – 
2.86 (m, 6H), 2.59 – 2.45 (m, 6H), 2.43 – 2.34 (m, 1H), 2.32 – 2.23 (dt, J = 13.0, 8.1 
Hz, 3H), 2.03 (s, EtOAc), 1.98 – 1.76 (m, 8H), 1.76 – 1.56 (m, 7H), 1.56 – 1.32 (m, 
7H), 1.24 (t, EtOAc).!!13C NMR (125 MHz, CDCl3) ! 174.5, 136.4, 132.7, 126.9, 122.4, 
119.6, 118.6, 111.2, 109.8, 71.0, 66.7, 60.5 (EtOAc), 52.9, 49.7, 43.9, 42.1, 37.7, 32.0, 




3,7(8H)-dicarboxylate (159).  To a stirring solution of ester 158 (0.1678 g, 0.62 mmol, 







and TrocCl (0.23 mL, 1.6 equiv, 2.5 equiv) under nitrogen.  After 1 h, the solution was 
warmed to rt and brought to 80 °C for 20 h.  Once cooled to rt, the solvent was 
removed in vacuo, diluted with CHCl3 (8 mL), washed with 1 M NaOH (1 x 8 mL), 
brine (1 x 8 mL), dried with Na2SO4, and concentrated to 0.3441 g of a brown solid.  
Purification was performed by flash chromatography (1:1 hexanes:EtOAc) yielding 
0.1433 g (50%) of white foam.  Rf  = 0.85 (1:1 hexanes:EtOAc).  1H NMR (500 MHz, 
CDCl3) ! 8.35 (d, J = 14.9 Hz, 1H), 7.54 (t, J = 6.5 Hz, 1H), 7.26 – 7.34 (m, 2H), 7.17 
(dt, J = 32.0, 7.3 Hz, 1H), 7.11 (m, 1H), 4.74 (dd, J = 13.9, 2.6 Hz, 3H), 4.01 (q, 
EtOAc), 3.64 – 3.76 (dd, J = 5.7, 2.7 Hz, 3H), 3.44 – 3.63 (m, 5H), 3.00 (d, 2H), 2.23 
(s, 2H), 2.03 (s, EtOAc), 1.79 – 1.95 (m, 1H), 1.37 – 1.55 (m, 1H), 1.25 (dt, J = 7.0, 3.8 
Hz, 2H), 1.20 (t, EtOAc).  13C NMR (125 MHz, CDCl3) ! 171.3 (EtOAc), 166.2, 166.2, 
154.9, 154.0, 147.3, 147.2, 136.1, 136.0, 129.1, 129.0, 128.6, 128.4, 128.0, 127.8, 
122.4, 122.4, 119.5, 119.5, 118.6, 118.5, 115.0, 114.8, 111.1, 111.0, 95.8, 95.7, 75.1, 
75.0, 74.8, 71.7, 70.9, 60.5 (EtOAc), 53.5, 52.3, 52.2, 49.4, 48.7, 46.3, 45.9, 42.0, 32.1, 






(E)-methyl 1,2,3,4,5,8-hexahydroazonino[5,4-b]indole-7-carboxylate (159a).  To a 
stirring solution of Troc-protected amine 159 (0.9801 g, 2.2 mmol, 1 equiv) in dry THF 
(48 mL) under nitrogen was added zinc powder (2.9286 g, 44 mmol, 20 equiv) and 
acetic acid (12.6 mL, 220 mmol, 100 equiv).  The suspension was allowed to stir at rt 
for 18 h.  The solvent was removed in vacuo, filtered, brought to 0 °C and taken up in 
saturated Na2CO3 (65 mL).  The solution was extracted with CH2Cl2 (3 x 50 mL), brine 
(1 x 40 mL), dried over Na2SO4, and concentrated to 0.6099 g of a white foam.  
Purification was performed by flash chromatography (1:1 hexanes:EtOAc to 85:15:1 
CH2Cl2:MeOH:NH4OH) yielding 0.444 g (75%) of white foam.  1H NMR (500 MHz, 
CDCl3) ! 8.44 (s, 1H), 7.52 (dt, J = 7.6, 1.1 Hz, 1H), 7.35 (m, 2H), 7.18 (ddd, J = 8.2, 
7.0, 1.2 Hz, 1H), 7.08 (ddd, J = 8.1, 7.0, 1.1 Hz, 1H), 3.75 (s, 3H), 2.92-3.02 (m, 2H), 
2.83-2.92 (m, 3H), 2.75-2.83 (m, 2H), 2.19 (ddd, J = 11.7, 5.7, 3.8 Hz, 2H).!!13C NMR 
(125 MHz, CDCl3) ! 166.6, 149.1, 136.2, 128.7, 128.5, 128.2, 122.4, 119.4, 118.7, 










7-carboxylate (160).  To a stirring solution of amine 159a (0.0601 g, 0.22 mmol, 1 
equiv) in dry THF (2 mL) was added K2CO3 (0.0974 g, 0.66 mmol, 3 equiv) and 
mesylate 111 (0.0888 g, 0.24 mmol, 1.1 equiv).  After 45 min of stirring, the solution 
was warmed to rt for 6.5 h, diluted with CH2Cl2 (5 mL), washed with saturated 
NaHCO3 (1 x 4 mL), brine (1 x 4 mL) and concentrated to 0.1589 g.  Purification was 
performed by flash chromatography (3:1 hexanes:EtOAc to 85:15:1 
CH2Cl2:MeOH:NH4OH) yielding 0.0956 g (96%) with a small mesylate impurity.  Rf = 
0.85 (1:1 hexanes:EtOAc).  1H NMR (500 MHz, CDCl3) ! 7.97 (s, 1H), 7.50 (d, J = 7.8 
Hz, 1H), 7.38 (t, J = 8.5 Hz, 1H), 7.32 (d, J = 8.1 Hz, 1H), 7.16 (t, J = 7.6 Hz, 1H), 7.09 
(t, J = 7.5 Hz, 1H), 6.18 (q, mesylate) 5.78 (q, J = 6.4 Hz, 1H), 4.88 (s, mesylate), 3.75 
(s, 3H), 3.43 (s, 2H), 3.04 (s, mesylate) 2.89 – 2.66 (m, 7H), 2.27 – 2.11 (m, 2H), 1.83 
(d, mesylate), 1.77 (d, J = 6.4 Hz, 4H), 1.54 (s, H2O).! !13C NMR (125 MHz, CDCl3) ! 








118.7, 116.6, 111.3, 110.9 (mesylate), 70.5, 53.8, 52.7, 52.3, 39.0 (mesylate), 32.1, 




tetrahydroazonino[5,4-b]indole-7,8(1H)-dicarboxylate (161).  To a stirred solution 
of amine 160 (0.1056 g, 0.23 mmol, 1 equiv) in dry CH2Cl2 (2 mL) was added DMAP 
(0.0164 g, 0.12 mmol, 0.5 equiv) and Boc anhydride (0.0981 g, 0.4 mmol, 1.7 equiv).  
After 1.5 h, the solution was concentrated to a yellow foam.  Purification was 
performed by flash chromatography (10:1 hexanes:EtOAc) yielding 0.0889 g (71%) of 
a yellow foam.  1H NMR (500 MHz, CDCl3) ! 8.17 (d, J = 8.2 Hz, 1H), 7.44 (d, J = 7.8 
Hz, 1H), 7.34 – 7.26 (m, 2H), 7.26 – 7.19 (m, 1H), 5.67 (q, J = 6.3 Hz, 1H), 3.69 (s, 
3H), 3.49 – 3.30 (m, 2H), 3.07 – 2.97 (m, 1H), 2.96 – 2.52 (m, 5H), 2.27 (dddd, J = 
20.3, 13.6, 9.8, 6.5 Hz, 2H), 1.82 – 1.67 (m, 4H), 1.63 – 1.46 (m, 13H).  13C NMR (125 








122.1, 118.7, 115.9, 111.3, 83.9, 70.5, 52.8, 52.7, 51.9, 34.8, 32.1, 31.8, 28.2, 26.6, 
25.5, 22.8, 21.8, 14.3.  
 
 
ethyl 2-chloro-2-oxoacetate (185).  To a flame-dried round-bottom flask was added 
oxalyl chloride (2.6 mL, 30 mmol, 2 equiv) at 0 °C.  Ethanol (0.88 mL, 15 mmol, 1 
equiv) was added drop-wise over 15 min.  Once the addition was complete, the solution 
was allowed to warm to rt over 2 h 20 min.  Distillation was performed (reported 
boiling point of 132-135 °C) to produce 1.4 g (68%) of the desired acid chloride 185.  
1H NMR (500 MHz, CDCl3) ! 4.39 (q, J = 7.2 Hz, 2H), 1.38 (t, J = 7.2 Hz, 3H).  13C 











(E)-ethyl 2-oxo-2-(1,2,4,5-tetrahydroazonino[5,4-b]indol-3(8H)-yl)acetate (187).  
To a stirring solution of harmicine 101 (0.1175 g, 0.55 mmol, 1 equiv) in dry THF (9 
mL) was added extra pure Na2CO3 (0.603 g, 5.55 mmol, 10 equiv) at rt followed by 
ethyl oxalyl chloride 185 (0.3 mL, 2.8 mmol, 5 equiv).  After 2 h of stirring, additional 
185 was added and heated to 60 °C for 13 h.  Once cooled to rt, the solution was diluted 
with CH2Cl2 (10 mL), washed with 2 M NaOH (1 x 10 mL), brine (1 x 10 mL), dried 
over Na2SO4, and concentrated.  Purification was performed by flash chromatography 
(2:1 hexanes:EtOAc) yielding 0.1547 g (90%) of a yellow foam.  Rf = 0.37 and 0.46 
(3:1 hexanes:EtOAc).  1H NMR (500 MHz, CDCl3) ! 7.81 (s, 1H), 7.76 (s, 1H), 7.52 
(d, J = 7.8 Hz, 1H), 7.44 (d, J = 7.2 Hz, 1H), 7.29 (t, J = 7.7, 14.0 Hz, 2H), 7.06 – 7.19 
(m, 4.5H), 6.64 (d, J = 10.6 Hz, 1H), 6.46 (d, J = 11.3 Hz, 1H), 5.99 – 6.06 (m, 2H), 
4.35 (q, J = 7.2, 14.3 Hz, 2.4H), 4.01 (q, J = 7.2, 14.3 Hz, 1.6H), 3.66 – 3.71 (m, 1H), 
3.61 – 3.66 (m, 1H), 3.52 – 3.57 (m, 2H), 3.38 – 3.42 (m, 2H), 3.06 – 3.12 (m, 2H), 
3.01 – 3.05 (m, 2H), 2.45 – 2.51 (m, 1H), 2.27 – 2.35 (m, 3H), 1.54 (bs, 7H), 1.38 (t, J 









NMR (125 MHz, CDCl3) ! 194.97, 168.69, 136.31, 134.89, 133.83, 127.95, 126.96, 




carboxylate (203).  Same procedure as compound 100a.  Rf= 0.68 (85:15:1 
CH2Cl2:MeOH:NH4OH).  1H NMR (500 MHz, CDCl3) ! 8.42 (s, 1H), 7.51 (dd, J = 7.7, 
4.0 Hz, 1H), 7.34 (dd, J = 7.9, 4.3 Hz, 1H), 7.16 (t, J = 7.5 Hz, 1H), 7.08 (t, J = 7.5 Hz, 
1H), 5.24 (s, CH2Cl2), 5.12 – 5.23 (ddd, J = 19.4, 10.7, 6.1 Hz, 1H), 4.94 (dd, J = 24.4, 
11.8 Hz, 1H), 4.61 (dd, J = 11.9 Hz, 1H), 3.96 – 4.21 (m, 3H), 4.10 (q, EtOAc), 2.92 – 
3.23 (m, 3H), 2.53 – 2.34 (m, 2H), 2.01 (s, EtOAc), 1.69 – 1.89 (m, 2H), 1.52 (s, H2O), 
1.41 (dd, J = 14.7, 6.3 Hz, 1H), 1.16 – 1.30 (m, 2H), 1.22 (t, EtOAc), 0.75 – 0.94 (ddd, 
J = 21.5, 10.4, 4.6 Hz, 1H).!!13C NMR (125 MHz, MeOD) ! 157.0, 156.1, 138.3, 138.2, 
137.6, 129.1, 129.0, 122.4, 119.8, 118.7, 112.1, 111.8, 111.6, 97.1, 97.1, 67.4, 67.3, 
52.3 (CH2Cl2), 51.3, 50.7, 50.0, 50.0, 49.6, 49.6, 49.5, 49.4, 49.3, 49.3, 49.1, 49.0, 48.8, 











carboxylate (203a).  To a stirring solution of the amido-alcohol 203 (0.5649 g, 1.39 
mmol, 1 equiv) dissolved in CH2Cl2 (15 mL) and added MnO2 (0.9705 g, 11.4 mmol, 8 
equiv).  The suspension was allowed to stir at rt for 18 h.  The solids were removed by 
filtration and the solution was concentrated to produce 0.5001 g of a white solid.  
Purification was performed by flash chromatography (1:1 hexanes:EtOAc) yielding 
0.4801 g (86%) of a light yellow solid.  Rf = 0.76 (85:15:1 CH2Cl2:MeOH:NH4OH).!!1H 
NMR (500 MHz, CDCl3) ! 9.15 (d, J = 8.4 Hz, 1H), 7.68 (ddq, J = 8.2, 1.9, 0.9 Hz, 
1H), 7.16 – 7.27 (m, 2H), 7.07 (dddd, J = 17.8, 8.0, 6.7, 1.2 Hz, 1H), 4.67 (s, 1H), 
4.264 (s, 1H), 3.61 (s, 2H), 3.26-3.52 (m, 4H), 2.91 (s, 2H), 2.33 (s, 2H).  13C NMR 
(125 MHz, CDCl3) ! 210.7, 194.9, 194.8, 168.1, 155.1, 153.9, 136.6, 136.5, 133.9, 
133.8, 128.1, 128.1, 126.9, 126.8, 120.7, 120.6, 120.4, 119.3, 112.3, 112.2, 95.5, 95.0, 












b]indole-3,8-dicarboxylate (142).  To a stirring solution of Troc-protected ketone 203a 
(0.4801g, 1.19 mmol, 1 equiv) in dry CH2Cl2 (50 mL) was added DMAP (0.0785 g, 0.60 
mmol, 0.5 equiv) and Boc anhydride (0.4649 g, 2.0 mmol, 1.7 equiv).  After 3 h, the 
solution was concentrated to a yellow brown foam.  Purification was performed by flash 
chromatography (2:1 hexanes:EtOAc) yielding 0.6285 g (99%) of a white foam.  Rf= 
0.56 (1:1 hexanes:EtOAc).  1H NMR (500 MHz, CDCl3) ! 8.03 (ddt, J = 14.0, 8.4, 0.9 Hz, 
1H), 7.54 (ddt, J = 7.9, 4.2, 1.0 Hz, 1H), 7.38 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H), 7.28 (dddd, 
J = 7.9, 7.0, 5.9, 0.9 Hz, 1H), 4.73 (s, 1H), 4.55 (s, 1H), 4.10 (q, EtOAc), 3.49 (td, J = 7.2, 
3.1 Hz, 2H), 3.31 – 3.44 (m, 2H), 3.12 (ddd, J = 19.9, 6.3, 4.3 Hz, 2H), 2.72 – 2.88 (m, 
2H), 1.93 – 2.06 (m, 2H), 2.01 (s, EtOAc), 1.54 – 1.62 (m, 9H), 1.47 – 1.53 (m, 1H), 1.44 
(s, 3H), 1.22 (qt EtOAc).  13C NMR (125 MHz, CDCl3) ! 198.01, 197.7, 154.9, 154.6, 
152.6, 149.7, 149.6, 136.9, 136.7, 135.5, 135.3, 128.7, 128.5, 127.0, 126.9, 123.3, 123.3, 
121.7, 121.4, 119.6, 119.5, 115.5, 115.4, 114.5, 111.7, 95.6, 95.1, 85.1, 85.0, 81.2, 75.6, 
75.6, 61.5 (EtOAc), 60.5, 58.3, 58.0, 50.6, 50.2, 49.1, 48.3, 40.5, 40.3, 28.1, 28.1, 28.0, 









(Z)-triethyl((2-iodobut-2-en-1-yl)oxy)silane (205).   To a stirring solution of iodo-
alcohol 110 (0.9822 g, 4.96 mmol, 1 equiv) in dry DMF (10 mL) was added imidazole 
(1.00 g, 14.88 mmol, 3 equiv) under nitrogen.  The solution was brought to 0 °C and 
TESCl (1.1 mL, 7.4 mmol, 1.5 equiv) was added over 15 min.  After stirring at rt for 20 
h, the reaction was quenched with H2O (5 mL), diluted with EtOAc (50 mL), separated, 
and the organic layer was washed with more H2O (3 x 15 mL), dried over Na2SO4 and 
concentrated.  Purification was performed by flash chromatography (100% hexanes) 
yielding 0.805 g (82%) of the desired 205.   1H NMR (500 MHz, CDl3) ! 5.96 (q, J = 
6.4 Hz, 1H), 4.28 (s, 2H), 1.77 (d, J = 6.5 Hz, 3H), 1.52 (H2O), 0.91 (t, J = 8.0 Hz, 9H), 




2,2-diphenyl-3,4-dihydronaphthalen-1(2H)-one (213).  To an oven-dried Schlenk 









mmol, 2 equiv), BINAP (0.1026 g, 0.16 mmol, 0.3 equiv), tetralone (0.07 mL, 0.53 
mmol, 1 equiv), bromobenzene (0.111 mL, 1.05 mmol, 2 equiv) and THF (2 mL).  The 
tube was capped, brought to -78 °C, and purged 5 times under vacuum refilling with 
nitrogen.  The Schlenk tube was allowed to warm to rt and placed in a pre-heated 75 °C 
oil bath for 18 h.  Once cooled to rt, the solution was poured over ice, diluted with 
EtOAc (10 mL), washed with NH4OH (1 x 10 mL), brine (1 x 10 mL), dried over 
Na2SO4, and concentrated to 0.3525 g.  Purification was performed by flash 
chromatography (95:5 hexanes:EtOAc) yielding 0.1202 g (76%) of light yellow foam.  
1H NMR (500 MHz, CDCL3) ! 7.94 (d, J = 8.1 Hz, 1H), 7.35 (hept, J = 7.4 Hz, 3H), 
7.18 (t, J = 7.5 Hz, 5H), 7.09 (dq, J = 16.7, 7.9, 7.5 Hz, 3H), 3.81 (dd, J = 13.0, 3.6 Hz, 
1H), 2.85 (d, J = 9.9 Hz, 2H), 2.28 (tt, J = 13.9, 7.2 Hz, 1H), 2.16 – 2.05 (m, 1H), 1.52 
(H2O).  13C NMR (125 MHz, CDCl3) ! 199.1, 149.0, 144.2, 142.7, 141.6, 140.7, 138.5, 
136.8, 136.0, 133.5, 133.4, 133.1, 130.2, 130.0, 129.4, 128.9, 128.7, 128.6, 128.4, 
128.2, 127.9, 127.2, 127.2, 126.8, 126.8, 113.6, 51.8, 32.2, 30.3, 29.7, 29.1, 27.4. 
! 176 
4.4.  Experimental procedures for the third-generation synthesis 
 
 
(S)-2-methyl-5-(2-methyloxiran-2-yl)cyclohex-2-enone (266).  To a stirring solution 
of (S)-carvone 236 (15.36 g, 102.3 mmol, 1 equiv) in dry CH2Cl2 (900 mL) was added 
mCPBA (26.34 g, 153.4 mmol, 1.5 equiv) and allowed to stir under nitrogen at rt for 24 
h.  The solution was washed with NaHCO3 (1 x 500 mL), 10% Na2SO3 (1 x 500 mL), 
NaHCO3 (1 x 300 mL), H2O (1 x 500 mL), dried over MgSO4, and concentrated.  
Purification was accomplished by flash chromatography (8:1 hexanes:EtOAc to 100% 
EtOAc) affording 13.09 g (77%) of epoxide 266 (Rf = 0.83 in 100% EtOAc).  1H NMR 
(500 MHz, CDCl3) ! 6.71 (tt, J = 6.3, 1.7 Hz, 1H), 2.66 (dd, J = 18.5, 4.6 Hz, 1H), 2.59 
– 2.50 (m, 2H), 2.44 – 2.33 (m, 1H), 2.29 – 2.13 (m, 2H), 2.09 – 1.99 (m, 1H), 1.78 – 
1.71 (h, J = 1.6 Hz, 3H), 1.54 (H2O), 1.34 – 1.26 (d, J = 8.4 Hz, 3H).  13C NMR (125 
MHz, CDCl3) ! 199.0, 198.9, 144.2, 144.0, 135.9, 135.8, 58.1, 58.0, 53.1, 52.6, 41.6, 






(S)-5-acetyl-2-methylcyclohex-2-enone (264).  To a stirring solution of epoxide 266 
(0.2676 g, 1.6 mmol, 1 equiv) in dry Et2O (50 mL) at 0 °C was added periodic acid 
(0.7144 g, 2.6 mmol, 1.6 equiv) and allowed to stir under nitrogen for 1 h.  The solution 
was warmed to rt over 3 h, added NaHCO3 (1 x 30 mL), separated, and the aqueous 
layer was wash with more Et2O (3 x 15 mL).  The organic layers were combined, dried 
over MgSO4, and concentrated to 0.2176 g of a bright yellow oil.  Purification was 
accomplished by flash chromatography (3:10 hexanes:EtOAc) affording 0.1668 g 
(68%) of diketone 264.  1H NMR (500 MHz, CDCl3) ! 6.78 – 6.63 (m, 1H), 3.19 – 2.99 
(m, 1H), 2.78 – 2.62 (m, 1H), 2.62 – 2.44 (m, 3H), 2.28 – 2.09 (m, 3H), 1.87 – 1.70 (m, 
2H).  13C NMR (125 MHz, CDCl3) ! 208.2, 197.3, 142.3, 135.3, 48.0, 39.8, 27.6, 27.2, 
15.7.     
 
 





(S,Z)-1-(5-(hydroxyimino)-4-methylcyclohex-3-en-1-yl)ethanone (268).  To a 
stirring solution of 2.5 M NH2OH!HCl (0.0311 g, 0.41 mmol, 1.25 equiv) in EtOH (1.6 
mL) was added diketone 264 (0.050 g, 0.33 mmol, 1 equiv) and allowed to stir at rt for 
18 h.  The solution was diluted in CH2Cl2 (5 mL), washed with H2O (1 x 5 mL), dried 
over MgSO4, and concentrated.  Purification was accomplished by flash 
chromatography (1:1 hexanes:EtOAc) affording 0.0494 g (90%) of oxime 268.  1H 
NMR (500 MHz, CDCl3) ! 6.04 – 5.89 (m, 1H), 3.23 (dd, J = 16.6, 4.4 Hz, 1H), 2.75 
(ddt, J = 11.6, 9.6, 4.7 Hz, 1H), 2.44 – 2.23 (m, 3H), 2.18 (s, 3H), 1.93 – 1.72 (m, 3H).  
13C NMR (125 MHz, CDCl3) ! 209.3, 206.9, 131.0, 130.7, 46.1, 30.9, 28.1, 26.9, 23.9, 
17.6. 
       
 
 (S,Z)-5-((Z)-1-(hydroxyimino)ethyl)-2-methylcyclohex-2-enone oxime (269).  To a 











NaOH (0.8 mL, 4.0 mmol, 3 equiv) was added diketone 264 (0.200 g, 1.3 mmol, 1 
equiv) in EtOH (6.6 mL) and allowed to stir at rt for 48 h.  The solution was diluted in 
CH2Cl2 (20 mL), washed with H2O (1 x 20 mL), dried over MgSO4, and concentrated.  
Purification was accomplished by flash chromatography (1:1 hexanes:EtOAc) affording 
0.2021 g (92%) of oxime 269.  1H NMR (500 MHz, CDCl3) ! 9.62 (bs, 1H), 9.01 (bs, 
1H), 5.99 (dd, J = 6.4, 2.0 Hz, 1H), 3.64 (q, J = 7.0 Hz, 1H), 3.28 (dd, J = 16.8, 4.4 Hz, 
1H), 2.65 – 2.49 (m, 1H), 2.43 – 2.09 (m, 4H), 1.98 – 1.77 (m, 7H), 1.32 – 1.17 (m, 
2H), 1.17 – 1.03 (m, 1H).  13C NMR (125 MHz, CDCl3) ! 204.6, 159.6, 155.9, 132.0, 
130.7, 58.6, 39.6, 28.6, 25.8, 18.5, 17.8, 12.3. 
 
 
(S)-2-methyl-5-(2-methyl-1,3-dioxolan-2-yl)cyclohex-2-enone (271).  To a stirring 
solution of diketone 264 (0.0802 g, 0.53 mmol, 1 equiv) in dry benzene (2 mL) was 
added p-TsOH (0.0263 g, .11 mmol, 0.2 equiv) and ethylene glycol (0.0659 g, 1.06 
mmol, 2 equiv).  The solution was brought to a reflux under nitrogen for 3.5 h.   Once 





mL), H2O (1 x 15 mL), dried over Na2SO4, and concentrated.  Purification was 
accomplished by flash chromatography (4:1 hexanes:EtOAc) affording 0.416 g (40%) 
of oxime 269.  Rf = 0.63 (2:1 hexanes:EtOAc).  Major Product:  1H NMR (500 MHz, 
CDCl3) ! 6.76 – 6.59 (m, 1H), 4.03 – 3.81 (m, 6H), 2.63 – 2.35 (m, 3H), 2.35 – 2.14 
(m, 5H), 1.78 – 1.67 (m, 3H), 1.31 – 1.17 (s, 3H), 0.91 (d, J = 6.7 Hz, 1H).   13C NMR 
(125 MHz, CDCl3) ! 199.8, 144.6, 135.5, 110.1, 65.2, 65.1, 44.0, 39.2, 27.2, 21.7, 15.8. 
 
 
(S)-1-(10-methyl-1,4-dithiaspiro[4.5]dec-9-en-7-yl)ethanone (273).  To a stirring 
solution of diketone 264 (0.3092 g, 2.03 mmol, 1 equiv) in dry MeOH (7 mL) at 0 °C 
was added BF3!OEt2 (0.3 mL, 2.44 mmol, 1.2 equiv) and 1,2-dithioethane 275 (0.205 
mL, 2.44 mmol, 1.2 equiv) in MeOH (3 mL) via syring pump over 6 h (0.51 mL/hr).  
Once warmed to rt, the solution was diluted in EtOAc (30 mL), washed with NaHCO3 
(1 x 60 mL), and the aqueous layer was washed with additional EtOAc (3 x 30 mL) and 
Et2O (3 x 15 mL).  The organic layers were combined and rinsed with brine (1 x 40 




Purification was accomplished by flash chromatography (15:1 hexanes:EtOAc) 
affording 0.042 g (9%) of the mono-protected ketone 273 (Rf =0.46 in 10:1 
hexanes:EtOAc) and 0.0115 g (2.5%) of di-protected 272 (Rf =0.5 in 10:1 
hexanes:EtOAc).  1H NMR (500 MHz, CDCl3) ! 5.50 (dq, J = 4.1, 1.4 Hz, 1H), 3.45 – 
3.27 (MeOH), 3.28 (m, 3H), 3.28 – 3.16 (m, 1H), 2.87 (tdd, J = 11.7, 5.3, 2.5 Hz, 1H), 
2.52 (dt, J = 13.4, 2.3 Hz, 1H), 2.17 (s, 3H), 2.15 – 2.07 (m, 2H), 1.95 – 1.92 (m, 3H).  




(S)-6-methyl-9-(2-methyl-1,3-dithiolan-2-yl)-1,4-dithiaspiro[4.5]dec-6-ene (272).  
See procedure for compound 273.  1H NMR (500 MHz, CDCl3) ! 5.58 – 5.44 (m, 1H), 
3.44 – 3.18 (m, 8H), 3.27 (MeOH), 2.94 – 2.67 (m, 6H), 2.67 – 2.56 (m, 1H), 2.37 – 
2.14 (m, 2H), 2.14 – 2.02 (m, 1H), 2.02 – 1.85 (m, 4H), 1.73 (s, 3H), 1.67 – 1.61 (m, 
1H), 1.37 – 1.11 (m, 8H).  13C NMR (125 MHz, CDCl3) ! 135.5, 125.9, 70.6, 70.4, 







(S)-6-methyl-9-(prop-1-en-2-yl)-1,4-dioxaspiro[4.5]dec-6-ene (277).  To a stirring 
solution of (S)-carvone 236 (0.3158 g, 2.1 mmol, 1 equiv) in dry benzene (15 mL) was 
added ethylene glycol (0.778 g, 4.2 mmol, 2 equiv) and PPTS (0.038 g, 0.15 mmol, 
0.07 equiv) and brought to a reflux for 22 h under nitrogen.  Once cooled to rt, the 
solution was concentrated to 0.3468 g (85%) of 277.  Rf = 0.6 in 10:1 hexanes:EtOAc.  
Major product:  1H NMR (500 MHz, CDCl3) ! 5.74 – 5.59 (m, 1H), 4.83 – 4.64 (m, 
2H), 4.11 – 3.99 (m, 2H), 3.99 – 3.85 (m, 2H), 3.72 (s, 5H), 2.73 – 2.20 (m, 3H), 2.13 
(dt, J = 17.4, 5.7 Hz, 1H), 2.08 – 1.81 (m, 4H), 1.81 – 1.53 (m, 8H).  13C NMR (125 




(5S)-5-(1,2-dihydroxypropan-2-yl)-2-methylcyclohex-2-enone (279).  To a stirring 








solution of H2SO4 (1.0653 g, 10.7 mmol, 0.4 equiv) in H2O (50 mL).  After stirring at rt 
for 2 h, the solution was diluted in H2O (100 mL) followed by NaHCO3 (2.55 g) to a 
pH of 6 and H3PO4 (27 drops) to a pH of  3.  The solution was extracted with Et2O (2 x 
100 mL), rinsed with H2O (1 x 50 mL), dried over Na2SO4, and concentrated.  The 
remaining salts were removed by dissolution in 1:1 Et2O:EtOH (100 mL), filtration, 
and further concentration to 4.49 g (90%) of diol 279 (Rf =0.36 in 100% EtOAc) as a 
colorless, viscous oil.  1H NMR (500 MHz, d6-DMSO) ! 6.83 (t, J = 7.9 Hz, 1H), 3.34 
– 3.25 (m, 1H), 3.25 – 3.16 (m, 1H), 2.45 – 2.05 (m, 5H), 1.67 (s, 3H), 1.01 (s, 3H).  
13C NMR (125 MHz, d6-DMSO) ! 199.8, 199.6, 146.2, 145.9, 133.7, 133.7, 72.10, 
67.2, 56.0, 41.1, 40.8, 38.5, 26.6, 26.2, 21.9, 21.7, 18.5, 15.3.      
 
 
(1S,5S)-2-methyl-5-(2-methyloxiran-2-yl)cyclohex-2-enol (281).  To a solution of 
epoxide 266 (16.41 g, 98.7 mmol, 1 equiv) was added 0.8 M sucrose (1.17 L, 937.9 
mmol, 9.5 equiv) followed by the portion-wise addition of NaBH4 (7.1 g, 187.5 mmol, 





separated, dried over Na2SO4, added NEt3 (3 drops), and concentrated.  The crude 




yl)oxy)diphenylsilane (282).  To a stirring solution of epoxy-alcohol 266 (15.00 g, 
101.6 mmol, 1 equiv) containing DMAP (3.2374 g, 26.4 mmol, 0.26 equiv) and 
imidazole (14.5216 g, 213.3 mmol, 2.1 equiv) in CH2Cl2 (300 mL) was cannula-
transferred a solution of TBDPSCl (30.674 g, 111.7 mmol, 1.1 equiv) in CH2Cl2 (100 
mL) and continued to stir under nitrogen at rt for 24 h.  The solution was washed with 
H2O (1 x 500 mL), brine (1 x 400 mL), dried over Na2SO4, and concentrated to 43.5 g 
of a yellow oil.  Purification was accomplished by flash chromatography (40:1 
cyclohexane:EtOAc) affording 31.07 g (62% according to 1H NMR integration) of the 
(1S)-syn-diastereomers 282 as the major product with minimal contamination of 
TBDPS-O-TBDPS byproduct.  Rf = 0.52 (40:1 cyclohexane:EtOAc).  1H NMR (500 
MHz, CDCl3) ! 7.74 – 7.65 (m, 5H), 7.44 – 7.32 (m, 8H), 5.41 – 5.31 (m, 1H), 4.23 (t, 





10.5 Hz, 3H), 1.45 – 1.37 (s, 11H), 1.08 (d, J = 3.4 Hz, 3H), 1.05 (s, 11H).  13C NMR 
(125 MHz, CDCl3) ! 137.8, 136.3, 136.2, 135.0, 134.1, 129.8, 129.7, 127.9, 127.7, 
127.7, 127.6, 122.7, 122.6, 72.6, 72.5, 58.8, 53.0, 52.9, 39.8, 39.4, 35.5, 27.7, 27.5, 




(235a).  To a flame-dried round-bottom flask was added containing HIO4!H2O 
(20.9557 g, 91.7 mmol, 1.2 equiv) in dry THF (500 mL) at 0 °C and cannula-
transferred epoxide 282 (31.07 g, 76.41 mmol, 1 equiv) in dry Et2O (150 mL) and 
continued to stir under nitrogen for 1 h.  Saturated Na2HCO3 (500 mL) was then added 
and allowed to warm to rt over 15 min.  The solution was filtered through Celite, 
separated, washed with 5% Na2S2O3 (1 x 300 mL), brine (1 x 150 mL), dried over 
MgSO4, and concentrated to 28.4 g of a colorless oil.  Purification was accomplished 
by flash chromatography (40:1 hexanes:Et2O) affording 23.56 g (79%) of the (1S)-syn-
diastereomers 235a as the major product with minimal contamination of ring-opened 




! 7.79 – 7.71 (m, 6H), 7.48 – 7.34 (m, 9H), 5.44 – 5.39 (m, 1H), 4.37 – 4.28 (m, 1H), 
2.75 (s, 0.5H), 2.44 – 2.35 (m, 1H), 2.15 (ddp, J = 13.6, 5.5, 2.7 Hz, 1H), 2.06 – 1.96 
(m, 1H), 1.93 (s, 4H), 1.78 – 1.72 (m, 3H), 1.64 – 1.53 (m, 1H), 1.09 (d, J = 9.0 Hz, 
15H).  13C NMR (125 MHz, CDCl3) ! 210.3, 137.6, 136.2, 136.2, 135.5, 134.9, 134.6, 
133.9, 129.8, 129.8, 129.7, 127.8, 127.7, 127.6, 122.04, 72.0, 47.1, 35.0, 27.7, 27.2, 




oxime (234a).  To a stirring solution of 2.5 M NH2OH!HCl (17 mL, 42.6 mmol, 1.25 
equiv) and 5 M NaOH (20.5 mL, 102.3 mmol, 3 equiv) was added ketone 235a (13.39 
g, 34.1 mmol, 1 equiv) in EtOH (170 mL) and brought to a reflux for 3.5 h.  The 
solution was concentrated to half its volume, diluted in CH2Cl2 (300 mL), washed with 
H2O (1 x 150 mL), dried over Na2SO4, and concentrated to 14.67 g.  Purification was 
accomplished by flash chromatography (40:1 hexanes:EtOAc to 2:1 hexanes:EtOAc) 






mixture of both (E) and (Z) oxime isomers in a ratio of 7:1, respectively.   Rf = 0.24 and 
0.10 (10:1 hexanes:EtOAc).  1H NMR (500 MHz, CDCl3) ! 9.48 (s, 1H), 7.85 – 7.71 
(m, 6H), 7.53 – 7.32 (m, 9H), 5.44 (d, J = 6.0 Hz, 1H), 4.37 – 4.29 (m, 1H), 2.34 – 2.22 
(m, 1H), 2.16 – 2.04 (m, 1H), 2.02 – 1.88 (m, 2H), 1.86 (s, 0.5H), 1.79 (s, 3H), 1.74 (s, 
3H), 1.72 – 1.61 (m, 3H), 1.41 – 1.28 (m, 2H), 1.17 (s, 11H), 1.09 (s, 3H).  13C NMR 
(125 MHz, CDCl3) ! 160.2, 137.5, 136.2, 136.2, 136.1, 135.4, 135.0, 134.9, 134.7, 
133.9, 129.8, 129.7, 129.7, 127.8, 127.7, 127.7, 127.6, 122.5, 72.2, 40.0, 36.4, 35.4, 





yl)oxy)silane (282a).  To a stirring solution of epoxy-alcohol 266 (4.93g, 29.3 mmol, 1 
equiv) containing imidazole (5.0211 g, 73.3 mmol, 2.5 equiv) in DMF (75 mL) was 
cannula-transferred a solution of TBSCl (8.8713 g, 58.6 mmol, 2 equiv) in DMF (35 





CH2Cl2 (200 mL), washed with H2O (1 x 175 mL), brine (1 x 100 mL), dried over 
Na2SO4, and concentrated to 9.75 g.  Purification was accomplished by flash 
chromatography (100% cyclohexane) affording 4.58 g (47%) of the (1S)-syn-
diastereomers 282a as the major product with minimal contamination of TBS-O-TBS 
byproduct.  Rf = 0.65 (10:1 hexanes:EtOAc).  1H NMR (500 MHz, CDCl3) ! 5.48 – 
5.35 (m, 1H), 4.19 (td, J = 9.7, 4.7 Hz, 1H), 2.64 – 2.46 (m, 2H), 2.17 – 1.83 (m, 3H), 
1.64 (dp, J = 2.6, 1.7 Hz, 3H), 1.33 – 1.15 (m, 4H), 0.96 – 0.80 (m, 10H), 0.13 – 0.00 
(m, 6H).  13C NMR (125 MHz, CDCl3) ! 137.6, 122.8, 122.5, 71.3, 71.2, 53.7, 52.8, 




(235b).  To a flame-dried round-bottom flask containing HIO4!H2O (4.2805 g, 18.5 
mmol, 1.2 equiv) in dry THF (150 mL) at 0 °C was cannula-transferred epoxide 282a 
(4.58 g, 15.39 mmol, 1 equiv) in dry Et2O (35 mL) and continued to stir under nitrogen 




min.  The solution was filter through Celite, separated, washed with 5% Na2S2O3 (1 x 
100 mL), brine (1 x 100 mL), dried over MgSO4, and concentrated to 4.35 g of a 
colorless oil.  Purification was accomplished by flash chromatography (20:1 
hexanes:Et2O) affording 2.32 g (59%) of the (1S)-syn-diastereomers 235a as the major 
product with minimal contamination of ring-opened byproducts 283 and 284.  Rf = 0.39 
(10:1 hexanes:EtOAc).  1H NMR (500 MHz, CDCl3) ! 5.47 – 5.31 (m, 1H), 4.22 – 4.08 
(m, 1H), 2.66 – 2.51 (m, 1H), 2.20 – 2.02 (m, 6H), 1.72 – 1.48 (m, 4H), 0.96 – 0.76 (m, 
12H), 0.13 – -0.06 (m, 7H).  13C NMR (125 MHz, CDCl3) ! 210.1, 137.4, 121.8, 70.29, 




oxime (234b).  To a stirring solution of 2.5 M NH2OH!HCl (10.3 mL, 25.6 mmol, 1.25 
equiv) and 5 M NaOH (12.3 mL, 61.5 mmol, 3 equiv) was added ketone 235b (5.51 g, 
20.5 mmol, 1 equiv) in EtOH (100 mL) and brought to a reflux for 24 h.  The solution 






200 mL), dried over Na2SO4, and concentrated to 5.08 g.  Purification was 
accomplished by flash chromatography (20:1 hexanes:EtOAc to 100% EtOAc) 
affording 4.47 g (77%) the (1S)-syn-diastereomers 234b as the major product with a 
mixture of both (E) and (Z) oxime isomers in a ratio of 7:1, respectively.  Rf = 0.36 and 
0.20 (10:1 hexanes:EtOAc).  1H NMR (500 MHz, CDCl3) ! 8.78 – 8.60 (m, 1H), 5.26 
(dd, J = 4.7, 2.1 Hz, 2H), 4.26 – 4.11 (m, 1H), 4.97 (t, J = 3.4 Hz, 1H), 2.59-2.65 (m, 
1H), 2.44-2.51 (m, 1H), 2.10 – 1.98 (m, 3H), 1.98 – 1.76 (m, 7H), 1.76 – 1.62 (m, 6H), 
1.62 – 1.48 (m, 2H), 2.68 – 2.55 (m, 18H), 0.95 – 0.79 (m, 12H).  13C NMR (125 MHz, 
CDCl3) ! 161.2, 160.7, 137.6, 135.3, 123.5, 122.4, 71.0, 68.5, 40.1, 36.7, 36.0, 35.3, 
29.2, 29.2, 26.1, 21.4, 19.9, 18.3, 18.3, 12.8, 11.5, -3.8, -4.0, -4.2, -4.4, -4.7. 
 
 
(5S)-5-acetamido-2-methylcyclohex-2-en-1-yl acetate (287).  To a stirring solution of 
oxime 234b (1.26 g, 4.4 mmol, 1 equiv) in dry CH2Cl2 (22 mL) brought to -20 °C was 
added MsCl drop-wise (0.375 mL, 4.8 mmol, 1.1 equiv) and continued to stir at this 
temperature for 50 min.  Once warmed to rt, the solution was diluted with CH2Cl2 (20 







mL), dried over Na2SO4, and concentrated.  The crude material was immediately 
dissolved in acetic acid (28 mL) and allowed to stir at rt for 22 h.  The solution was 
concentrated en vacuo, brought to 0 °C and added 10% NH4OH (60 mL) and CH2Cl2 
(60 mL), washed with Na2HCO3 (1 x 60 mL), brine (1 x 60 mL), dried over Na2SO4, 
and concentrated to 0.59 g of a dark orange oil.  Purification was accomplished by flash 
chromatography (4:1 hexanes:EtOAc to 95:5:1 CH2Cl2:MeOH:NH4OH) affording 
0.042 g (33%) of acetamide 287 (Rf = 0.54 in 4:1 hexanes:EtOAc) and 0.45 g (44%) of 
mesylated acetamide 288 (Rf = 0.74 in 4:1 hexanes:EtOAc).  Spectroscopic data for 
287:  1H NMR (500 MHz, CDCl3) ! 5.59 – 5.44 (m, 1H), 4.34 (s, 1H), 3.69 (d, J = 3.5 
Hz, 1H), 2.32 – 2.20 (m, 2H), 1.96 – 1.88 (m, 1H), 1.84 (s, 3H), 1.75 (s, 3H), 1.72 – 
1.66 (m, 1H).  13C NMR (125 MHz, CDCl3) ! 157.1, 133.0, 131.9, 123.6, 70.9, 45.0, 




(233a).  To a stirring solution of oxime 234a (4.2559 g, 8.76 mmol, 1 equiv) in CH2Cl2 







1.2 equiv) and continued to stir at this temperature for 30 min.  Once warmed to rt, the 
solution was diluted with CH2Cl2 (75 mL), washed with cold 1 M HCl (1 x 150 mL), 
Na2HCO3 (1 x 150 mL), brine (1 x 100 mL), dried over Na2SO4, and concentrated to 
3.97 g of a white foam.  Purification was accomplished by flash chromatography (10:1 
hexanes:EtOAc) affording 1.22 g (34%) of acetamide 233a (Rf = 0.81 in 95:5:1 
CH2Cl2:MeOH:NH4OH) and 1.73 g (41%) of mesylated acetamide 304 (Rf = 0.36 in 
4:1 hexanes:EtOAc).  1H NMR (500 MHz, CDCl3) ! 7.76 – 7.66 (m, 4H), 7.50 – 7.36 
(m, 6H), 7.23 (d, J = 7.9 Hz, 1H), 5.40 (t, J = 4.2 Hz, 1H), 4.28 – 4.13 (m, 2H), 2.30 – 
2.13 (m, 2H), 2.04 (ddd, J = 14.2, 5.1, 3.7 Hz, 1H), 1.96 – 1.90 (s, 3H), 1.78 – 1.71 (dt, 
J = 13.9, 4.0 Hz, 1H), 1.64 (s, 0.5H), 1.54 – 1.47 (m, 2H), 1.16 – 1.06 (m, 9H).  13C 
NMR (125 MHz, CDCl3) ! 169.4, 136.2, 136.1, 136.0, 135.9, 135.0, 134.6, 133.4, 
133.3, 130.1, 130.0, 129.8, 129.7, 129.6, 127.9, 127.8, 127.7, 127.6, 122.5, 122.3, 70.0, 











1H NMR (500 MHz, CDCl3) ! 7.76 – 7.67 (m, 5H), 7.41 (dq, J = 14.6, 7.4 Hz, 7H), 
5.38 (d, J = 5.8 Hz, 1H), 4.38 – 4.24 (m, 1H), 3.02 (s, 4H), 2.47 – 2.33 (m, 1H), 2.18 – 
1.95 (m, 2H), 1.93 – 1.83 (m, 1H), 1.80 (s, 3H), 1.75 (s, 3H), 1.68 – 1.56 (m, 2H), 1.09 
(s, 11H).  13C NMR (125 MHz, CDCl3) ! 169.5, 137.8, 136.1, 134.9, 133.8, 129.9, 
129.7, 127.7, 127.6, 121.6, 71.7, 39.9, 36.4, 35.8, 31.6, 28.5, 27.2, 25.4, 22.7, 20.1, 
19.5, 14.2, 13.6. 
 
 
(1S,5S)-5-(ethylamino)-2-methylcyclohex-2-enol (311).  To a flame-dried round-
bottom flask containing acetamide 233a (1.2024 g, 2.95 mmol, 1 equiv) in 1,2-dioxane 
(15 mL) was added LiAlH4 (1.1354 g, 29.5 mmol, 10 equiv) portion-wise and brought 
to a reflux under nitrogen for 17 h.  Once cooled to rt, the solution was brought to 0 °C 
and added H2O (1.2 mL), 20 % NaOH (1.2 mL), and more H2O (3.6 mL).  This was 
filtered, rinsed with EtOH (2 x 20 mL) and CH2Cl2 (2 x 20 mL), and concentrated to 
1.3907 g.  Purification was accomplished by flash chromatography (100% CH2Cl2 to 
85:15:1 CH2Cl2:MeOH:NH4OH) affording 0.260 g (58%) of ethylamine 311 (Rf = 0.16 






(t, J = 4.7 Hz, 1H), 3.14 – 3.02 (m, 1H), 2.84 – 2.53 (m, 3H), 2.38 – 2.20 (m, 1H), 2.15 
– 1.91 (m, 2H), 1.73 (t, J = 2.1 Hz, 4H), 1.15 – 0.99 (m, 3H).  13C NMR (125 MHz, 
CDCl3) ! 137.2, 119.4, 68.6, 51.6, 42.2, 34.3, 33.0, 21.0, 15.4. 
    
 
(1S,5S)-5-(ethyl((Z)-2-iodobut-2-en-1-yl)amino)-2-methylcyclohex-2-enol  (312).  
To a flame-dried round-bottom flask containing ethylamine 311 (0.2807 g, 1.81 mmol, 
1 equiv) in dry THF (9 mL) was added K2CO3 (3.8172 g, 27.1 mmol, 15 equiv) and 
mesylate 111 (1.0901 g, 3.6 mmol, 2 equiv).  After stirring at rt for 2 days, the base was 
removed by filtration and the solution was concentrated.  Purification was 
accomplished by flash chromatography (10:1 hexanes:EtOAc to 100% CH2Cl2 to 
95:5:1 CH2Cl2:MeOH:NH4OH) affording 0.3823 g (63%) of amine 312 (Rf = 0.68 in 
95:5:1 CH2Cl2:MeOH:NH4OH).  1H NMR (500 MHz, CDCl3) ! 5.84 (q, J = 6.4 Hz, 
1H), 5.44 – 5.30 (m, 1H), 4.06 (t, J = 7.2 Hz, 1H), 3.35 – 3.19 (m, 2H), 2.84 (dtd, J = 






(t, J = 7.1 Hz, 3H).  13C NMR (125 MHz, CDCl3) ! 136.9, 122.0, 70.5, 61.9, 54.0, 43.5, 
35.6, 28.8, 21.9, 19.5, 12.7. 
 
 
(S,Z)-5-(ethyl(2-iodobut-2-en-1-yl)amino)-2-methylcyclohex-2-enone (316).  
Manganese(II) dioxide (0.1577 g, 1.8 mmol, 16 equiv) was added to amine 312 (0.0376 
g, 0.11 mmol, 1 equiv) in dry CH2Cl2 (4 mL) and allowed to stir at rt under nitrogen for 
24 h.  The solids were filtered through a Celite plug and concentrated.  Purification was 
accomplished by flash chromatography (10:1 hexanes:EtOAc to 100% EtOAc) 
affording 0.012 g (33%) of ketone 316 (Rf = 0.88 in 2:1 hexanes:EtOAc).  1H NMR 
(500 MHz, CDCl3) ! 6.74 (d, J = 7.3 Hz, 1H), 5.90 (q, J = 6.4 Hz, 1H), 3.39 – 3.26 (m, 
1H), 3.26 – 3.13 (m, 2H), 2.65 – 2.47 (m, 3H), 2.47 – 2.27 (m, 3H), 1.83 – 1.66 (m, 
5H), 1.03 (t, J = 7.1 Hz, 3H).  13C NMR (125 MHz, CDCl3) ! 200.2, 144.6, 135.9, 
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1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate 
HMPA……….…………………………..……………..….…hexamethylphosphoramide 
HOMO…………………………..……………..….…highest occupied molecular orbital 
HWE……….…………………………..……………..……Horner-Wadsworth-Emmons 
IC50…………………………………………………..……inhibitory concentration, 50% 
IR……………………………………………………………...……………….....infrared 
KHMDS………………………………...……………...!potassium hexamethyldisilazide 
LAH……………………………………………………….….lithium aluminum hydride 
LC-MS……………………………………....liquid chromatography-mass spectrometry 
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